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Plants are the most important natural resources. They can serve as energy source 
or provide raw materials for many industrial applications. The plant materials used mostly 
consist of plant cell walls. The cell walls are very rigid and heterogeneous networks of 
biopolymers such as proteins, lignin and most importantly polysaccharides which 
encapsulate every plant cell. These structures account for physical strength and defense 
mechanisms of the plant and play an important role in plant development. Pectins are 
very complex and highly branched cell wall polysaccharides. However, their distribution, 
function and biosynthesis have not yet been fully understood. In order to improve the 
economic usability of the cell wall, a better understanding of the composition, functions 
and biosynthesis of cell wall polysaccharides is essential. Libraries of chemically 
synthesized well-defined oligosaccharides and functionalized glycosyl donors can serve 
as important tools to advance existing experimental methods for investigating structure 
and biosynthesis of plant polysaccharides. 
In chapter 2.1, the automated solid-phase synthesis of 23 arabinogalactan (AG) 
oligosaccharide fragments of pectin side chains is described. Automated glycan assembly 
(AGA) allowed the assembly of a library of structurally related type-I and type-II AGs on a 
linker-functionalized solid support from a set of differently protected galactose, arabinose 
and glucuronic acid monosaccharide building blocks (BBs). The synthetic glycan 
structures obtained were used to assign the exact binding epitopes of cell wall glycan-
directed mAbs using glycan microarrays. Furthermore, the synthetic type-I AGs have 
been used to determine the substrate specificities of three endo-galactanases which are 
cell wall-degrading enzymes that are used to deconstruct pectin polymers for structural 
analysis. A detailed knowledge of the substrate specificities of these cell wall-degrading 
enzymes is required to deduce the composition of the original polysaccharide.  
In chapter 2.2, solid-phase and solution-phase syntheses of apiose-substituted 
α(1,4)-homogalacturonan backbone structures, as found in rhamnoglacturonan-II (RG-II) 
were initiated. A set of three galactose BBs and one apiose BB was applied in AGA. 
However, the automated solid-phase synthesis of the backbone scaffold suffered from 
limited diastereoselective control during the first glycosylation reaction with the linker and 
the low nucleophilicity of the C4-hydroxyl group of galactose. In a solution-phase test 
series the diastereoselectivity during the glycosylation reaction with the linker could be 
improved using a fluorinated linker, but satisfactorily results were not obtained. 
Subsequently, two galacturonic acid lactone BBs were tested in solution-phase to 
assemble a (1,4)-linked galacturonic acid backbone consisting exclusively of α-linkages. 
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However, the galacturonic acid lactone BBs were also not applicable to assemble 
oligogalacturonates beyond disaccharides. 
In chapter 2.3, four differently functionalized UDP-galactopyranoses (UDP-Galp) 
and one functionalized UDP-arabinofuranose (UDP-Araf) were chemically synthesized. 
The azido- or amino-functionalized sugar-nucleotides served as enzyme substrates in first 
proof-of-principle studies towards the development of a new high-throughput assay for the 
characterization of putative plant glycosyltransferases on glycan microarrays. It was 
shown that the tested transferases tolerate these modifications of the glycosyl donor 
substrates. The azido- or amino-functionalized residues were incorporated into acceptor 
oligosaccharides on microarray surfaces by the glycosyltransferases and the enzymatic 
reaction products were subsequently visualized by selective reaction of fluorescent 





Pflanzliche Rohstoffe sind von enormer wirtschaftlicher Bedeutung. Sie sind 
sowohl als Energieträger als auch als Ausgangsstoff vieler industrieller Prozesse. Der 
Großteil dieser Rohstoffe wird aus den Pflanzenzellwänden gewonnen. 
Pflanzenzellwände sind hochkomplexe und sehr stabile Netzwerke aus diversen 
Biopolymeren wie Proteinen, Lignin und Polysacchariden. Die Zellwände tragen sowohl 
zur physikalischen Stabilität als auch zu Abwehrfunktionen der Pflanzenzelle bei und 
spielen zudem eine wichtige Rolle in der Pflanzentwicklung. Pektine sind eine Klasse von 
Polysacchariden in der Pflanzenzellwand und bestehen aus komplexen, hoch 
verzweigten Polysacchariden, deren Vorkommen, Funktion und Biosynthese allerdings 
noch immer nicht vollständig verstanden sind. Um die ökonomische Nutzbarkeit dieses 
Zellwandmaterials zu verbessern, ist ein vertieftes Verständnis der Zusammensetzung 
und der Funktion von Zellwandpolysacchariden wesentlich. Bibliotheken synthetischer, 
strukturell definierter Oligosaccharide und funktionalisierter Glycosyldonoren können 
wertvolle Werkzeuge sein, um die experimentellen Methoden zur Untersuchung der 
Struktur und Biosynthese von pflanzlichen Polysacchariden zu verbessern.  
In Kapitel 2.1 wird die automatisierte Festphasensynthese von 23 
Arabinogalactan-Oligosacchariden, die als verzweigende Seitenketten in Pektinen 
vorkommen, beschrieben. Mit der automatisierten Festphasensynthese konnte eine 
Bibliothek von strukturell verwandten Typ-I und Typ-II Arabinogalactanen an einem 
Linker-funktionalisiertem Harz mit Hilfe verschiedener Galactose-, Arabinose- und 
Glucuronsäure-Monosaccharid-Bausteine hergestellt werden. Die erhaltenen 
synthetischen Glykane wurden anschließend benutzt, um die exakten Bindungsepitope 
monoklonaler Antikörper, die Zellwandstrukturen binden, mit Hilfe von Glykan Microarrays 
zu bestimmen. Außerdem wurden die synthetischen Typ-I Arabinogalactane benutzt, um 
die Substratspezifitäten von drei endo-Galactanasen, die Pektine in Zellwänden 
zersetzen, zu bestimmen. Die Bestimmung der Enzymsubstratspezifitäten von Pektin-
zersetzenden Enzymen ermöglicht es, über Verdauungsexperimente genauere Aussagen 
über die Struktur der Polysaccharide zu machen.  
In Kapitel 2.2 werden sowohl Festphasensynthesen als auch Synthesen in Lösung 
von Apiose-substituierten α(1,4)-Homogalacturonan-Strukturen, die in pektinischem 
Rhamnoglacturonan-II vorkommen, untersucht. Für die automatisierte 
Festphasensynthese wurden drei Galactose und ein Apiose Baustein entwickelt. 
Während der Glykosylierung des Festphasen-Linkers mit dem ersten Galactose-Baustein 
wurde eine unzureichende Diastereoselektivität beobachtet. Die geringe Nucleophilie der 
Galactose C4-Hydroxygruppen führte zusätzlich zu niedrigen Ausbeuten in der 
XIV 
 
Festphasensynthese von Apiose substituierten α(1,4)-Homogalacturonanen. In Lösung 
konnte die Diastereoselektivität der ersten Glycosylierung mit Hilfe eines fluorierten 
Linkers verbessert werden. Es wurden desweiteren mehrere Galacturonsäurelacton-
basierte Monosaccharid-Bausteine in Lösung als alternative α(1-4)-selektive 
Glycosyldonoren getestet. Dabei stellte sich heraus, dass auch diese Bausteine zu 
unreaktiv sind, um größere Oligogalacturonan Strukturen zu synthetisieren. 
In Kapitel 2.3 wird die chemische Synthese von vier funktionalisierten UDP-
Galactopyranosen (UDP-Galp) als auch die Synthese von funktionalisierter UDP-
Arabinofuranose (UDP-Araf) beschrieben. Die Azid- oder Amin-funktionalisierten Zucker-
Nukleotide dienten als Enzymsubstrate in vorläufigen Studien zur Entwicklung neuer 
Hochdurchsatzmethoden für die Charakterisierung von Glycosyltransferasen auf Glykan-
Microarrays. Es konnte gezeigt werden, dass die untersuchten Glycosyltransferasen die 
Modifizierung der Glycosyldonorsubstrate tolerieren. Die Azid- oder Amin-
funktionalisierten Bausteine wurden von den getesteten Transferasen auf 
Oligosaccharidakzeptoren auf der Microarrayoberfläche übertragen und die 
enzymatischen Reaktionsprodukte konnten auf der Oberfläche durch selektive Reaktion 
der eingeführten Azid- oder Amingruppen mit Fluoreszenzfarbstoffen visualisiert werden.  
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1.1  Biomass as Resource 
The global energy consumption is constantly growing on average at 2% per year 
due to population- and economic growth.1 Atmospheric carbon dioxide levels, the major 
cause of global warming, are rising accordingly.2 Nowadays huge efforts are made to 
establish alternative, renewable energy sources that have a lower environmental impact. 
In 2016, the world energy council estimated the contribution of renewable energies to the 
global energy consumption at 18% in which the energy derived from biological raw 
materials (biomass) accounted approximately 14%.3 A big part of the biomass used, is 
transformed into biofuels which are one option for reducing the carbon emissions in the 
transport sector. Biofuels are defined as 1st-, 2nd- and 3rd-generation biofuels. Until today 
1st-generation biofuels which are produced from food crops with high content of starch or 
oil contribute the major part to biofuel production. As the production of 1st-generation 
biofuels directly competes for land and water needed for food production, current 
research efforts focus on the further development of 2nd- and 3rd-generation biofuels. 2nd-
Generation biofuels are produced from non-food biomass by utilization of cellulose, 
hemicellulose and lignin (lignocellulosic biomass).4 3rd-Generation biofuels are derived 
from algae. Energy crops grown for the production of 2nd-generation biofuels include for 
example simple plants such as switchgrass which tolerate cold temperature, have low 
water and nutrition requirements and can grow on a broad range of land types not suited 
for food production.5  
 
Figure 1: Conversion pathway from lignocellulosic biomass to second generation 
biofuels. 
Exploitation of lignocellulosic biomass is hampered by some technical and economic 
challenges. To make the desired polysaccharides available, recalcitrance caused by lignin 
has to be overcome before the polysaccharides can be hydrolyzed. Hydrolysis is 





enzymatic hydrolysis which is highly favorable over acidic hydrolysis due to higher yields, 
higher selectivity, less environmental impact and production of less or no by-products.6 
After the hydrolysis, the monomeric sugars are subjected to fermentation processes, 
yielding bioethanol which can be used as biofuel (fig. 1). Enzyme costs are a major 
drawback7 of the utilization of lignocellulose polysaccharides and lowering the costs by 
improved biomass processing is required. Facilitation of biomass processing could be 
achieved by alteration of the lignocellulose composition in bioenergy plants8 or by 
exploration of existing plants with higher amounts of easily accessible and digestible 
polysaccharides9. In order to do so the structure and biosynthesis of plant cell wall 
polysaccharides have to be understood in detail.  
 
1.2  The Plant Cell Wall  
1.2.1  Form and Function 
On top of the cell membrane plant cells are coated with a cell wall that provides 
protection and mechanical support to the plant cell.10 The cell wall is formed by a highly 
complex network of biopolymers that also plays an important role in the intercellular 
communication and the plant’s defense responses against potential pathogens.11 Despite 
the high variability in the cell wall composition of different plant species and cell types, cell 
wall structures can be categorized into primary and secondary cell walls. The primary cell 
wall is primarily found on growing cells and is a flexible network of polysaccharides 
capable of expansion. The secondary cell wall on the other hand is a rigid structure which 
also contains the phenolic polymer lignin and is found on cells that have ceased growth.12  
 
Figure 2: Schematic representation of a plant cell. Cellulose microfibrils , 
represented as thick rods, are embedded into a matrix of hemicellulose and pectin 







Polysaccharides found in plant cell walls include cellulose, hemicellulose and pectin (fig. 
2). Each class of cell wall polysaccharides has characteristic structural features that lead 
to different mechanical properties and functions of the polysaccharides.  
 
1.2.2  Cellulose 
Cellulose is the major component of the plant cell wall and therefore a highly 
abundant material on earth, with a wide range of traditional applications, e.g. as cotton in 
textile industry, pulp material in paper products or as additive in cosmetics.14 In recent 
years cellulose has also gained attention as a raw material for the production of more 
advanced materials like cellulose nanomaterials.15 Cellulose forms a network structure on 
the outside of the plasmamembrane of plant cells and thereby provides mechanical 
strength to plants that allows them to grow as tall as 100 m. The rigid network of cellulose 
in the plant cell wall is build up from water-insoluble string-like highly ordered crystalline 
microfibrils which consist of approximately 36 linear β(1,4)-linked D-glucopyranose chains 
(fig. 3).16 Each chain can contain up to 25,000 glucose units organized in a pattern of 
cellobiose basic repeating units, accounting for a twofold screw-axis symmetry.17 Intra-
molecular hydrogen bonds between the C3-hydroxyl group and the ring oxygen of the 
adjacent glucose unit fixate this spatial orientation of the cellobiose units (fig. 3). This high 
symmetry of the glucan chains allows the single polymeric molecule to align with other 
β(1,4)-glucan chains through intermolecular hydrogen bonds, thereby forming very rigid 
microfibrils.  
 
Figure 3: Schematic depiction of cellulose. Aggregates of microfibrils form a string-
like network. Each microfibril consists of several β(1,4)-glucan polymers that are 





1.2.3  Hemicellulose 
In contrast to cellulose, hemicelluloses cover a much more heterogeneous class of 
polysaccharides. Hemicelluloses are non-crystalline cell wall polysaccharides that have 
β(1,4)-linked backbones of D-pyranose moieties, mainly glucose, xylose and mannose.18 
The major classes of hemicelluloses are xyloglucans, mannans and xylans (fig. 4). 
Xyloglucans are ubiquitous plant polysaccharides that consist of a β(1,4)-D-glucan 
backbone decorated with α(1,6)-linked xylose substituents that can be further elongated 
with other glycosyl or nonglycosyl residues.19 Mannans are polysaccharides composed of 
a β(1,4)-D-mannose backbone substituted with α(1,6)-galactose monosaccharides. They 
are found in all cell walls but the molar ration of mannose to galactose varies with plant 
species between 1:1 to 4:1.20 Xylan polysaccharides of land plants are composed of a 
β(1,4)-D-xylose backbone that, depending on the plant species, are highly decorated with 
various monosaccharide moieties.21 Depending on the type of substituents, xylans can be 
subdivided into homoxylan, arabinoxylan, glucuronoxylan and arabinoglucuronoxylan. A 
forth class of important hemicelluloses are mixed-linkage glucans. Mixed-linkage glucans 
are only prevalent in grasses and cereals22 and therefore often not considered as a major 
hemicellulose. The structure of mixed-linkage glucans is similar to cellulose, as it is build 
up from unbranched, linear β(1,4)-linked glucose residues, but have an alternative linkage 
(β(1,3)-linkage) before every third or fourth glucose residue.23,24  
 
Figure 4: Classes of hemicellulosic polysaccharides and schematic representation 
of their structures. 
Hemicelluloses are generally considered to be tethering glycans that bind to 
cellulose microfibrils through non-covalent interactions and thereby play an important role 
in cell wall growth and stability.25 Recently, it has also been shown that hemicellulosic 
mannan structures form covalent linkages to lignin and thereby “glue” the polysaccharide 
component of the secondary cell wall to the lignin matrix.26 Additionally, hemicelluloses 
are considered to act as signaling molecules, as it has for example been shown that 





1.2.4  Pectin 
Pectin polysaccharides are very complex and heterogeneous matrix polymers, 
mainly found in the primary cell wall of all land plants, and are almost absent in the 
secondary cell wall.28 Primary cell wall polysaccharides consist of approximately 35% 
pectin in dry weight.29 From the primary cell wall the pectin structures are easily extracted 
using acidified hot water. Due to their high solubility in aqueous solutions, pectin 
polysaccharides are long known and are broadly used in food production as gelling, 
stabilizing or thickening agents.30 In the plant cell walls, pectin structures fulfill a variety of 
tasks. Pectins are involved in intercellular adhesion, control the porosity of the cell wall on 
a growing plant cell, activate plant defense responses and provide a gel-like matrix for the 
deposition of cellulose microfibrils.31 As part of the daily human diet, pectins also fulfill a 
nutritional function and many studies have shown beneficial health effects of pectin 
polysaccharides due to their prebiotic character in the intestine.32,33 To fully understand 
the functions of pectin in plant growth and development and to verify the beneficial health 
effects of nutritional pectins, the chemical structure of pectin has been investigated 
intensively. Though the composition of pectin polysaccharides varies with the source, 
generally five polysaccharides domains are found in pectin polysaccharides: The major 
domain, homogalacturonan (HG), that comprises 60-70% of the pectin structure, 
rhamnogalacturonan I (RG-I) that makes up 20-35% of pectin, rhamnoglacturonan II (RG-
II) that can represent up to 10% of pectin and the less abundant apiogalacturonan and 
xylogalacturonan. It is believed that these pectin domains are covalently linked via their 
backbones. However, the exact structure and connectivity is still under debate.34 
1.2.4.1 Homogalacturonan 
Homogalacturonan (HG) makes up the smooth region of pectin as it is a linear 
homopolymer of α(1,4)-linked galacturonic acids that can be partially methylesterified at 
the C6 carboxylic acid or O-acetylated at the C2- or C3-position.35 HG domains in pectin 
polysaccharides contain 80-120 galacturonic acid residues.36 The extend of 
methylesterification is highly regulated by the cell and plays an important role in plant 
development.37 The gelating properties of HG can be controlled by the degree of 
methylesterification. Unmethylated C6 carboxylic acids are negatively charged and HG 
regions with more than ten free carboxylic acids in line can coordinate to Ca2+ ions which 
may allow the coordination of a second HG molecule.38 The Ca2+-induced dimerization 





1.2.4.2 Rhamnogalacturonan I 
Rhamnogalacturonan-I (RG-I) is usually extracted together with HG, but is a much 
more complex, branched pectin domain. The backbone of RG-I has the disaccharide 
repeating unit α(1,4)-D-galacturonic acid-α(1,2)-L-rhamnopyranose.37 Depending on the 
plant source, this backbone can be highly branched at the C4-position of the rhamnose 
residues with neutral arabinan, galactan or arabinogalactan side chains. These side-
chains can be very heterogeneous in structure and composition. Arabinan structures from 
RG-I are often found to be α(1,5)-linked with terminal α(1,3)-linked arabinose or galactose 
residues. The galactan side chains usually contain β-(1,4)-linked galactose residues, with 
a length of up to 43-47 residues.39 Even more complex are arabinogalactan (AG) side 
chains which include type-I AGs and type-II AGs. Type-I AGs are the most prevalent side-
chain structures found in RG-I polymers. The precise composition of type-I AG side 
chains differs between plant species and tissues, but many general structural elements 
are conserved. All type-I AGs are composed of a Gal-β(1,4)-Gal backbone that may be 
substituted with α(1,3)-linked single arabinofuranoses, short α(1,3)- or α(1,5)-linked 
arabinan oligosaccharides, or with β(1,6)-linked galactose residues (fig. 5).34 Type-II AGs 
are build up by β(1,3)-linked galactan backbones that are highly decorated with β(1,6)-
galactan chains that might be further substituted with α(1,3)-L-arabinofuranoses.13,29,37 
Type-II AGs are not only found as side-chains in RG-I, but are also associated with 
arabinogalactan-proteins (AGPs) which consist of AG polysaccharides attached to a 
hydoxyproline-rich peptide backbone. AGPs often co-extract with pectin structures. Direct 
proof of their functions in the plant cell wall remains elusive.40 The type-II AGs can also be 
further modified by the attachment of single glucuronic acid residues at the non-reducing 
ends of the β(1-6)- or the β(1,3)-galactan chains.41 The described complexity and diversity 
of RG-I polysaccharides clearly implies important biological functions. However, a detailed 






Figure 5. Schematic representation of RG-I polysaccharides. A) RG-I backbone 
substituted with different side-chain polysaccharides at the C4-position of certain 
rhamnose residues. B) Type-I AG consists of a β(1,4)-galactan backbone decorated 
with various galactose and arabinose substitutions. C) Type-II AG consists of a 
β(1,3)- linked galactan backbone highly branched with side-chains consisting of 
β(1,6)- linked galactans that may be further substituted with α(1,3)- linked arabinose 
residues. 
1.2.4.3 Rhamnogalacturonan II  
Among the four major domains that constitute the pectin polymers, 
rhamnogalacturonan-II is the structurally most complex polysaccharide. It comprises 13 
different monosaccharide sugars in 21 different glycosidic linkages, among them the rare 
monosaccharides apiose, aceric acid, Kdo and Dha.42 Structural elucidation of RG-II has 
made vast progress in the last 20 years and has led to constant refinements. RG-II has a 
HG backbone carrying six distinct side chains. Side chains A and B are octa- and 
heptasaccharides respectively, with a D-apiose residue β(1,2)-linked to the backbone as 
the first monosaccharide unit. Side chains C and D are disaccharides linked to the C2-
position of a backbone galacturonic acid residue. Side chains E and F are L-
arabinofuranose monosaccharides α(1,3)-linked to the HG backbone. The RG-II structure 
is remarkably preserved in higher plant species,43 and often only minor modifications are 
found in the side-chains,44 suggesting an important role of RG-II in plant development. It 





ester between the apiosyl residues of the side chain A of neighboring moleculs, 
organizing the pectin structure and influencing plant growth (fig. 6)45.  
 
Figure 6: Structure of RG-II. Oligosaccharide side chains A-F are connected to a 
homogalacturonan backbone (distances between side chains are not representative).  




1.2.5  Biosynthesis of Plant Cell Wall Glycans 
Plant cells deposit large amounts of differentiated polysaccharides in the cell wall 
during plant growth and development. In the course of building up the cell wall structures, 
a plant cell can modify the composition of the polysaccharides with regard to the required 
properties of the cell wall structures by the enhanced production of certain 
polysaccharides. For the assembly of this variety of polysaccharides in the plant cell wall, 
a complicated biological machinery is needed and it is obvious that the investigation of 
cell wall biosynthesis is of major interest in order to advance the basic understanding of 
plant development and to optimize cell wall utilization. Plenty genes encoding 
glycosyltransferases, which transfer an activated sugar to an acceptor substrate, have 
been identified by genetic studies. The gene products (glycosyltransferases) are mainly 
characterized by the description of phenotypical changes of transgenic knock-out plants 







Figure 7: Schematic representation of primary cell wall  synthesis. Cellulose is 
synthesized by large cellulose synthase complexes on the plasma membrane. 
Hemicellulose and pectin are synthesized in the Golgi apparatus and transported to 
the wall surface in vesicles . Adapted from Cosgrove.
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Today the biosynthesis of the major cell wall component cellulose is relatively well 
understood. Cellulose is synthesized at the plasma membrane by membrane-integrated 
cellulose synthase complexes and the nascent cellulose microfibrils are directly secreted 
into the cell wall (fig. 7). The microfibrils are assembled at rosette-like structures 
consisting of six hexagonally arranged subunits which itself consist of multiple cellulose 
synthase proteins (CESA). Each CESA is a glycosyltransferase (GT) and synthesizes 
linear β(1,4)-glucan chains from cytosolic UDP-activated glucose. During the synthesis of 
the β(1,4)-glucan chains the activated glucose monosaccharides are attached to the C4-
hydroxyl group at the non-reducing end of the growing polymer which remains attached to 
the synthase. Despite the good understanding of the cellulose polymerization process, the 
initiation of cellulose synthesis is still under debate and has to be further investigated.47,48 
In contrast to cellulose, the cell wall matrix polysaccharides (hemicellulose and pectin) are 
synthesized from activated monosaccharide donors (sugar nucleotides) exclusively in the 
Golgi apparatus and only then transported to the cell surface in Golgi-derived vesicles 
(fig. 7).49 The assembly of complex branched hemicelluloses or pectins in the Golgi-
apparatus involves a set of glycosyltransferases, sugar-nucleotide transporters and 
sugar-nucleotide-interconversion enzymes that have to act concertedly.  
The β(1,4)-backbone structures of hemicellulosic xyloglucans, mannans and mixed-linked 
glucans are synthesized by glycosyltransferases from the cellulose synthase like family 
(CAZy family: GT2).50 Xylan backbones are believed to be synthesized by GTs from other 
GT families which have only partly been described. Some enzymes responsible for the 





more remain unknown. The mechanisms controlling the patterning of side chain 
substitutions of xyloglucans, mannans and xylans have not yet been elucidated. 
The synthesis of pectin polysaccharides in the Golgi-apparatus requires a large number of 
GTs due to their complex structure. It is hypothesized that at least 67 different 
transferases are needed.34 Until today only few of these transferases have been identified 
and even fewer have been characterized regarding their substrate specificity in vitro 
through heterologous expression.51 Moreover, it is not yet understood if pectin 
polysaccharides are synthesized in a consecutive way by successive additions of sugar 
monosaccharides to the non-reducing end of the growing polymer or if pectin subdomains 
are synthesized individually first before they are stitched together. 
The backbone structure of homogalacturonan is synthesized by galacturonosyltransferase 
complexes that transfer D-GalA residues in an α(1,4)-linkage from UDP-D-GalA onto the 
non-reducing end of HG acceptors.52,53 The biosynthesis of rhamnogalacturonan-I 
backbones requires a galacturonosyltransferase and a rhamnosyltransferase, but none of 
the involved enzymes have been identified yet.51 So far, only few transferases involved in 
the synthesis of RG-I arabinan54,55 or galactan56 side chains have been identified and 
mechanistically characterized by in vitro incubation of the enzymes with acceptor 
substrates and analysis of the enzymatic reaction products. The biosynthesis of RG-II 
requires at least 21 glycosyltransferases, assuming that one enzyme can form one 
glycosidic linkage.57 Hitherto, little progress by forward or reverse genetics has been 
made in identifying the actual glycosyltransferases involved. Due to redundancy or 
lethality of mutations in transgenic knock-out plants, phenotypical changes of the mutated 
plants could not be investigated.58 
To further answer the questions why plants developed such complex pectin structures 
and how modifications of these structures may influence plant development, a more 
detailed understanding of pectin biosynthesis is urgently required. Research towards 
understanding the biosynthesis of RG-I or RG-II is hampered by a lack of corresponding 
well-defined RG-II oligosaccharide fragments and of suited assays to characterize a large 
number of putative glycosyltransferases. Access to comprehensive libraries of pectin 
oligosaccharides and the development of novel high-throughput assays to screen 
glycosyltransferases would strongly accelerate research towards a better understanding 






1.2.6  Plant Cell Wall Analysis 
1.2.6.1 Plant Cell Wall Monosaccharide Composition Analysis 
To be able to obtain detailed information on structures of plant cell wall 
polysaccharides, such as the ones described above, the monosaccharide composition 
and the linkage-types can be investigated. Typically, the monosaccharide composition of 
cell wall polysaccharides is analyzed by gas chromatography-mass spectrometry (GC-
MS) based methods.59 Therefore, the polysaccharides are extracted from the plant 
material, hydrolyzed under acidic conditions and the resulting monosaccharides are 
derivatized into aldol acetates after “hydride”-mediated reduction.60 Formation of the 
acetylated alditols facilitates the separation of the acid hydrolyzates of polysaccharides by 
gas chromatography, and the monosaccharides can be analyzed by their retention time 
relative to internal standards. However, identification of peracetylated alditol acetate 
derivatives does not allow for drawing any conclusions on the structure of the parent 
polysaccharide as no information about the linkage types are generated. Information 
about the linkage types can be obtained by a methylation analysis. In a methylation 
analysis, hydroxyl groups not involved in glycosidic linkages in the parent polysaccharide 
are methylated before hydrolysis of the polysaccharide. Methylation of the 
polysaccharides is achieved by reaction with methyl iodide61. After hydrolysis of the 
polysaccharide the partially methyl protected monosaccharides are reduced and 
derivatized to the partially methylated alditol acetates in which only the positions that were 
involved in glycosidic linkages carry an acetyl moiety.59 The partially methylated alditol 
acetates are subsequently separated by GC and the peaks are analyzed by MS. 
Unfortunately, information about the anomeric configuration of the monosaccharides is 
lost during derivatization and has to be analyzed by other means such as NMR 
spectroscopy of intact polysaccharides or oligosaccharide fragments thereof.62  
 
1.2.6.2 Plant Cell Wall Glycan-Directed Monoclonal Antibodies 
The cell wall polysaccharides form a very complex network structure that differs 
between plant species and tissues with regard to cell biological events by the deposition 
of different types of polysaccharides. In muro localization of specific polymers in the plant 
tissue is necessary to investigate the contribution of individual polysaccharides to cell wall 





visualize polymer deposition in plant tissues and to trace polysaccharide modifications 
during cell wall differentiation (fig. 8).63 For the detection of specific substructures 
(epitopes) of the polymers, plant cell wall glycan-directed monoclonal antibodies (mAbs) 
have emerged as most powerful tool.64 After the mAbs bind to specific epitopes in the cell 
wall, they can be detected with labeled secondary antibodies which are visualized by light 
or electron microscopy.65 Nowadays, a set of more than 180 plant cell wall glycan-directed 
mAbs66 has been generated by hybridoma techniques.67  
 
Figure 8: In muro analysis of cell wall glycans using mAbs in f luorescence 
microscopy experiments. A) Immunofluorescence of the type-I AG directed mAb 
LM26 binding to isolated cells in a transverse section of sugar beet storage root. B) 
Same section with overlaid bright f ield image.
68
 (White arrows indicate 
immunolabeled cells, yellow arrows indicate specialized cells next to the labeled 
cells) 
The available mAbs are routinely used to identify polysaccharides in plant tissues, but the 
information gained is often limited as the exact binding epitopes of the antibodies mostly 
remain unknown. Commonly, mAbs are generated by a hybridoma technique, where 
myeloma cells are fused with spleen cells from a mouse which was immunized with 
extracted oligo- or polysaccharides beforehands.67 Usually, the generated mAbs are 
purified and probed with either extracted polysaccharides or purified monosaccharides to 
determine their binding specificities in enzyme-linked immunosorbent assays (ELISA)66 or 
in carbohydrate microarrays69. However, extracted polysaccharides contain many 
possible binding epitopes, hence determination of the exact binding epitope of the mAb is 
not possible. And isolated oligosaccharides may contain impurities of unknown glycans, 
even after extensive purification, and thereby may create false positive results. An 
alternative approach using synthetic oligosaccharides enables the determination of the 
exact binding epitopes and circumvents issues with impurities. Microarrays equipped with 
synthetic oligosaccharides have been shown to be versatile tools to identify protein-glycan 
interactions.70 Synthetic glycans can be immobilized on microarray surfaces in very small 
quantities by different covalent or non-covalent methods.71 Incubation of the immobilized 





labelled secondary antibody then enables the characterization of the mAb with regard to 





















































Figure 9: Schematic representation of a carbohydrate microarray assay for 
determining the binding specif icity of an antibody. Oligosaccharides are covalently 
l inked to a microarray surface and probed with mAbs. Antibodies that bind to specif ic 
structures are subsequently labeled with a secondary antibody carry ing a fluorescent 
label. 
 
1.2.6.3 Enzymatic Cell Wall Degradation 
Knowledge about the occurrence and structure of plant cell wall polysaccharides is 
important for their application as raw material, e.g. in biofuel production. The 
monosaccharide composition of cell wall extracted polysaccharides can be analyzed as 
described in chapter 1.2.5.1 and polysaccharide motifs can be localized using 
immunohistochemical methods (chapter 1.2.5.2). However, degradation of extracted 
polysaccharides into smaller oligosaccharides which can be further analyzed e.g. by NMR 
spectroscopy72 is a commonly applied73-76 alternative analytical method that allows a rapid 
analysis of cell wall composition. The polysaccharides can be depolymerized by 
physicochemical or enzymatic methods in which enzymatic degradation is highly 
favorable due to higher selectivity under milder conditions.77 Glycosyl hydrolases (GHs), 
capable of hydrolyzing polysaccharides, are classified into 153 families depending on 
their amino acid sequence.78 Among them, a wide range of pectin degrading enzymes is 
found which are further categorized into two groups. The first group acts on the HG 
backbone while the second group acts on the highly branched RG regions of pectin, 
releasing shorter fragments of the side chains.77 While pectin-modifying enzymes of the 
first group are routinely applied in the food industry, publications on the second group are 
very limited due to the limited access to well-defined substrates for biochemical 
characterization of the enzymes.79 Availability of libraries of well-defined pectin-related 
oligosaccharides would therefore be of great value to characterize pectin-degrading 
enzymes. Only if the substrate specificities of these enzymes are known the detailed 





1.3  Synthetic Glycans  
The chemical synthesis of plant-derived oligosaccharides offers a great opportunity 
to obtain well-defined model compounds as analytical tools. Well-defined and pure 
synthetic oligosaccharides can facilitate the characterization of the substrate specificities 
of plant cell wall glycan-directed mAbs, glycosyl hydrolases and glycosyltransferases. 
Although vast progress in the production of oligosaccharides as probes for biological 
research or as lead compounds for drug and vaccine discovery has been made in the last 
decades,80 the chemical synthesis of oligosaccharides remains challenging. The synthesis 
of complex branched carbohydrate structures requires sophisticated protecting group 
strategies to enable differentiation of the reactive sites, and elaborated reaction conditions 
to maintain stereocontrol during the glycosylation reactions. However, current examples 
of syntheses of large carbohydrate structures such as the biggest synthetic glycan to 
date, consisting of 92 monosaccharide units81, show the potential of chemical glycan 
synthesis. 
 
1.3.1  The Glycosylation Reaction 
The fundamental reaction in carbohydrate chemistry is the glycosylation reaction 
in which a hemiacetal glycosyl donor is reacted with a glycosyl acceptor in the presence 
of a promotor to form a glycosidic linkage. 130 years ago, Fischer reported the 
glycosylation reaction of an unprotected monosaccharide with various alcohols using 
hydrochloric acid as the promotor.82 Nowadays, many variations of this basic reaction 
principle are applied in carbohydrate synthesis. Typically, the monosaccharide glycosyl 
donor is activated through the installation of an anomeric leaving group which reacts with 
an electrophilic promotor to yield a reactive intermediate that can further react with a 
nucleophilc acceptor (scheme 1). The most commonly used glycosyl donors are glycosyl 
halides83, glycosyl imidates84, thioglycosides85 and glycosyl phosphates,86 but many more 
have been described.87  
 





The common mechanistic depiction of the glycosylation reaction (scheme 1) describes the 
reaction mechanism of the glycosylation reaction as an SN1 mechanism, with the 
formation of an oxocarbenium ion as the rate determining step.88 The reactive 
oxocarbenium ion is attacked by a nucleophilic acceptor to form a glycosidic bond. The 
reaction of the nucleophile with the oxocarbenium ion leads to the formation of a 1,2-cis- 
or a 1,2-trans isomer and often gives mixtures of both isomers. Despite the progress 
being made in the field of glycan synthesis, controlling the stereoselectivity during the 
glycosylation reaction remains a major challenge, as many factors which have not yet 
been fully understood influence the reactivity of the glycosyl donor and acceptor and the 
stereoselectivity in the glycosidic bond formation.88 Often, the stereoselectivity is 
controlled through participating protecting groups at the C2-position of a glycosyl donor or 
at more remote positions. Typically, 1,2-trans isomers are obtained selectively when the 
carbonyl group of a participating ester protecting group at the C2-position can attack the 
oxocarbenium ion to form an acyloxonium ion. The cyclic acyloxonium ion shields one of 
the diastereotropic faces, allowing the nucleophilic attack only to occur from the opposite 
face (scheme 2). Remote protecting groups located at the “upper” side can also be used 
to exploit anchimeric assistance from the other diastereotropic side of the oxocarbenium 
ion, leading to the selective formation of 1,2-cis glycosidic linkages (scheme 2).89,90  
 
Scheme 2: Basic mechanisms of glycosylation reactions with anchimeric assistance 
of participating protecting groups at C2- or C4-posit ion of the glycosyl donor.  
Further, the stereoselectivity in a glycosylation reaction can be controlled by the reaction 
temperature, as the anomeric effect91 favors the formation of the axially linked product in a 
thermodynamically controlled reaction, whereas formation of the equatorially linked 
product is kinetically favored. In addition, solvent effects can have a significant impact on 
the stereoselectivity of a glycosylation reaction. Using acetonitrile as the solvent for the 
glycosylation reaction enhances the formation of the equatorially linked product due to an 
axial coordination of acetonitrile to the anomeric carbon of the oxocarbenium ion. In 
contrast, the usage of ether solvents can enhance the formation of the axially linked 





oxocarbenium ion. However, the solvent effect is still not fully understood and the exact 
mechanisms remain to be clarified.92 In summary, each glycosylation is a unique reaction 
that has to be carefully designed to avoid common side reactions such as hydrolysis of 
the glycosyl donor, eliminations of the leaving group, orthoester-formation or aglycon 
transfer (transfer of non-glycosyl residues such as released leaving groups to the 
oxocarbeniumion) and to provide high stereoselectivity.93 
 
1.3.2  Synthesis of Plant Glycans 
The chemical synthesis of plant glycans can provide essential molecular tools for 
studying plant cell wall structure and function. However, the chemical synthesis of these 
glycans has only received limited attention in comparison to the synthesis of mammalian 
or bacterial glycans.94 Due to the high complexity of plant glycan structures, the reported 
syntheses focus on the assembly of shorter oligosaccharide fragments of the 
polysaccharide structures. A comprehensive overview over plant glycans synthesized so 
far has been given by Kinnaert et al. recently.95 The majority of the reported syntheses 
relied on cumbersome series of solution-phase glycosylation-, deprotection- and 
purification steps, employing protected monosaccharide or disaccharide glycosyl donors. 
It is evident that a systematic synthetic approach to comprehensive libraries of closely 
related fragments of cell wall glycans would have an important impact on the investigation 
of plant cell wall structure and function. 
 
1.3.3  Automated Glycan Assembly 
Chemical syntheses of highly repetitive natural macromolecules such as 
peptides96 and oligonucelotides97 are nowadays routinely performed on solid-phase in an 
automated fashion. The assembly of structurally complex molecules on a solid support 
has many advantages over the assembly in solution-phase. Linking the growing molecule 
to a solid support allows the application of high excesses of reagents and simplifies the 
purification of intermediates or final products, as reagents can easily be washed off the 
solid-phase. The automated solid-phase synthesis of oligosaccharides (automated glycan 
assembly / AGA) has been introduced in 200198 and is not yet as routinely used as 
automated peptide- or oligonucleotide synthesis. In contrast to the synthesis of peptides 
or oligonucleotides, the synthesis of oligosaccharides requires a more sophisticated 
protecting group strategy as well as very elaborate activation and deprotection 





resin, which is equipped with a cleavable linker that has to be inert to all reaction 
conditions applied during the automated synthesis. After attachment of the first 
monosaccharide to the linker through a glycosylation reaction, a temporary protecting 
group of the monosaccharide is removed selectively, providing a free hydroxyl group 
which can then act as a glycosyl acceptor. Subsequently, cycles of alternating 
glycosylation and deprotection reactions are applied until the desired oligosaccharide is 
assembled (scheme 3). Acetyl capping can be applied after each glycosylation step to 
block all unreacted nucleophiles, minimizing the accumulation of deletion sequences.102 In 
the end, the oligosaccharide is cleaved from the solid support and the permanent 
protecting groups are removed by methanolysis and hydrogenolysis.  
 
Scheme 3: Schematic representation of an automated glycan assembly procedure.  
To ensure a successful synthesis of the oligosaccharide structures, the monosaccharide 
building blocks (BBs) used must be carefully designed. Permanent protecting groups 
(PGs) mask all hydroxyl groups that are not manipulated during the oligosaccharide 
synthesis. Temporary PGs can be selectively cleaved off on the solid support and allow 
elongation of the structure at specific positions. Commonly, benzyl ethers (Bn), benzoyl 
esters (Bz), azides and trichloroacetyl (TCA) groups are used as permanent PGs.101 
Fluorenylmethoxycarboyl (Fmoc)101, levulinoyl (Lev)101, (2-methyl)naphthyl (Nap)103 and 2-
(azidomethyl)benzoyl (Azmb)104 routinely serve as orthogonal temporary PGs.  
To show how AGA can be applied to obtain complex biological carbohydrate probes for 
example for vaccine development, the automated solid-phase synthesis of the tumor 
vaccine candidate Globo-H105 is exemplary shown in scheme 4. The reported synthesis of 
Globo-H105 demonstrated how complex glycan probes containing multiple 1,2-trans and 
1,2-cis linkages can be assembled automatically. Six BBs equipped with phosphate or 
imidate leaving groups were applied. Five of the employed BBs contained the temporary 





activation of the glycosyl donors. The oligosaccharide was assembled in an automated 
fashion by iterative glycosylation and deprotection steps on a solid support equipped with 
octenediol linker 1, which was cleaved by olefin cross-metathesis, giving a pentenyl linker 
functionalized oligosaccharide. BBs with a participating PG (pivaloyl (Piv), TCA or Fmoc) 
in the C2-position enabled the stereoselective installation of 1,2-trans glycosidic linkages. 
The installation of the required 1,2-cis galactosidic linkage between the third (3) and the 
second BB (4) was achieved by using a BB without participating PG in the C2-position 
and activation of the BB at low temperature (-50 °C) in the presence of the α-directing 
solvent diethylether. Stereoselctive installation of the fucosyl BB (7) was supported by 
remote participation of Piv-ester groups. Once the hexasaccharide was assembled, the 
fully protected oligosaccharide 8 was cleaved from the solid support and isolated in 30% 
yield after column chromatography. Subsequently, the permanent PGs were removed 
using birch conditions. 
 







In the Max Planck Institute of Colloids and Interfaces (MPIKG) several fully automated 
oligosaccharide synthesizers106 are available. Centerpiece of the synthesizers is a 
reaction vessel in which the linker-functionalized solid support (resin) is placed on top of a 
filter. Solvents are supplied from a solvent cabinet to the reaction vessel by applying 
argon pressure. The temperature inside the reaction vessel is controlled by a thermostat 
and can be regulated from -50° C to +50° C. Activator-, deprotection- and building block-
solutions are delivered to the reaction vessel in high precision via syringe pumps. Mixing 
of the reaction mixture is ensured by bubbling argon through the vessel (fig. 10). After 
each step, excess reagents are drained through the filter by argon overpressure and the 
resin is washed with different solvents. 
 
Figure 10: Schematic representation of the modules of an automated 
oligosaccharide synthesizer.  
After a completed synthesis of an oligosaccharide the resin is taken out of the reaction 
vessel and the oligosaccharide is cleaved from the solid support. Today, the solid support 
is commonly furnished with a photo-labile linker that is stable towards the most frequently 
applied glycosylation and deprotection conditions.107 The photolabile linker containing a 
p-nitrophenyl moiety (scheme 5) is cleaved from the solid support by UV light (305 nm) in 
a continuous flow reactor, yielding protected oligosaccharides equipped with a 
carboxybenzyl (Cbz) protected aminopentyl linker at the reducing end.  
Since the first report of an automated solid-phase synthesis of an oligosaccharide in 
2001, the technique has proven to be a powerful tool to access a wide range of 





biologically interesting probes such as potential vaccine candidates108,109 or to synthesize 
long oligomers up to 30mers110 and 50mers102,111 which can be used to study material 
properties of carbohydrates. 
  
Scheme 5:  Cleavage of the most commonly used photo-labile linker for AGA. 
 
1.4  Aims of this Thesis 
The scientific motivation of this work was to provide a number of synthetic glycan 
tools for plant cell wall research. These glycan tools are plant cell wall-related probes that 
can be used to study for example the substrate specificities of cell wall-modifying 
enzymes or to assign the binding epitopes of mAbs used for high resolution imaging of 
cell wall polysaccharides. A better understanding of structure, function and biosynthesis of 
cell wall polysaccharides is crucial to enhance the usability of plant polysaccharides as 
resources for energy and materials. These polysaccharides include pectin 
polysaccharides which are in the context of biofuel production often neglected. Pectin can 
change the accessibility of hemicellulose or cellulose to enzymatic degradation112 and 
pectin itself is a source of carbohydrates that can be further processed.113 
This work aimed at the synthesis of well-defined pectin oligosaccharides as probes 
for the characterization of cell wall glycan-directed mAbs and of cell wall-degrading 
glycosylhydrolases. Additionally, the synthesis of functionalized sugar nucleotides as 
substrates for the development of novel high-throuput assays for the characterization of 
pectin-related glycosyltransferases was an important goal of this work.  
The first aim was the synthesis of type-I and type-II AG oligosaccharides found in 
pectin. Automated glycan assembly was chosen to establish a library of structurally 
related oligosaccharides from galactose-, arabinose- and galacturonic acid 
monosaccharide BBs. The synthesis of type-I and type-II AGs required two sets of BBs 
with different protecting group patterns, allowing the installation of complex side chains to 
differently linked galactan backbones (chapter 2.1).  
The second aim was the synthesis of a small library of RG-II backbone 
oligosaccharides substituted with the most internal monosaccharide (apiose) of side 





challenges had to be addressed, such as the installation of multiple α(1,4)-galacturonic 
acid linkages and the synthesis of the apiose BB. Hence, several synthetic approaches to 
assemble the oligosaccharide on solid-phase or in solution-phase were designed to 
accomplish this goal. 
The third aim of this thesis was the chemical synthesis of azido- and amino-
functionalized sugar nucleotides for the development of new high-throughput assays to 
screen putative plant glycosyltransferases for their substrate specificities. It was planned 
to incubate glycan microarrays equipped with synthetic plant oligosaccharides with the 
functionalized sugar nucleotides and to visualize the enzymatic reaction products through 
their selective reaction with fluorescent probes (chapter 2.3).  
 




2 Results and Discussion 
2.1 Automated Glycan Assembly of Arabinogalactans1 
2.1.1 Synthesis of Type-I Arabinogalactans 
2.1.1.1 Previous Chemical Syntheses of Type-I Arabinogalactans 
β(1,4)-Linked oligogalactans are challenging synthetic targets due to the low 
nucleophilicity of the axial C4-hydroxyl function of galactose which can be even lower 
when sterically demanding protecting groups at the C3- and C6-position are used. Only 
few syntheses of β(1,4)-D-galacto-oligosaccharides have been described in literature114-
119, some of which only reached the trisaccharide level114,115. The first chemical synthesis 
of a β(1,4)-D-galacto-trisaccharide was reported by Schuerch et al. who coupled glycosyl 
halide mono- or disaccharide donors to a galactose acceptor with a free hydroxyl group at 
the C4-position upon activation with silver triflate in a labor intensive ten step 
procedure.114 Later, Kováč et al. reduced the number of synthetic steps for the synthesis 
of the β(1,4)-D-galacto-trisaccharide by using a different set of protecting groups. 
However, the use of electron-withdrawing ester protecting groups reduced the reactivity of 
the C4-hydroxyl function drastically and thereby reduced the yields immensly.115 
Significant progress towards the synthesis of longer β(1,4)-galactan structures could be 
made when Lichtenthaler et al. reported the synthesis of a β(1,4)-D-galacto-
hexasaccharide in a 2+2+2 approach using disaccharide thioglycosides as glycosyl 
donors.116 The most impressive examples for the solution-phase synthesis of type-I AGs 
have recently been reported by Andersen et al.118 They described the synthesis of a small 
library of oligogalactans including structures with seven successive β(1,4)-linked 
galactose residues. The syntheses have been achieved by iterative glycosylations with n-
pentenyl disaccharides followed by a late state glycosylation of a hexasaccharide core 
                                               
1
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with single galactose or arabinose moieties or short galactan or arabinan 
disaccharides.118 Unlike linear- and β(1,6)-branched 1,4)-linked galactan 
oligosaccharides, α(1,3)-substituted type-I AG oligosaccharides have not been prepared 
so far.116,118  
 
2.1.1.2 Automated Glycan Assembly of Type-I Arabinogalactans 
Due to the highly repetitive structure of type-I AGs, automated glycan assembly is 
well suited to assemble libraries of type-I AGs from a small set of monosaccharide BBs 
(scheme 6). The BBs were designed for the synthesis of a comprehensive library of type-I 
AG oligosaccharides which contain characteristic structural features such as α(1,3)-
substitution of the β(1,4)-galactan backbone with arabinose, substitution of the backbone 
with short α(1,3)- or α(1,5)-arabinans or single β(1,3)-linkages in the galactan backbone. 
β(1,3)-Galactan linkages have been found in type-I AG from potato.120 Three differentially 
protected arabinose and three differentially protected galactose BBs were required 
(scheme 6). 
 
Scheme 6: Chemical structure of a type-I AG polysaccharide and the required 
building blocks for the automated glycan assembly of representative oligosaccharide 
fragments. 




The two galactose BBs required for the synthesis of the β(1,4)-linked galactan 
backbone (BB1121 and BB2) were equipped with a base labile Fmoc group in the C4-
position for chain elongation. For the installation of side-chains in the C3-position, BB2 
was equipped with a temporary Lev protecting group that can be cleaved using hydrazine 
and is fully orthogonal to the Fmoc group.101,122,123 The third galactose BB (BB3)124, with 
an Fmoc protecting group in the C3-position, was used for elongation of the galactose 
solely in the C3-position. All remaining hydroxyl groups in BB1, BB2 and BB3 are not 
modified during the oligosaccharide assembly process and were permanently protected 
as benzyl ethers and benzoyl esters. The benzoyl protecting group in the C2-position 
provides the required stereocontrol for β-selective glycosylation. Additionally, by using 
dibutyl phosphate as the anomeric leaving group in the galactose building blocks, β-
stereoselectivities during glycosylation reactions are maintained by avoiding α-directing 
ether solvents105 which are commonly used during the activation of thioglycosides on solid 
support.101 It has been observed before, that the activation of galactose thioglycoside BBs 
in the presence of ether solvents results in poor 1,2-trans stereoselectivities even in the 
presence of participating 2-O-protecting groups.125-127 
Three different L-arabinofuranose BBs (BB4-BB6) were used for the installation of 
single arabinose substituents, α(1,3)-linked arabinan disaccharides, and an α(1,5)-linked 
arabinan trisaccharide. The arabinose building blocks were equipped with benzoyl esters 
as permanent protecting groups and a temporary Fmoc-protecting group at the respective 
position that is elongated during oligoarabinan synthesis. The arabinose BBs were used 
as thioglycoside donors as arabinose thioglycoside BBs provided good results in solution- 
or solid-phase syntheses previously.103,128 
All three galactose BBs (BB1, BB2 and BB3) were synthesized starting from 
peracetylated β-D-galactose 9 (scheme 7). The BBs BB1 and BB3 were obtained by a 
divergent synthesis starting from the reported benzylidene protected intermediate 10129 
and have been previously used in the automated glycan assembly of few linear type-I and 
type-II arabinogalactan oligosaccharides (Max Bartetzko, MSc thesis, MPIKG).130 BB2 
was synthesized starting from literature known intermediate 12.131 The levulinoyl group 
was introduced in good yields at the C3-position by DIC-promoted esterification giving 13. 
Subsequent selective opening of the benzylidene acetal yielded intermediate 14 with a 
free hydroxyl group in the C4-position, which allowed the introduction of Fmoc as a 
second temporary protecting group at the C4-position. Exchange of the anomeric 
thioether leaving group for a phosphate provided the corresponding glycosyl donor BB2 
(scheme 7). 






Scheme 7: Synthesis of galactose BBs BB1, BB2 and BB3. Reagents and 
conditions: a) LevOH, DIC, DMAP, rt, DCM, 85%; b) Et 3SiH, TFAA, TFA, rt, DCM, 
quant.; c) FmocCl, pyridine, rt, DCM, 66%; d) HOP(O)(OBu) 2 , NIS, TfOH, 0 °C, DCM, 
69%. 
The arabinose BB6 was synthesized as previously described for the 
corresponding D-arabinofuranose128 and BB4132 was available in the laboratory and kindly 
provided by Deborah Senf. Arabinose BB5 was available from 2,3,5-tri-O-benzoyl-1-
methyl-α-L-arabinofuranose (16), which was also kindly provided by Deborah Senf. 
Methanolysis of the ester protecting groups of 16 gave 17. Selective protection of the C4-
and the C5-hydroxyl functions as cyclic silyl acetal yielded 18, which could be selectively 
protected in the C2-position with a benzoyl ester, yielding 19. Deprotection of the C3- and 
the C5-hydroxyl groups by removal of the silyl acetal with HF·pyridine and selective 




protection of the primary hydroxyl function using benzoic acid in a Mitsunobu reaction 
gave access to the desired intermediate 21. The free C3-hydroxyl group in 21 was then 
reacted with FmocCl to give 22 which was further reacted with ethanethiol to obtain the 
final arabinofuranose building block BB5 (scheme 8).  
 
Scheme 8: Synthesis of arabinose BB5. Reagents and conditions: a) NaOMe, rt, 
MeOH/DCM, 99%; b) ( tBu)2Si(OTf)2, 2,6-lutidine, -5 °C, DMF, 58%; c) BzCl, rt,  
pyridine, 94%; d) HF·pyridine, 0 °C to rt, THF, 71%; e) BzOH, DEAD, Ph 3P, rt, THF, 
77%; f) FmocCl, pyridine, rt ,DCM, 81%; g) EtSH, Et 2O·BF3 , 0 °C, DCM, 76%.  
After obtaining BB1–BB6, the automated glycan assembly of eight 
oligosaccharide fragments of pectic type-I AG polysaccharides was performed by 
alternating glycosylation and deprotection procedures on a solid support functionalized 
with a photo-labile linker (23) that yields oligosaccharides with an aminopentyl linker at 
the reducing end.107 Glycosylations with phosphate building blocks BB1–BB3 were 
generally performed using two times 3.8 equivalents building block and stoichiometric 
amounts of the activator TMSOTf. Thioglycoside building blocks BB4–BB6 were used in 
two glycosylation cycles adding 3.8 equivalents building block each and activated with a 
slight excess of NIS133 together with catalytic amounts of triflic acid. Deprotection of Fmoc 
was achieved with triethylamine (20% in DMF). Levulinoyl protecting groups were 
removed with a hydrazine acetate solution (0.15 M). Following assembly of the galactan 
backbone, capping with benzoic anhydride in the presence of dimethylaminopyridine 
(DMAP) allowed for temporary Fmoc protecting groups to be used for the selective 
elongation of arabinan side chains. The fully deprotected oligosaccharides were obtained 
following light-induced cleavage from the solid support, methanolysis of the ester 
protecting groups, and hydrogenolysis of the benzyl ethers and the Cbz-group at the 
linker. 
The synthesis of a β(1,4)-linked galactan disaccharide (24) and a linear β(1,4)-
linked galactan tetrasaccharide (25) on solid support was achieved in good yields 
previously (Max Bartetzko, MSc thesis, MPIKG).130 Therefore the linear β(1,4)-linked 
galactan hexasaccharide 26 was prepared accordingly by alternating glycosylations with 
BB1 and Fmoc deprotection reactions (scheme 9). The low reactivity of the axial C4-
hydroxy nucleophile of galactose was likely responsible for the low yields that were 




obtained after multiple formations of this challenging glycosidic linkage. β(1,4)-, β(1,3)-
Mixed-linkage galactan tetrasaccharide 27, a structural component in the backbone of 
type-I AGs in potato120, was prepared in moderate yields by incorporation of BB3 as the 
second BB in the AGA process (scheme 4). Arabinogalactan oligosaccharides 28-30 that 
contain α(1,3)-linked arabinose either at the central (28 and 30) or the terminal position of 
the backbone (27) were prepared by incorporation of the levulinoyl substituted BB (BB2) 
into the galactan backbone synthesis and selective removal of the levulinoyl protecting 
group after full assembly of the galactan backbone before final attachment of BB4 
(scheme 9).  
 
Scheme 9: Automated glycan assembly of type-I arabinogalactan oligosaccharides  
26-30. Reagents and conditions: a) Twice 3.8 equiv of BB1, BB2 or BB3 , TMSOTf, 
DCM, -35 °C (5 min) → -20 °C (30 min) or -30 °C (5 min) → -10 °C (30 min); b) 
Three cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 0.15 M 
hydrazine in pyridine/AcOH/H 2O (4:1:0.25), 25 °C (30 min); d) Twice 3.8 equiv BB4,  
NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min); e) hν (305 nm); f) 
NaOMe, THF, 16 h; g) H2, Pd/C, EtOAc/MeOH/H2O/AcOH, 16h. 26: 2%, 27: 16%, 28:  




6%, 29: 7% 30: 5% (yields are based on resin loading). The letter code below the 
structures represents the synthesizer modules and deprotection steps used for the 
syntheses. 
Arabinose BBs BB5 and BB6 were required for the synthesis of short α(1,3)- and 
α(1,5)-linked arabinan oligomers. These arabinan oligosaccharides were either attached 
to a single galactose unit (32 and 33) or a galactan trisaccharide backbone (29). The 
oligosaccharides 30 and 31 were synthesized by attachment of 3-O-Fmoc protected 
galactose BB3 to the solid support and iterative Fmoc removal and glycosylation 
reactions with BB5, BB6 or BB4 (scheme 10). The synthesis of the more complex type-I 
arabinogalactan oligosaccharide 31 required a capping step after assembly of the β(1,4) 
backbone to ensure exclusive attachment of the second arabinose moiety to the C3-
position of the first side-chain arabinose moiety. For that purpose, the terminal Fmoc-
group was removed after assembly of the β(1,4)-galactan backbone and the resulting free 
hydroxyl group was masked as an ester. It was found that the standard capping protocol 
previously applied in automated glycan assembly,103 employing acetic anhydride in 
pyridine, was not suitable in this case – the resulting acetyl groups did not withstand the 
conditions required for the removal of Lev-groups. Thus, benzoyl esters were used 
instead of acetyl groups as capping moieties. These are more stable to the hydrazine 
used for Lev-deprotection.134 Quantitative capping was achieved by incubating the resin-
bound oligogalactan for 30 min at 40 °C with a solution of benzoic anhydride and DMAP 
in DCE (scheme 10). Using the benzoyl capping method, compound 31 was synthesized 
successfully. All fully de-protected type-I arabinogalactan oligosaccharides (26-33) were 
obtained after light-induced cleavage from the solid support, global deprotection by 
methanolysis and subsequent hydrogenolysis in yields of 4-38% after HPLC purification. 
The purity of all de-protected type-I AGs was ensured by analysis with HPLC, NMR-
spectroscopy, and high-resolution mass spectrometry. 





Scheme 10:  Automated glycan assembly of type-I arabinogalactan oligosaccharides 
29-31 including arabinan side-chains. a) Twice 3.8 equiv of BB1,  BB2 or BB3 , 
TMSOTf, DCM, -35 °C (5 min) → -20  °C (30 min) or -30  °C (5 min) → -10 °C 
(30 min); b) Three cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 
0.15 M hydrazine in pyridine/AcOH/H2O (4:1:0.25), 25 °C (30 min); d) Twice 3.8 
equiv BB4 , BB5 or BB6 NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min); 
e) Three cycles of 0.5 M Bz2O and 0.25 M DMAP in DCE, pyridine, 40 °C (30 min); f) 
hν (305 nm); g) NaOMe, THF, 16 h; h) H2 , Pd/C, EtOAc/MeOH/H2O/AcOH, 16h. 31:  
8%, 32: 17%, 33: 38% (yields are based on resin loading). The letter code below the 
structures represents the synthesizer modules and deprotection steps used for the 
syntheses. 
It is noteworthy that a slow isomerization of hexasaccharide 30 was observed 
upon storing the oligosaccharide as a stock solution in water (2 mM). While the HPLC 
analysis of 30 revealed a single product peak immediately following the last deprotection 
reaction, an additional peak of identical mass appeared after storing 30 for several days in 
water at 4 °C. 1H-NMR analysis revealed a shift of the signal for the anomeric arabinose 
proton from 5.48 ppm to 5.24 ppm (fig. 11). Apparently, the arabinofuranose isomerized 
into the corresponding β-arabinopyranose.  





Figure 11: Isomerization of arabinogalactan 30. Left: HPLC analysis (ELSD trace) 
and 
1
H-NMR chemical shift of the anomeric arabinose proton of 30 directly after 
synthesis. Right: HPLC analysis and 
1
H-NMR chemical shifts of the anomeric 
arabinose proton of 30 after storage in aqueous solution for several  days. 
This isomerization reaction may have been intramolecularly catalyzed by the 
aminoalkyl linker. Base-catalyzed isomerizations of methyl arabinofuranosides into 
arabinopyranosides in the presence of pyridine have been observed previously.135 None 
of the other arabinogalactan oligosaccharides underwent isomerization. 
 
2.1.2 Synthesis of Type-II Arabinogalactans 
2.1.2.1 Previous Chemical Syntheses of Type-II Arabinogalactans 
While the synthesis of type-I arabinogalactans (AG) is difficult due to the low 
reactivity of the axial C4-hydroxyl function, the synthesis of type-II arabinogalactans is 
comparably easier because of higher reactivities of the C3- and the C6-hydroxyl groups. 
Several approaches towards the synthesis of type-II AG fragments have been published. 
Most of these syntheses focus on β(1,6)-galactans partially substituted with 
L-arabinofuranoses. A comprehensive overview of the synthesized type-II AG structures 
with a β(1,6) backbone was published in a recent review.95 One of the most impressive 
work found in literature is the assembly of a β(1,6)-galactan backbone consisting of up to 
15 residues which are partially substituted at the C2- or C3-positions with 
arabinofuranosyl moieties.136 Li and co-workers synthesized these arabinogalactans of 
varying length from five different monosaccharide building blocks in a block-wise 
approach in a series of tedious glycosylation-, deprotection- and purification steps.  
Only few syntheses of well-defined β(1,3)-linked galactans have been reported. Most of 
them were disaccharides and trisaccharides.126,127,137-140 Longer β(1,3)-galactan structures 




have been synthesized by Kováč and co-workers who used a single building block to 
assemble a series of linear β(1,3)-galactans up to a heptamer.125 However, the synthesis 
suffered from relatively low yields and inconvenient purification procedures due to the 
formation of undesired side-products such as α-glycosides or orthoesters. Recently, 
another report describing the synthesis of linear and β(1,6)-branched β(1,3)-galactans by 
iterative couplings of monosaccharide and disaccharide thioglycoside donors has been 
published.141 They achieved β(1,6)-branching of the β(1,3)-galactan backbone by 
incorporation of a monosaccharide building block with a temporary acetyl protecting group 
at the C6-position. Selective removal of the acetyl protecting group allowed the installation 
of single arabinofuranose or single galactose and β(1,6)- or β(1,3)-digalactan side chains 
at different positions of the β(1,3)-heptagalactan backbone after the full assembly of the 
backbone. Nevertheless, access to a more elaborated library of complex type-II AGs 
containing features of the β(1,3)-galactan backbone and/or the β(1,6)-galactan side 
chains that may be partially substituted with arabinofuranosyl or glucuronic acid moieties 
is still missing for comprehensive biological studies. 
 
2.1.2.2 Automated Glycan Assembly of Type-II Arabinogalactans 
In order to produce a large number of structurally related type-II arabinogalactans 
by automated glycan assembly, a number of monosaccharide BBs had to be designed 
(scheme 11). Linear β(1,3)-galactan oligosaccharides and β(1,6)-galactan side-chains 
with partial decorations of arabinofuranosyl oligosaccharides or glucuronic acid residues 
can be assembled from a set of five BBs (BB3–BB4 and BB7–BB9). Additionally to the 
two BBs, which were used in the synthesis of type-I AGs and described in chapter 2.1.1.2 
(BB3 and BB4), two additional galactose BBs were required. BB7 was equipped with a 
temporary Fmoc protecting group in the C3-position for β(1,3)-galactan chain elongation 
and an orthogonal Lev protecting group in the C6-position, which allowed the installation 
of β(1,6)-linked side chains after removal of the Lev group on solid support. The galactose 
BB8 had Fmoc as the single temporary protecting group in the C6-position. This BB can 
be used for elongation of β(1,6)-galactan chains. In the C2-position of both BBs, benzoyl 
esters (Bz) ensure selective formation of the β-anomers through neighboring group 
participation. All remaining positions were protected with benzyl ethers. Additionally, the 
glucuronic ester donor BB9 was employed to terminate β(1,6)-galactans with a β(1,6)-
linked glucuronic acid moiety. A precursor of glucuronic acid BB9 equipped with a thiol 
leaving group was available in my laboratory142 and was kindly provided by my colleague 




Andrew Kononov. The thioglycoside leaving group of the precursor was exchanged for 
the phosphate leaving group using an established procedure.142  
 
Scheme 11: Chemical structure of a type-II arabinogalactan polysaccharide and the 
required building blocks for the assembly of representative oligosaccharide 
fragments on solid support.  
The synthesis of BB7 with two orthogonal protecting groups at the C3- and C6-
positions started from common intermediate 34 which was prepared from 9 in six steps 
following an established procedure (Max Bartetzko, MSc thesis, MPIKG).130 The primary 
hydroxyl group of 32 was protected as a levulinoyl ester in high yields using levulinic acid 
under standard esterification conditions. Removal of the tert-butyldimethylsilyl protecting 
group at the C3-position using boron trifluoride etherate provided 36 in quantitative yield. 
Installation of the temporary Fmoc protecting group at the C3-position gave 35 which 
finally could be transformed into the desired BB7 by exchange of the anomeric leaving 
group for a phosphate (scheme 12). 





Scheme 12: Synthesis of galactose BB7. Reagents and conditons: a) LevOH, DIC, 
DMAP, rt, DCM 91%; b) Et2·BF3, 0 °C, MeCN, quant.; c) FmocCl, pyridine, rt, DCM, 
75%; d) HOP(O)(OBu)2, NIS, TfOH, 0 °C, DCM, 92%. 
Glycosyl phosphate BB8 was synthesized from 38143, which was provided by my 
colleague Heung Sik Hahm. The thioether leaving group was exchanged for the 
phosphate using NIS and catalytic amounts of TfOH (scheme 13).  
 
Scheme 13: Synthesis of galactose BB8. Reagents and conditions: 
a) HOP(O)(OBu)2 , NIS, TfOH, 0 °C, DCM, 80%. 
With the required building blocks in hand, further type-II AG fragments were 
synthesized on solid support in addition to previously synthesized linear β(1,3)-linked tri-
(39) and tetragalactan (40) structures (Max Bartetzko, MSc thesis, MPIKG).130 As 
expected, synthesis of a (1,6)-linked trigalactoside proceeded in high yields and perfect 
stereoselectivity when using phosphate BB8. Hence, the stage was set to assemble 
linear and branched galactan oligosaccharides 41-46. Glycosylations were performed in 
two cycles using 3.8 equivalents of galactose building blocks BB3, BB7 and BB8 and 
equimolar amounts of TMSOTf. Every glycosylation was followed either by an Fmoc- or 
Lev-deprotection step, depending on which position of the respective galactose unit was 
subsequently elongated. All branched structures were synthesized by assembling the 
linear (1,3)-linked backbone first and subsequently attaching the (1,6)-linked side chain. 
After completion of the automated syntheses, the protected oligosaccharides were 
cleaved from the solid support and treated with sodium methoxide in methanol. The 
resulting semi-protected products were subjected to hydrogenolysis and the fully 
deprotected oligogalactans 41-46 were obtained in 5-43% overall yield, based on the 
calculated loading of linker-functionalized resin 23 (scheme 14). In the case of glucuronic 
acid containing tetrasaccharide 46 the β(1,6)-galactan chain was assembled using only 




one time five equivalents of BB8 per glycosylation step, as high conversions in 
glycosylation reactions employing BB8 were observed in the synthesis of oligosaccharide 
41. The terminal glucuronic acid residue on the other hand was coupled using two times 
five equivalents of BB9 and stoichiometric amounts of the activator TMSOTf at elevated 
temperatures as has been used previously for this BB.142  
 
Scheme 14: Automated glycan assembly of type-II arabinogalactan oligosaccharides 
41-46. Reagents and conditions: a) Twice 3.8 equiv BB3,  BB7,  BB8  or one time 5 
equiv BB8 for the synthesis of 46, TMSOTf, DCM, -35 °C (5 min) → -20 °C (30 min); 
a’) twice 5 equiv BB9 TMSOTf, DCM, -15 °C (45 min) → 0  °C (15 min); b) Three 
cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 0.15 M hydrazine in 
pyridine/AcOH/H2O (4:1:0.25), 25 °C (30 min); d) hν (305 nm); e) H2O2 , H2O, 
THF, -5 C to rt, 16 h; f) NaOMe, THF, 16 h; g) H 2, Pd/C, EtOAc/MeOH/H 2O/AcOH, 
16h.  41: 39%,  42: 15%, 43: 10%, 44: 7%, 45: 5% 46: 43% (yields are based on resin 
loading). The letter code below the structures represents the synthesizer modules 
and deprotection steps used for the syntheses.  




After cleavage of the completely assembled oligosaccharide 46 from the solid 
support, the ester was saponificated using lithium hydroxide and hydrogen peroxide. The 
resulting tetrasaccharide containing the free carboxylic acid was subjected to 
methanolysis and subsequent hydrogenolysis. The fully deprotected tetrasaccharide 46 
was obtained in 43% overall yield.  
Addition of L-arabinose building block BB411 to the previously used set of 
galactose building blocks (BB3, BB7, BB9) enabled the production of seven additional 
oligosaccharides that represent substructures of type-II arabinogalactan (scheme 15). In 
the synthesized AG oligosaccharides, the arabinose unit is either attached to the (1,3)-
linked galactan backbone (47, 48, 50) or to the (1,6)-linked galactan side chain (49, 51-
54). The syntheses of the more elaborate oligosaccharides 43-45 required capping steps 
during the automated synthesis to ensure the selective attachment of the arabinose to the 
desired galactose unit. Capping of the C3-position of the terminal galactose at the β(1,3)-
galactan backbone was achieved as described above for the synthesis of type-I AG 
oligosaccharide 31 using benzoic anhydride and DMAP. After capping of the backbone, 
the side-chain was introduced by iterative Lev-deprotection and glycosylation reactions. 
The arabinose building block BB4 was then selectively attached to the side chain after 
Fmoc-deprotection. 
The same glycosylation protocols that were established for the synthesis of 
oligogalactans 41-46 were applied for AG oligosaccharides 47-53. Thioglycoside BB4 
was activated with NIS and catalytic amounts of TfOH in DCM. After cleavage of the 
products from the solid support, global deprotection and purification, AG oligosaccharides 
47-53 were obtained in yields between 5 and 39%, based on the calculated resin loading 
(scheme 15). 





Scheme 15: Automated glycan assembly of arabinose containing type-II 
arabinogalactan oligosaccharides 47-53. Reagents and conditions: a) Twice 3.8 
equiv BB3,  BB7 or BB8, TMSOTf, DCM, -35 °C (5 min) → -20 °C (30 min); b) Three 
cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 0.15 M hydrazine in 
pyridine/AcOH/H2O (4:1:0.25), 25 °C (30 min); d) Twice 3.8 equiv BB4, NIS, TfOH, 
DCM/dioxane, -40 °C (5 min) → -20 °C (40 min); e) Three cycles of 0.5 M Bz2O and 
0.25 M DMAP in DCE, pyridine, 40 °C (30 min); f) hν (305 nm); g) NaOMe, THF, 16 
h; h) H2, Pd/C, EtOAc/MeOH/H2O/AcOH, 16h. 47: 17%, 48: 17%, 49: 16%, 50: 10%, 
51: 16%, 52: 11%, 53: 9% (yields are based on resin loading). The letter code below 
the structures represents the synthesizer modules and deprotection steps used for 
the syntheses. 




Finally, BB3, BB4 and BB7 were used to assemble two type-II AG structures 
which resemble β(1,6)-galactose side chains that are capped with an arabinofuranosyl 
residue at the C3-position of the terminal galactose residue. Since BB8 with a single 
temporary protecting group in the C6-position was not available in sufficient amounts at 
the time of the synthesis, the synthesis of oligosaccharides 54 and 55 was performed 
using the more complex BB7. Key step in the syntheses of 54 and 55 using BB7 was the 
exchange of the Fmoc protecting group at the C3-position of BB7 with a benzoyl ester on 
solid support after each glycosylation reaction with BB7. After every capping step removal 
of the levulinoyl protecting group at the C6-position allowed extension of the β(1,6)-
galactan chain. BB3 was finally used to terminate the β(1,6)-galactan chain, allowing the 
introduction of an α-linked arabinose at the C3-position on the terminal galactose after 
removal of the Fmoc group (scheme 16). Light-induced cleavage from the solid support, 
followed by global deprotection and purification steps, gave tetrasaccharide 54 in 
moderate yield (10%) and hexasaccharide 55 in low yield (1%). The difficult handling of 
the semi-protected oligosaccharide after methanolysis of the ester protecting groups 
lowered the overall yield of 55 drastically. The semi-protected version of 55 formed 
aggregates which could only partially be dissolved in methanol and methanol solvent 
mixtures that were used for hydrogenolysis. The purity of all deprotected type-II AGs was 
ensured by characterization with analytical HPLC, NMR-spectroscopy, and high-
resolution mass spectrometry. 





Scheme 16: Automated glycan assembly of type-II arabinogalactan oligosaccharides 
54 and 55 using BB7 for backbone elongation. Reagents and conditions: a) One time 
5 equiv BB3 or BB7 , TMSOTf, DCM, -35 °C (5 min) → -20 °C (30 min); b) Three 
cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 0.15 M hydrazine in 
pyridine/AcOH/H2O (4:1:0.25), 25 °C (30 min); d) Twice 3.8 equiv BB4, NIS, TfOH, 
DCM/dioxane, -40 °C (5 min) → -20 °C (40 min); e) Three cycles of 0.5 M Bz2O and 
0.25 M DMAP in DCE, pyridine, 40 °C (30 min); f) hν (305 nm); g) NaOMe, THF, 16 
h; h) H2, Pd/C, EtOAc/MeOH/H2O/AcOH, 16h. 54: 10%, 55: 1% (yields are based on 
resin loading). The letter code below the structures represents the synthesizer 
modules and deprotection steps used for the syntheses. 
 
2.1.2.3 Automated Glycan Assembly of Type-II Arabinogalactans with 
Free Reducing Ends Using a Traceless Linker 
Having established reliable routes towards the assembly of type-II AGs by means 
of AGA, the synthesized BBs (BB3,BB4, BB7 and BB8) were used to test a lately 
developed photo-labile traceless linker for the syntheses of complex and branched 




glycans.144 Free reducing end glycans produced by AGA represent valuable probes for 
biological assays that do not tolerate unnatural modifications or can serve as standards 
for LC/MS measurements145. Linker 56 (fig. 12) has been designed in analogy to the 
established photo-labile linker 23107 which provides oligosaccharides equipped with an 
alkyl linker after UV-light induced cleavage from the solid support. By introducing a benzyl 
spacer in the newly developed linker 56, oligosaccharides equipped with a reductive-labile 
group at the reducing end are obtained. This benzylic group is removed upon a final 
hydrogenolysis reaction, releasing the free reducing end glycan after global 
deprotection.146-148  
 
Figure 12:  Photo-labile l inkers for the solid phase synthesis of oligosaccharides. 
23: Linker commonly used in AGA for the synthesis of aminopentyl -functionalized 
oligosaccharides. 56:  Traceless linker for the solid phase synthesis of free-reducing 
end oligosaccharides.  
First, the applicability of the traceless photo-labile linker for automated glycan 
assembly was evaluated by synthesizing a simple linear target structure. To obtain a 
β(1,3)-linked galactan trisaccharide with free reducing end, BB3 was coupled to a 
Merrifield resin equipped with linker 56 in three rounds of glycosylation and subsequent 
Fmoc-deprotection steps. Photo-induced cleavage of the trisaccharide from the solid 
support and purification using preparative normal phase HPLC gave the protected 
trisaccharide in good yield (49%). Global deprotection by methanolysis and subsequent 
hydrogenolysis gave the fully deprotected free reducing end trisaccharide 57 together with 
2-(p-tolyl)ethane-1-amine as a side product.  
 
Scheme 17: Formation of a heminaminal ether 58 from 57 and the amine released 
during the hydrogenolysis. 
During concentration of the product under reduced pressure the amine partially 
reacted with the open chain form of the trisaccharide to form a hemiaminal ether149 57 




which could be converted back into the free reducing end trisaccharide 57 by acidic 
hydrolysis (scheme 17). More complex branched structures 59 and 60 could be 
synthesized from BB3, BB7, BB8 and BB4 when also Lev-deprotection and benzoyl 
capping procedures where included into the process (scheme 18). After global 
deprotection and subsequent acidic hydrolysis of the hemiaminal side products α/β-
mixtures of type-II AG oligosaccharides 59 and 60 were obtained in yields (10% for 59 
and 4% for 60) comparable to the ones obtained in syntheses of similar target structures 
employing the standard aminopentyl linker 23.  
 
Scheme 18: Automated glycan assembly of free reducing end type-II 
arabinogalactan oligosaccharides 53, 55 and 56.  Reagents and conditions: a) Twice 
4 equiv BB3, BB7 or twice 3 equiv BB8, TMSOTf, DCM, -35 °C (5 min) → -20 °C (30 
min); b) Three cycles of 20% NEt3 in DMF, 25 °C (5 min); c) Three cycles of 0.15 M 
hydrazine in pyridine/AcOH/H 2O (4:1:0.25), 25 °C (30 min); d) Twice 3 or 4 equiv 
BB4, NIS, TfOH, DCM/dioxane, -40 °C (5 min) → -20 °C (40 min); e) Three cycles of 
0.5 M Bz2O and 0.25 M DMAP in DCE, pyridine, 40 °C (30 min); f) hν (305 nm); g) 
NaOMe, THF, 16 h; h) H2, Pd/C, EtOAc/MeOH/H 2O/AcOH, 16h. 57: 8%, 59: 10%, 
60: 4% (yields are based on resin loading). The letter code below the structures 
represents the synthesizer modules and deprotection steps used for the syntheses . 
 




The successful syntheses of free reducing end AG oligosaccharides 57, 59 and 60 
proved that linker 56 is compatible with all common protocols for AGA, including 
glycosylations with glycosyl phosphates and thioglycosides, cleavage of temporary 
protecting groups such as Fmoc and Lev and capping of free hydroxyl functions as 
benzoyl esters. 
 
2.1.3 Characterization of Arabinogalactan-Directed Monoclonal 
Antibodies 
A great number of mAbs are commonly used to identify and localize pectin 
structures in plant cell walls.150,151 The library of arabinogalactan oligosaccharides 
prepared by AGA provided an excellent toolbox to determine the exact binding epitopes of 
AG-directed mAbs. My colleague Dr. Ruprecht printed 26 synthetic type-I and type-II 
(arabino-)galactans on microarray slides to identify the binding epitopes of 43 AG directed 
mAbs.152 It was found that the vast majority of the tested antibodies binds to β(1,6)-linked 
galactans with a slight variety towards the substitution pattern of the β(1,6) galactan 
chain. More differentiated binding patterns were observed in the case of seven particular 
AG-directed mAbs. In figure 13 the microarray scans after incubation of the array with 
antibodies JIM 14 and JIM 16 are exemplary shown. 
 
Figure 13: Identif ication of the binding epitopes of AG directed mAbs. Shown are the 
representative scans of microarrays incubated with JIM14 and JIM16. The 
compounds were printed in four different concentrations as indicated on the right. 
Light l inkages and light monosaccharide symbols on the  upper structures indicate 
posit ions that are allowed but not required for binding. Posit ions that must not be 
substituted are indicated by red bars.  
JIM14 bound to five structures containing at least three consecutive β(1,6)-linked 
galactose moieties which may be arabinosylated at the central galactose residue. 
Interestingly, JIM14 differentiated between compounds 54 and 55 indicating that it binds 
to internal epitopes of β(1,6)-galactans but not to the non-reducing end of β(1,6)-




galactans. JIM 16 showed a completely different binding pattern as it only bound to 
compounds 42 and 51, implying that it recognizes a β(1,3)-galactan backbone when 
substituted with a single β(1,6)-linked galactose moiety. 
 
2.1.4 Identification of Substrate Specificities of β(1,4)-endo-Galactan 
Hydrolases  
The type-I arabinogalactan oligosaccharides assembled by AGA (26 to 33) 
together with the previously synthesized β(1,4)-linked galactan disaccharide (24) and the 
previously synthesized β(1,4)-linked galactan tetrasaccharide (25) (Max Bartetzko, MSc 
thesis, MPIKG) represent useful probes to investigate the specificity of endo-
galactanases. Hydrolases that degrade plant cell wall polysaccharides are important tools 
to analyze the structure of cell wall polysaccharides.73,74 Short oligosaccharide fragments 
released by the enzymes can be analyzed by HPLC, mass spectrometry and NMR 
spectroscopy to draw conclusions on the structure of the original AG polysaccharides. 
However, information on the minimal oligomer length required for hydrolysis and the 
degree of arabinose substitution tolerated by the enzyme is essential. Three 
representative 1,4)-endo-galactanases from glycosyl hydrolase (GH) family 53 were 
investigated: E-EGALN from Aspergillus niger, E-GALCJ from Cellvibrio japonicus, and 
E-GALCT from Clostridium thermocellum. Oligosaccharides (24-33) were incubated with 
the enzymes for 3 h at 40 °C before stopping the reaction by heat inactivation of the 
enzyme at 80 °C. The resulting digestion products were analyzed by HPLC coupled to an 
ELS-detector and a mass spectrometer. HPLC analysis of the digestion products revealed 
different minimal length requirements for hydrolysis by the galactanases (fig. 14). While 
E-GALCJ completely degraded tetragalactoside 25, E-EGALN as well as E-GALCT only 
partially hydrolyzed 25. Since neither the linker-functionalized mono- nor disaccharide 
was detected, E-GALCJ probably hydrolyzed the linker first and then cleaved the central 
bond of the resulting free reducing tetrasaccharide. Hexasaccharide 26, in contrast to 
tetrasaccharide 25, was hydrolyzed equally well by the two galactanases, although 
slightly different product patterns were observed. Mixed-linkage tetragalactoside 27 
remained intact during incubation with the galactanases, proving the strict selectivity of 
the galactanases for β(1,4)-glycosidic linkages. Next, the effect of arabinose substitution 
on digestion efficiency was investigated. Arabinogalactan tetrasaccharide 28 was not 
hydrolyzed by any of the galactanases. Hexasaccharide 30, bearing an arabinose residue 
in the central position, was cleaved by E-EGALN and E-GALCT but not E-GALCJ 
between the first two galactose units.  





Figure 14: Digestion of synthetic arabinogalactan oligosaccharides with the β(1,4)-
endo-galactanases E-GALCJ, E-EGALN and E-GALCT and analysis of the resulting 
hydrolysis products by HPLC-MS. (a) HPLC analysis of the products after incubation 
of the respective oligosaccharides ( indicated by boxes) with the galactanases. Peaks 
are annotated with AG fragments either carrying an aminopentyl l inker or with free 
reducing end (with or without red bar). Note that α- and β-anomers of the free 
reducing sugars elute as separate- or double-peaks. (b) The cutting sites derived 
from (a) are summarized and indicated by arrows. (c) General requirements for 
arabinose substitutions relative to the cutting site of E -GALCJ and E-EGALN 
galactanases. “X” denotes galactose residues that must not be substituted with 
arabinofuranose. The reducing end of the structures is located on the right.  




Thus, E-EGALN and E-GALCT do tolerate arabinose substitution in the -2 subsite 
relative to the site of hydrolysis. The isomerized hexasaccharide 30-i was not digested by 
E-EGALN or E-GALCT, suggesting a specific recognition of the arabinofuranose. Further 
information was provided by analysis of the hydrolysis products obtained after digestion of 
pentasaccharide 29 having the arabinose substitution in the terminal position. E-GALCJ 
tolerated arabinose substitution in the -3 subsite and cleaved the bond between the first 
two galactose residues. E-GALN and E-GALCT on the other hand additionally cleaved the 
bond between the second and third galactose unit, demonstrating their ability to accept 
arabinose substitution in both the -2 and -3 subsite. Neither galactanase tolerated 
substitution in direct proximity to the cleavage site as no corresponding hydrolysis 
fragments were detected. In summary, the results demonstrate that the substrate 
specificities of these GH53 1,4-endo-galactanases differ in the number of subsites that 
are important for substrate binding and in their tolerance for arabinose substitution. 
 
2.1.5 Conclusion and Outlook 
In conclusion, a comprehensive library of pectic AG oligosaccharides has been 
synthesized from nine different monosaccharide BBs using AGA. The library contains 
eight type-I AG fragments with β(1,4)-galactan backbones of different length and varying 
arabinose or oligo-arabinan substitutions. The library further contains 15 type-II AG 
fragments resembling structural features such as the β(1,3)-galactan backbone, β(1,6)-
galactan side chains, different arabinose substitutions or side-chains terminated with 
glucuronic acid. Furthermore, the same synthetic AGA protocols used for the assembly of 
type-I and type-II AG oligosaccharides were applied to test a newly developed photo-
labile linker that releases free-reducing end oligosaccharides. The synthetic strategy 
applied in the solid-phase syntheses of the AG oligosaccharides relied on galactose BBs 
equipped with the orthogonal temporary protecting groups Fmoc and Lev at the 
respective positions used for chain elongation or branching. By establishing a benzoyl 
capping procedure that was performed during the assembly on solid support, the number 
of accessible structures was further increased while keeping the number of 
monosaccharide BBs limited. The structures were obtained in satisfying yields after 
cleavage from the solid support and global deprotection. All glycans equipped with an 
aminopentyl linker were printed together with previously synthesized shorter β(1,3)- and 
β(1,4)-galactans130 as glycan microarrays. Binding studies using AG-directed mAbs on the 
microarrays enabled the determination of the exact binding epitopes for several anti-AG 
antibodies.152 The newly obtained information will facilitate the identification of AG 




structures in plant cell walls by immunolabeling studies. The type-I oligosaccharides 
further served as valuable tool to determine the substrate specificities of β(1,4)-endo-
galactanases. It was discovered that the galactanases recognize and hydrolyze 
arabinogalactan oligosaccharides of different lengths and arabinose substitution patterns. 
These findings have implications for future structural analyses of pectic polysaccharides. 
In summary, synthetic AG oligosaccharides have proved to be highly valuable tools to 
increase our understanding of plant cell wall biology. In the future, further extension of the 
library with longer and more elaborately substituted β(1,4)-galactans will allow even more 
detailed investigations into plant cell wall structures.  
 
  




2.2 Synthesis of RG-II Fragments 
2.2.1 Previous Chemical Synthesis of RG-II Fragments 
Despite the great scientific need for well-defined fragments of RG-II, only a small 
number of syntheses have been published.95 The assembly of unsubstituted HG 
oligosaccharides is rather straightforward and the syntheses of quite large 
oligosaccharides have been described in literature. Ogawa et al. reported the synthesis of 
a α(1,4)-dodecagalacturonic acid that was assembled from digalactoside building blocks 
equipped with benzyl-, benzylidene- and acetyl protecting groups. The disaccharide 
donors were used as glycosyl fluorides. After complete assembly of the 
dodecasaccharide the acetyl groups were removed and the hydroxyl groups were 
oxidized by a sequence of Swern oxidation and oxidation with NaClO2 in water. 
Subsequently, the final α(1,4)-dodecagalacturonic acid was obtained by global 
deprotection using palladium on charcoal under a hydrogen atmosphere.153 The synthesis 
of partially methylated tri- and hexasaccharide fragments of HG by post-glycosylation 
oxidation has been reported by Clausen et al. They introduced two orthogonal protecting 
groups at the C6-positions of the galactose building blocks to allow selective synthesis of 
the free acid or the methyl ester after assembly of the oligosaccharide.154,155 Interestingly, 
both groups report high α-selectivity for the (1,4)-glycosylation reactions when employing 
2,3-dibenzylated or 2,3,4-tribenzylated galactose building blocks. Although the 1,2-cis-
configuration of the glycosidic linkages in the galacturonic acid backbone cannot be 
ensured via participating mechanism of neighboring protecting groups remote 
participation from C4 or C6 and solvent effects during the glycosylation reactions can 
promote the desired α-selectivity. So far only two groups have reported the synthesis of 
oligosaccharides containing both, an apiose and a galacturonic acid residue.156,157 Reimer 
and co-workers synthesized a β-D-Apif-α(1,2)-D-GalpA-OMe disaccharide by 
glycosylation of the C2 hydroxyl group of a protected galacturonate acceptor with a 
thioapiofuranose donor and subsequent global deprotection.156 
Later, Field and co-workers published the synthesis of a β-Rhap-β(1,3)-Apif-
α(1,2)-GalpA-OMe trisaccharide starting from the same galacturonic acid acceptor 61 
previously used by Reimer and co-workers. Successive glycosylations with 2,3-O-
carbonate-protected rhamnopyranosyl bromide BB 63 and 2,3-O-benzylidene-protected 
apiofuranosyl thioglycoside BB 62 (scheme 19) provided fully protected trisaccharide 
fragment 64 which could be deprotected by sequential hydrogenolysis, acidic cleavage of 
the isopropylidene acetal, methanolysis and saponification of the ester to give 65. 





Scheme 19: Synthesis of apiose-containing trisaccharide fragment 65 of RG-II by 
Field and co-workers.
157
 Note that the rhamnose moiety is β- l inked to the apiose 
residue unlike in the natural structure . 
Syntheses of side chain A and B motifs from disaccharides156-159 to 
hexasaccharides160 were reported. Some of the resulting compounds have been used to 
confirm the molecular structure of RG-II. A fragment of side chain A with a central 
rhamnose moiety substituted with galacturonic acid at the C2- and C3-position and with 
fucose at the C4-position has been synthesized by Chauvin et al. in 2005. They 
glycosylated a rhamnose acceptor with a fucose glycosyl donor at the C4-position and 
galactose glycosyl donors at the C2- and the C3-position followed by a late stage 
oxidation of the  primary hydroxyl functions of the galactose residues to the corresponding 
carboxylic acids using TEMPO.159 Synthetic tetra- and hexasaccharide fragments of side 
chain B have been reported by Rao et al.160,161. In their synthesis of the side chain B 
hexasaccharide fragment a central arabinopyranose moiety was decorated with a β-linked 
rhamnopyranose at the C3-postion before it was reacted with a D-Galp-α(1,2)-2-O-methyl-
Fuc disaccharide acceptor upon activation of the anomeric thiol leaving group of the 
arabinopyranose. Finally, a β(1,2)-rhamnose-β(1,3)-arabinofuranosise side chain was 
installed at the C2-position of the arabinopyranose by sequential deprotection and 
glycosylation reactions. This synthesis impressively showed how also structurally complex 
and sterically very demanding side chain fragments of RGII can be assembled chemically. 
Unfortunately, due to the recent corrections of the stereochemistry of the Rhap-Apif-
linkage in the side-chains A and B by Gilbert et al.162, many of the side-chain 
oligosaccharide syntheses became obsolete, and oligosaccharide samples with correct 
stereochemistry are urgently needed.  




So far, no syntheses of HG backbone structures substituted with parts of the RG-II 
side-chains have been reported. Libraries of HG backbone structures branched with 
truncated side-chains would be valuable tools for the production and characterization of 
RG-II specific antibodies and to characterize RG-II-modifying enzymes such as 
glycosyltransferases. HG backbone oligosaccharides of RG-II substituted with small side-
chain structures are for example interesting synthetic tools for clarifying the question if 
during biosynthesis the RG-II side-chains are coupled en block to a preexisting HG 
backbone in the cell wall or if the side-chains are consecutively attached to the backbone 
while it is synthesized in the Golgi-apparatus.163  
 
2.2.2 Automated Glycan Assembly of Substituted Homogalacturonan 
Fragments 
Tetrasaccharide 66 (scheme 20) was identified as a central target structure for 
developing a general synthetic strategy towards a synthetic library of RG-II 
oligosaccharides that resembles branched HG backbone motifs of different lengths. The 
retrosynthetic analysis (scheme 20) of 66 reveals a number of chemical challenges 
associated with its synthesis. Foremost, oligosaccharides containing several uronic acids 
are challenging targets, as protected uronic acid glycosyl donors are of comparably low 
reactivity due to the electron-withdrawing ester function.164 An elegant way to bypass this 
problem is the post-glycosylation oxidation strategy in which the oligosaccharide is fully 
constructed using glycosyl donors without the carboxylic acid function before the C6-
hydroxyl groups are oxidized to the corresponding carboxylic acid. Another synthetic 
challenge is the inherent low nucleophilicity of the galactose C4-hydroxyl group165 as 
described in chapter 2.1.1. The third synthetic challenge towards the preparation of 
structure 66 is the need for a suitable apiose building block. As D-apiose is a very rare 
sugar, the building block has to be synthesized from D-mannose157, L-arabinose157, D-
xylose166 or de novo167. 
Inspired by the above described syntheses of oligogalacturonans, a new synthetic 
approach towards the synthesis of RG-II fragments employing automated glycan 
assembly has been designed. The galacturonic acid backbone should be assembled from 
galactoside BBs equipped with a set of protecting groups that allows introduction of side 
chains at the C2-position of specific galacturonic acid moieties as well as a post-
glycosylation oxidation after cleavage of the assembled oligosaccharide from the solid 
support. 





Scheme 20: Retrosynthesis of a HG-tr isaccharide substituted with apiose, the first 
monosaccharide of RG-II side chains A and B.  
In order to enable a post-glycosylation oxidation, the three galactose building 
blocks (BB10-BB12) were equipped with an ester protecting group at C6 which can be 
selectively removed after the glycosylation reactions, making the primary hydroxy group 
available for oxidation to the acid. For a first synthetic test on the solid support, BB10 was 
equipped with a levulinoyl ester at the C6-position, as this temporary protecting group is 
routinely used in automated glycan assembly and can be removed by applying routine 
protocols on solid support. Removal of the protecting groups at the C6-positions of the 
galactan backbone on solid support reduces the required number of chemical 
modifications of the oligosaccharide in solution. Alternatively, BB10 was equipped with an 
acetyl ester at the C6-position that has to be removed after cleavage of the 
oligosaccharide from the solid support, as methanolysis of ester groups on the solid 
support is difficult. However, this BB might provide better glycosylation yields. BB10 and 
BB11 carry an Fmoc group at C4 as a temporary protecting group to allow elongation of 
the α(1,4)-linked backbone. Installation of ester and carbonate groups at the C6- (BB12) 
or C4- and C6- (BB10 and BB11) position should promote the formation of α-glycosidic 
linkages due to remote participation of these protecting groups.168 BB11 was further 




protected with an O-naphthyl ether in the C2-position. The naphthyl ether serves as a 
non-participating temporary protecting group that can be cleaved on solid support under 
oxidative conditions,103,104 liberating the hydroxy function at C2 for further glycosylation 
with apiose BB13. The remaining hydroxy groups of the galactose building blocks were 
protected with benzyl ethers. 
The apiose BB was equipped with a 2,3-O-benzylidene protecting group which renders 
the apiose glycosyl donor β-stereoselective and can be removed under the same 
conditions as the benzyl protecting groups.157 At the C3’-position, the apiose BB carried a 
naphthyl ether which later may be removed during the automated glycan assembly 
process for further elongation of the side chain. All building blocks were used as 
thioglycosides and activated under standard conditions.101  
BB10 – BB12 were synthesized in a divergent manner starting from intermediate 10 
which is available from peracetylated D-galactose 9 in four steps.129 To synthesize BB10 
and BB12, the benzylidene-protected intermediate 10 was further protected in the C2- 
and C3-positions with benzyl groups, yielding intermediate 67169. BB12 for termination of 
the α(1-4)-backbone chain was obtained by regioselective reductive opening of the 
benzylidene acetal with BH3, yielding quantitatively intermediate 68. The resulting free 
primary hydroxyl group at the C6-position was then protected as an acetyl ester to yield 
BB12. To get access to BB10, which allows α(1,4)-chain elongation after removal of the 
temporary protecting group at the C4-position, the benzylidene acetal was fully removed 
under strongly acidic conditions using a TFA/H2O-mixture. Subsequently, the primary 
hydroxyl function of 69170 was selectively protected either as a levulinoyl ester (70a) or as 
an acetyl ester (70b) by applying standard esterification methods. Finally, the Fmoc 
protecting group was installed as a temporary protecting group at the C4-position. 
To obtain naphthyl protected BB11, the intermediate 10 was selectively protected with a 
benzyl group in the C3-position, following the same two step procedure130 as described 
above for the synthesis of BB1. Installation of the naphthyl ether at the C2-position was 
performed with naphthyl bromide and 72 was obtained in good yield. Subsequent removal 
of the benzylidene acetal under acidic conditions, giving 4,6-dihydroxy intermediate 73, 
was only achieved in moderate yields. The reaction could not be pushed to completion, as 
longer stirring under acidic conditions provoked cleavage of the naphthyl ether. The acetyl 
protecting group at the C6-position (74) and the Fmoc protecting group at the C4-position 
(BB11) were introduced as described for BB10 in good yields.  





Scheme 21: Synthesis of D-galactopyranose BBs BB10,  BB11 and BB12. Reagents 
and conditions: a) LevOH, DIC, DMAP DCM, -6 °C to rt, 81%; b) AcOH, DCC, DMAP 
DCM, 0 °C to rt, 82%; c) FmocCl, pyridine, DCM, rt, 57% for BB10a , 75% for BB10b ;  
d) BH3 , TMSOTf, DCM, 0 °C to rt, quantitative; e) AcOH, DIC, DMAP DCM, 0 °C to 
rt, 58%; f) NapBr, NaH, DCM/DMF, 0  °C to rt, 89%; g) TFA/H2O, DCM, rt, 51% h) 
AcOH, DIC, DMAP, DCM, 0 °C to rt, 66%; i) FmocCl, pyridine, DCM, rt, 67%.  
Apiose BB13 was synthesized from reported 2,3-O-isopropylidene-1-thio-α-D-
erythrofuranoside (81) (scheme 22).157 Intermediate 81 was synthesized following 
literature procedures157 via the 2,3-O-isopropylidene protected L-arabinose dithioacetal 
78. Oxidative cleavage of the vicinal C4 and C5 hydroxyl groups of 78 yielded aldehyde 
79. This aldehyde was then reacted in an aldol-Cannizzaro reaction to give the acyclic 
version of apiose derivative 80 which could be cyclized using NIS as a promoter. It is 
noteworthy that the 2,3-O-isopropylidene acetal protecting group in apiose has been 
described as too stable to be removed from an oligosaccharide without decomposition 




and therefore was exchanged for a 2,3-O-benzylidene protecting group which can be 
readily removed under hydrogenolytic conditions.157 Attempts to exchange the acetal 
protecting group in presence of the naphthyl protecting group failed due to the lability of 
the Nap group to strong acids. The 3’-hydroxy group of intermediate 81 was thus 
temporarily protected as an acetyl ester. This allowed the exchange of the acetal 
protecting group to yield the 2,3-O-benzylidene acetal 83. Subsequent deprotection of the 
3’C-OH under basic conditions and installation of the naphthyl ether yielded the desired 
BB13. 
 
Scheme 22: Synthesis of apiose BB13. Reagents and conditions: a) AcOH, DCC, 
DMAP DCM, 0 °C to rt, 97%; b) TFA/H2O, DCM rt then PhCH(OMe)2 , CSA, rt, 35%, 
c) NaOMe, MeOH, rt, 96%, d) NapBr, NaH, 0  °C to rt, 86%. 
With the four desired BBs (BB10–BB13) in hand, suitable reaction conditions for 
the assembly of target structure 66 by AGA were explored. In an initial test series the 
levulinoyl protected BB10a was compared to the acetyl protected BB10b regarding its 
efficiency in glycosylation reactions. Therefore BB10a was coupled to the photo-labile 
linker-functionalized resin 23 by glycosylation with NIS and catalytic amounts of TfOH 
using two cycles of 3.8 equiv BB at -10 °C. After Fmoc-deprotection, another glycosylation 
using two cycles with 3.8 equiv BB10a at -10 °, Fmoc-deprotection and removal of the 
Lev-groups were performed. HPLC analysis of the crude product after UV-light induced 
cleavage from the solid support revealed that mainly linker-bound monosaccharide was 
formed in the form of an α/β-mixture (fig. 15). This means that the glycosylation between 
the linker and the first monosaccharide did not proceed in a stereoselective manner, 
probably because the primary hydroxyl group of the linker was too nucleophilic for 




significant stereochemical control in the reaction.171 Next, acetyl protected BB10b was 
tested in AGA to see if a change in the protecting group at the C6-position improves 
glycosylation efficiency. The acetyl protected disaccharide 85b was assembled on solid 
support by two rounds of glycosylation and deprotection. The glycosylations were again 
performed with NIS and catalytic amounts of TfOH using two cycles of 3.8 equiv of BB at -
10 °C. HPLC analysis after cleavage of the product from the solid support showed that the 
desired disaccharide was obtained as the major product. The stereochemistry of this 
product was determined by 2D-NMR spectroscopy after HLPC purification (fig. 15). The 
second glycosylation reaction resulted in the exclusive formation of the desired α-(1,4)-
glycosidic linkage between the two galactose moieties. Interestingly, the isolated 
disaccharide was found to be almost exclusively β-linked to the linker (fig. 15 B and C) 
suggesting that the β-linked monosaccharide is a better glycosyl acceptor than the α-
linked monosaccharide.165,172 
Any attempts to assemble longer α(1,4)-galactan oligosaccharides using the same 
glycosylation conditions as described above, gave unsatisfying results (fig. 16). The yields 
in the syntheses of trisaccharides 86 and 87 were low and purification of the desired 
compounds by HPLC proved to be very difficult, due to the formation of diastereomeric 
mixtures of the oligosaccharides that were linked either in an α-orβ-configuration to the 
linker. 
  








Figure 15: A) Comparison of galactosyl donors BB10a and BB10b in the automated 
glycan assembly of disaccharides 85a and 85b. Reagents and conditions: 2 x 3.8 
equiv of BB10a or BB10b , NIS, TfOH, DCM/dioxane, -30 °C (5 min)  -10 °C (30 
min); b) 3 cycles of 20% NEt3 in DMF, 25 °C, c) (5 min), N2H4·HOAc (155 mM) in 
pyridine/AcOH/H2O 4:1:0.25, 25 °C (30 min); d) h (305 nm). B) Crude NP HPLC 
chromatograms of 85a and 85b (ELSD trace). 85a was only obtained in traces. C)  C-
H coupled HSQC-NMR of product 85b: coupling constant (C1’-H1’) of 168 Hz 
indicates an - l inkage between the galactose moieties and coupling constant (C1 -
H1) of 156 Hz indicates a  -linkage between the first galactose moiety and the 
linker.
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Figure 16: A) Automated glycan assembly of trisaccharides 86 and 87 . Reagents 
and conditions: 2 x 3.8 equiv of BB1b, BB2 or BB3 NIS, TfOH, DCM/dioxane, -30 °C 
(5 min)  -10 °C (30 min); b) 3 cycles of 20% NEt 3 in DMF, 25 °C (5 min), c) h (305 
nm). B) HPLC-chromatograms of the crude products (ELSD trace). The letter code 
below the structures represents the synthesizer modules and deprotection steps 
used for the syntheses. 
 




2.2.3 Solution-Phase Synthesis of the RG-II Galacturonan Backbone 
2.2.3.1 Solution-Phase Synthesis of the RG-II Galacturonan Backbone 
using a Fluorinated Linker  
To see if the stereo-control over the first glycosylation reaction can be improved, a 
series of test glycosylations was run in solution phase to exploit the use of a different 
linker. Recently, it was shown that the use of a modified linker which carries two fluorine 
atoms in close proximity to the nucleophilic hydroxyl group can improve the 
stereoselectivity in the glycosylation of the linker. The fluorine atoms decrease the oxygen 
nucleophilicity and thereby switch the stereochemical outcome of the reaction to 
preferentially form the α-glycosides.173 Small amounts of the fluorinated linker were kindly 
provided by my colleague Dacheng Shen. 
Reacting BB10b with 2,2-difluoro-3-amino-1-propanol-linker 88 after activation of 
the thioglycoside donor with NIS and catalytic amounts of TfOH at 0 °C followed by 
removal of the Fmoc-protecting group gave linker-functionalized monosaccharide 89 in 
good yield (70%) (fig. 4). Compound 89 was exclusively obtained as the α-anomer which 
was confirmed by 2D-NMR spectroscopy analysis (fig. 17). 89 was subsequently reacted 
with thioglycoside donor BB11. After removal of the temporary Fmoc-protecting group, 
linker-functionalized disaccharide 90 was obtained and the α-selectivity of the 
glycosylation reaction was again confirmed by 2D-NMR spectroscopy analysis (fig. 17). 
Anyhow, due to poor yields (28% for glycosylation and subsequent Fmoc removal) in the 
second glycosylation reaction only small quantities of disaccharide (90) were obtained. 
Attempts to further use disaccharide 90 as an acceptor substrate in a glycosylation 
reaction with donor BB12 were not successful. Several factors may have contributed to 
the failure of this glycosylation reaction: i) The low nucleophilicity of a galactose C4-
hydroxyl group is even lower when the acceptor galactose is α-configured. Theoretical 
calculations showed that the C4-OH of an α-linked galactose cannot form a strong 
hydrogen bond with the pyranosyl oxygen atom and is therefore less nucleophilic.174 ii) 
The bulky naphthyl group at the C2-position might have increased the steric bulk around 
the axial C4-hydroxyl group, as the naphthyl moiety is most likely pushed above the ring 
plane of the acceptor galactose as the space below the ring plane is occupied by the first 
galactose moiety bound via the 1,2-cis-glycosidic linkage. Hence, it was concluded that 
the assembly of longer α(1,4)-galactan structures in reasonable amounts is not possible 
with this set of BBs. 





B)                                                                      C) 
 
Figure 17: A) Solution-phase synthesis of α(1,4)–linked galactan oligosaccharides using a 
difluorinated linker. Reagents and conditions: a) NIS, TfOH 0 °C to rt then b) NEt3 rt; Yields: 
89: 70% two steps, 90 28% two steps B) Coupled HSQC-NMR of 89 showing a coupling constant 
of 172 Hz for C1-H1 (peak appears as duplet of a duplet due to fluorine coupling) indicating a 1,2-
cis-linkage. C) Coupled HSQC-NMR of 90 reveal coupling constants of 172 Hz for C1-H1 and for 
C1’-H1’, indicating the presence of two 1,2-cis-linkages.
 
  




2.2.3.2 Solution-Phase Synthesis of the RG-II Galacturonan Backbone 
Using Galacturonic Acid Lactone Buidling Blocks 
Although the stereoselectivity for the attachment of the first galactose moiety to the 
linker could be improved significantly by the usage of the fluorinated linker 88, the results 
in the syntheses of longer α(1,4)-galactans employing BBs BB10b to BB12 remained 
unsatisfying. Therefore, it was decided to change the synthetic strategy and BB design to 
overcome the inherent low reactivity of the C4-hydroxyl group of α-linked galactose 
residues. A very attractive strategy to incorporate -galacturonic acid moieties into 
oligosaccharide structures has been published by Codée et al. They employed 
galacturonic acid 3,6-lactones in the synthesis of trisaccharide repeating units of the 
capsular polysaccharide of Streptococcus pneumonia, Sp1. The employed galacturonic 
acid lactone BBs (BB14 and BB15) are conformationally locked and thus more reactive 
and selective in glycosylations, providing -linked galacturonides in good yields.175 The 
activation of the galacturonic acid lactone BBs by a preactivation-based strategy with 
diphenyl sulfoxide and triflic anhydride at -45 °C gave rise to -selective glycosylation, 
presumably through the intermediacy of an axial β-triflate that is replaced by the 
nucleophile in an SN2 type reaction.
176 It was shown that the C4 hydroxyl groups of these 
BBs were good nucleophiles and can act as glycosyl acceptors.175 By locking the sugar in 
the 1C4-chair conformation, the C4-hydroxyl group is forced into an equatorial position 
which increases its nucleophilicity. Based on these results, it was anticipated that the 
RG-II galacturonic acid backbone could be synthesized by consecutive coupling of 
lactone building blocks BB14, BB15 and BB16 (scheme 22). The galacturonic acid 
lactone BB14 was synthesized following literature procedures175,177 by chemo- and 
regioselective oxidation of the primary hydroxy group of 2,4-O-dibenzyl-3,6-dihydroxy-1-
thio galactopyranoside and concurrent intramolecular lactonization with the C3 hydroxyl 
function. BB15 was prepared following an eight step literature synthesis.175 2-O-naphthyl-
protected BB16 was analogously synthesized from 92. The naphthyl protecting group 
remained stable during the TEMPO and BAIB mediated oxidation of the primary hydroxyl 
function (scheme 22).  





Scheme 22: A) Retrosynthetic approach towards a protectedα(1,4)-galacturonic acid 
oligosaccharide with a 2-O-naphthyl protecting group at the central GalA unit group for later 
installation of a RG-II side chain. B) Galacturonic acid lactone BB synthesis starting from 
peracetylatedβ-D-galactose. BB14 and BB15 were synthesized following literature procedures. 
BB16 was synthesized analogously to BB15. Reagents and conditions: a) TEMPO, BAIB, DCM, rt; 
b) AcOH/H2O 65 °C; ethyl chloroformate, DIPEA, rt, 17% over three steps. 
With the galacturonic acid lactone BBs in hand, the assembly of galacturonic acid 
oligosaccharides was tested. The desired oligosaccharides were assembled from the 
non-reducing end to the reducing end by iterative preactivation of the glycosyl donor 
followed by addition of the acceptor and purification of the resulting oligosaccharide. 
Preactivation of donor BB14 by the addition of diphenyl sulfoxide and triflic anhydride in 
the presence of tri-tert-butyl pyridine as buffer at -45 °C led to formation of a reactive β-
triflate intermediate which was reacted with acceptor BB15 or BB16 at -60 °C. 
Unfortunately, the desired disaccharides 93a and 93b were only obtained in moderate 
yields (28%-35%). The disaccharide 93a was obtained as an anomeric mixture of the α- 
and β-thioglycosides (fig. 18), indicating that an aglycon transfer occurred which is a 




commonly observed side reaction when a glycosyl acceptor possessing a thioglycoside 





Figure 18: A) Assembly of two galacturonic acid lactone building blocks followed by lactone 
opening and subsequent protection of the carboxylic acid function. Reagents and conditions: a) 
Ph2SO, TtBPy, Tf2O -60 °C to -45 °C then to -60 °C and addition of acceptor BB15 or BB16; b) 
TMSONa, DCM, rt; c) Cs2CO3, BnBr, DMF, rt. B) Coupled HSQC-NMR of 93a shows two different 
coupling constants for C1-H1 (JC-H = 160 Hz and JC-H = 172 Hz) as result of an aglycon transfer 
side reaction. Coupled HSQC-NMR of the diastereomeric mixture of 95a. 
The lactone rings of disaccharides 93a and 93b were hydrolyzed applying 
TMSONa as a nucleophile and the resulting carboxylic acids were subsequently esterified 
by treatment with BnBr and Cs2CO3 (fig 18). 2D NMR-spectroscopic analysis confirmed 
that only the α-linked disaccharides 94a and 94b were obtained (fig. 18). The syntheses 
of longer galacturonic acid lactone oligosaccharides were planned to be performed by 
preactivation of lactone disaccharides 93a and 93b and addition of further lactone BB 




acceptor (BB15). The reaction was monitored by TLC and MS, but no reaction progress 
was observed. Even when the temperature was slowly increased to -10 °C after 
preactivation with Ph2O and Tf2O, no product formation was observed by MS or TLC. Also 
exchanging the activators to the strongly electrophilic reagents 
dimethyl(methylthio)sulfonium triflate (DMTST)178 at temperatures from -78 °C to rt or 
dimethyldisulfide and Tf2O
179 at -78 °C to rt did not activate the lactone BBs, but only led 
to decomposition of the glycoside donor at higher temperatures.  
These results confirmed previous findings by van der Marel et al. who could only 
activate galacturonic acid lactone monosaccharides by preactivation with 
diphenylsulfoxide and triflic anhydride or in situ by the extremely electrophilic p-
nitrophenylsulfenyl triflate promoter system but not with a NIS/triflic acid promoter system. 
As all attempts to activate 93a or 93b failed, the successive usage of galacturonic acid 
lactone BBs for the assembly of longer structures was considered a synthetic dead end 
(scheme 23). 
 
Scheme 23: Activation of donors 93a and 93b for glycosylation reaction with acceptor BB15 could 
not be realized. Conditions and reagents: a) Ph2SO, TtBPy, Tf2O -60 °C to -45 °C then to -60 °C 
and addition of acceptor BB6 followed by slow warming to room temperature while tight monitoring 
of the reactionby TLC and MS. 
 
2.2. 4 Conclusion and Outlook 
In conclusion, the assembly of a RG-II fragment library using different types of BBs 
either using AGA or solution-phase synthesis was attempted. To assemble an apiose 
substituted homogalacturonan backbone on solid support, three galactose building blocks 
suited for a post-glycosylation oxidation strategy and one apiose BB have been 
synthesized. Though the protectedα(1,4)-galactan trisaccharides (86 and 87) could be 
synthesized on solid phase using AGA, the yields remained unsatisfactorily low due to the 
low nucleophilicity of the C4-hydroxyl group of galactose. It was found that the low 
reactivity of the C4 nucleophile is especially problematic when the acceptor galactose 
moiety is equipped with a naphthyl protecting group at the C2-position. Furthermore, the 




observed limited diastereoselective control over the first glycosylation reaction with the 
linker made the isolation of sufficient amounts of material for post-assembly modifications 
of the oligosaccharide impossible. In a solution phase test series the diastereoselectivity 
during the glycosylation reaction with the linker could be improved using a fluorinated 
linker giving the α-linked glycan exlusively. Unfortunately the following glycosylation 
reactions in solution phase still remained low yielding due to the inherent low 
nucleophilicity of the C4-OH of the galactose BBs. 
To overcome the impeding low nucleophilicity of the C4-OH of galactose, a series 
of galacturonic acid lactone BBs was synthesized and evaluated for their potential to 
assemble α(1,4)-linked galacturonic acid oligosaccharides. By locking the galacturonic 
acid as lactone in the 4C1-conformation
 and forcing the C4-OH into an equatorial position 
the reactivity of the C4-OH should be increased. It was shown that two galacturonic acid 
lactone BBs can be reacted α-selectively by preactivation of the donor substrate with 
diphenyl sulfoxide and triflic anhydride. Unfortunately, larger galacturonic acid 
oligosaccharides could not be synthesized as the disaccharide donors 93a and 93b could 
not be activated for further glycosylation.Libraries of RG-II backbone structures of 
different length carrying different side-chain fragments remain challenging but highly 
interesting synthetic targets. To achieve the assembly of a comprehensive library of RG-II 
fragments in high yields by AGA, new monosaccharide building blocks will have to be 
designed and evaluated. One useful modification of the BBs could be the exchange of the 
2-O-naphthyl protecting group of BB11 to a less sterically demanding temporary 
protecting group such as PMB. The results of the preliminary studies presented in this 
chapter imply that a solid support equipped with a fluorinated linker173 may be used in 
AGA to overcome problems in the stereocontrol during the first glycosylation reaction that 
attaches the galactose BB to the linker. Furthermore, the yields in AGA might be 
improved applying capping steps after each glycosylation reaction as recent studies have 
demonstrated.102 
  




2.3 Chemical Synthesis of Functionalized Sugar Nucleotides for 
Glycan Microarray Screenings of Plant Glycosyltransferases 
2.3.1 High-throughput Characterization of Plant Glycosyltransferases  
During the last decade, many enzymes that are involved in cell wall 
polysaccharide biosynthesis (mainly glycosyltransferases) have been identified by genetic 
screens.180 Unfortunately, biochemical characterization of these enzymes lags behind, 
partly due to a lack of suitable assays which allow a high-throughput characterization of 
the substrate specificities of glycosyltransferases. Novel approaches towards quantitative 
high-throughput analyses of plant glycosyltransferase activities that are applicable with a 
wide range of enzymes, are operationally simple and give reproducible results, are highly 
needed to push forward the biochemical characterization of plant 
glycosyltransferases.The major obstacle in the development of high-throughput methods 
so far has been the lack of well-defined oligosaccharide acceptor substrates. Due to our 
development of glycan microarrays that are equipped with plant related oligosaccharides 
obtained by AGA, further progress towards high-throughput methods may be realized. A 
possibility to determine the substrate specificities of glycosyltransferases is to incubate 
such a microarray with the respective enzyme and to determine which oligosaccharide 
served as a substrate. However, detection of glycosyl transferase binding is less 
straightforward than in the case of mAbs or lectins, as the glycosyl transferases do not 
bind permanently to the array. Therefore, specific detection of the products of the 
enzymatic reactions is required. In the literature several methods to detect the products of 
enzymatic reactions on microarrays have been described. A very versatile approach is to 
use mass spectrometry for the detection of the glycans immobilized as self-assembled 
monolayers on gold181 or on a lipid bilayer conjugated to an indium-tin oxide surface,182 
but so far these specialized chips are not commercially available and the number of 
glycans that can be immobilized is significantly lower than for standard arrays. Other very 
sensitive assays use 14C-labled sugar donors69 or 3H-labled sugar donors183, which allow 
the radiometric detection of incorporated monosaccharides to specific glycans on the 
array. Though this technique is very sensitive, handling of the radioactive probes needs 
specialized equipment, trained personal and produces radioactive waste that has to be 
costly disposed and therefore is unsuited for the development of high-throughput assays. 
A third method to detect the enzymatic reaction products on the microarray is the use of 
lectins or antibodies as molecular probes.184,185 However, specific molecular probes for 
the reaction products often are not available. The fourth method of detection makes use 




of chemically functionalized sugar nucleotide donors. When chemically modified, the 
donor substrate can be detected on the microarray after the enzymatic reaction by 
introduction of a label at the functionalized groups.186 Though chemical modifications of 
the sugar nucleotide donors may not be accepted by all classes of glycosyltransferases, 
small modifications of the sugar nucleotide donors such as the introduction of azide- or 
alkyne-functionalities are generally well tolerated by glycosyltransferases, as reported in 
metabolic glycan engineering studies.187-191 All the methods summarized above are 
valuable tools for the detection of the reaction products on glycan microarrays after 
incubation with glycosyltransferases and sugar nucleotides.  
In this chapter, the development of a new high-throughput method for the 
characterization of plant glycosyltransferases using carbohydrate microarrays is 
described. In this assay, microarrays equipped with plant-derived oligosaccharides are 
incubated with putative glycosyltransferases and functionalized UDP-sugar donors (fig. 
19). After incubation, the enzymes and the side products are washed off the microarray 
surface and a fluorescent label is attached to the functionalized monosaccharide units 
that have been incorporated into the oligosaccharide acceptors immobilized on the 
surface (fig. 19). Read-out of the fluorescent signals on the microarray surface then 
allows to determine the acceptor substrate specificities of the glycosyltransferases (fig. 
19).  
It was envisioned that UDP-sugar donors functionalized with azido- or amino-
groups would serve best for this purpose as azido- or amino-functionalities are small and 
easily reacted with a fluorescent dye by copper catalyzed “click”-chemistry192 or NHS-
ester coupling. Two functionalized UDP-Galps (97 and 99) were chosen as initial donors 
for realizing proof of principle experiments. Galactose is ubiquitous in pectin 
polysaccharides and in hemicelluloses. Still, many galactosyltransferases involved in the 
biosynthesis of galactose containing polysaccharides have not been biochemically 
characterized yet. The sugar donor for the synthesis of these galactose containing 
polysaccharides is UDP--D-Gal.193 Natural UDP-Galp is commercially available and can 
serve as positive control to evaluate the tolerance of the putative galactosyltransferases 
towards modifications of the UDP-Galp substrates in a HPLC assay. The use of azido-
functionalized UDP-donors enables the use of a reliable labeling strategy based on 
copper catalyzed “click”-chemistry for the attachment of an alkyne-linked fluorophore to 
the products of the enzymatic reactions on the array surface. The azido functionalized 
UDP-Galps (97 and 99) may later be reduced to the corresponding amino-functionalized 
UDP-Galps (98 and 100). Besides functionalized UDP-Galp, functionalized UDP-Araf 101 
was chosen to be synthesized (fig. 19). L-Araf is a common component of plant cell wall 
polysaccharides. The biosynthesis of branched pectic arabinan structures for example 




requires up to 18 different arabinosyltransferases194 which use UDP--L-Araf as donor 
substrates.195 However, until today very few arabinofuranosyltransferases have been 
biochemically characterized. The characterization of arabinosyltransferases was mainly 
hampered by the limited availability of UDP-L-Araf.194 So far, only the characterization of 
one arabinosyltransferase using exogenous acceptor substrates and UDP--L-Araf has 
been reported.196 To establish a high-throughput assay for arabinosyltransferases as 
described above, access to sufficient amounts of functionalized UDP-Araf as well as non-



























































Figure 19: Microarray assay for the high-throughput characterization of plant 
glycosyltransferases employing functionalized sugar  nucleotides. A) The microarray 
that is equipped with synthetic oligosaccharides of defined structures is incubated 
with a putat ive glycosyltransferase and a functionalized sugar-nucleotide. B) After 
the enzymatic reaction the microarray is washed, and the functionalized 
monosaccharides incorporated into surface bound glycans are labeled by reaction 
with a f luorescent probe. C) Read-out of the f luorescent signals. D) Functionalized 
sugar-nucleotides to be synthesized.  




2.3.2 General Considerations for the Chemical Synthesis of Sugar-
Nucleotides 
Glycosyltransferases assemble monosaccharide precursors into larger glycan 
structures by successively adding sugar-nucleotides to oligosaccharide acceptors. Sugar-
nucleotides are activated forms of monosaccharides which are composed of a sugar 
derivative and a nucleoside diphosphate (NDP-sugars) or a nucleoside monophosphate 
(NMP-sugars).197 The majority of monosaccharide donors for the biosynthesis of plant 
glycans are NDP-sugars.193 Chemical synthesis that makes naturally occurring sugar-
nucleotides or modified analogues available in large quantities as substrates for the study 
of glycan biosynthesis, as enzyme inhibitors or as tools for assay development is of great 
importance. The chemical synthesis of sugar nucleotides is non-trivial and needs 
sophisticated synthetic approaches: Low solubility in organic solvents and susceptibility of 
the glycosidic and pyrophosphate bonds to hydrolytic cleavage complicate the handling 
and purification of the compounds.197 NDP-sugars are usually synthesized from an 
activated nucleoside monophosphate and a glycosyl monophosphate, which are coupled 
to form the pyrophosphate (fig. 20). The advantage of this synthetic approach is the 
predetermined anomeric configuration of the sugar monophosphates which prevents the 
formation of diastereomeric mixtures of the final compound. 
 
Figure 20: General synthetic strategy for the synthesis of NDP-sugars. The pyrophosphate bond is 
formed by coupling of a glycosyl phosphate and an activated nucleoside monophosphate.  The 
nucleoside monophosphate is activated by installation of a suitable leaving group (LG). 
The most commonly used nucleoside monophosphate derivatives for the synthesis 
of sugar-nucleotides are phosphoric acid amides, usually nucleoside 
phosphoromorpholidates.198,199 Generally, condensation reactions between a sugar 1- 
phosphate and a nucleoside monophosphate morpholidate are slow and the chemical 
yields are low. The reaction can be accelerated by the addition of catalytic amounts of 1H-
tetrazole which acts as both an acidic and a nucleophilic catalyst.200 Meier et al. reported 
a conceptually new approach to sugar nucleotides that employs pyranose-1-phosphates 
and cyclo-saligenyl (cycloSal) nucleosyl phosphate triesters as active esters (scheme 
24).201 They showed that the cycloSal method can be applied to couple various protected 
sugar phosphates with the nucleosides of thymine, cytosine, uracil, guanine and adenine. 




Coupling is achieved efficiently using mild conditions and DMF as the solvent in good 
overall yields (22-88%).  
 





2.3.3 Chemical Synthesis of Functionalized UDP-Galactopyranose 
The synthesis of compound 97 was realized by applying the cycloSal method 
established by Meier et al.201,203 for coupling 6-azido galactose phosphate 105 with 
activated uridine monophosphate 110. Functionalization of the C6-position of galactose 
was performed first as it requires few synthetic steps and the synthesis of 6-azido-
UDP-Galp was already reported in literature using UMP-morpholidate chemistry.204 
However, it was decided to synthesize the functionalized UDP-galactoses using the 
cycloSal strategy, as higher yields and shorter reaction times were anticipated.  
 
Scheme 25: Synthesis of the acetyl protected intermediates 105 and 110 A) Synthesis of 2,3,4-tri-
O-6-azido-6-deoxy--D-galactopyranosyl 1-phosphate (105) from 1,2:3,4-di-O-isopropylidene--D-
galactose (102).
204
 Reagents and conditions: a) 2-Chloro-4H-benzodioxaphosphorin-4-one, NEt3, 
dioxane, rt, then H2O, rt, then H3PO3, MeCN, rt, 67% b) tBuOOH, I2, THF, rt, 30%. B) Synthesis of 
5-chloro-cycloSal-2’,3’-O-diacetyluridine monophosphate (110) by coupling 2,3-di-O-acetyl uridine 
(109) with 5-nitro-cycloSal phosphorochloridite (107). Reagents and conditions: c) NEt3, MeCN, 
0°C to rt then oxone, water, rt, 24% over two steps. 




The synthesis of key intermediate 103 was performed according to literature 
procedures205 starting from protected galactose 102. With 103 in hand, the anomeric 
phosphate group was installed via the galactopyranosyl phosphite intermediate 104. 
Phosphitylation of 103 with 2-chloro-4H-benzodioxaphosphorin-4-one gave a reactive 
cyclic phosphite which was converted into 104 by hydrolysis, yielding an anomeric 
mixture. The anomeric mixture was dissolved again in MeCN and equilibrated into the 
thermodynamically favored-anomer 104 using phosphorous acid as reported in 
literature.204 Subsequently, the anomeric phosphite group of 104 was oxidized to give the 
corresponding phosphate 105.  
In order to obtain cycloSal-activated UMP 110, compound 107201, which was 
obtained from 5-nitrosalicylic acid by reduction of the acid with borane and further reaction 
with phosphorous trichloride, was reacted with partially protected uridine 109206. 
Formation of the pyrophosphate bond in 97 was achieved by coupling acetyl protected 
galactose 1-phosphate 105 with the active ester 110. The two components were stirred at 
rt in DMF under argon atmosphere in the presence of molecular sieves. Removal of the 
acetyl protecting groups upon stirring with triethylamine in a mixture of water and 
methanol gave then the desired uridine 5’-(6-azido-6-deoxy--D-galactopyranosyl) 
diphosphate (97) which could be isolated in 25% yield after ion exchange chromatography 
and subsequent solid phase extraction using a Carbograph column (scheme 26).  
To obtain 4-azido functionalized galactose phosphate 99, a synthesis starting from 
the commercially available compound 111 was designed. Literature known intermediate 
112207 was obtained by acetylation of the primary hydroxyl group in 111, subsequent 
mesylation of the C4-hydroxyl group and displacement of the mesyloxy function at the C4-
position by an azide in an SN2 reaction under inversion of the C4 stereocenter. Exchange 
of the anomeric methoxy group by an acetyl group then gave the desired intermediate 
112 as reported in literature.207 Selective de-O-acetylation at C1 using hydrazinium 
 
Scheme 26: Synthesis of UDP-6-azido-Galp (97) starting from acetyl protected uridine cycloSal 
phosphate triester 110 and the acetyl protected galactosyl 1-phosphate 105. Reagents and 
conditions: Molecular sieves (4 Å), DMF, rt; then MeOH/H2O/NEt3 (7:3:1), rt, 25% over two steps. 




acetate in DMF205 allowed the installation of the anomeric phosphate as described above 
for the synthesis of 104 (scheme 27).  
Coupling of 114 to active ester 110, as described above for the synthesis of 
compound 97 and subsequent removal of the acetyl protecting groups by methanolysis 
gave the functionalized galactosyl nucleotide donor 99 (scheme 28).  
Synthesis of amino-functionalized UDP-Galp 98 and 100 was achieved by stirring 
the azide in water together with palladium on activated carbon under a hydrogen 
atmosphere yielding UDP-6-amino-Galp 98. Though the reduction of compound 99 turned 
out to be rather slow and was thus more prone to side reactions such as the reduction of 
the uracil double bound, the reduction to 4-amino-UDP-Galp 100 could be achieved under 
the same reaction conditions as for the synthesis of 98 (scheme 29). 
 
Scheme 29: Synthesis of UDP-6-amino-Galp 98 and UDP-4-amino-Galp 100. Reagents and 
conditions: a) 10 wt % Pd/C, H2, H2O, rt, 84% for 98 and quant. for 100. 
 
Scheme 27: Synthesis of 4-azido-galactosyl 1-phosphate 114 from advanced glucose intermediate 
111. Reagents and conditions: a) N2H4•AcOH, DMF, 50 °C then 2-chloro-4H-
benzodioxaphosphorin-4-one; NEt3, dioxane, rt; then H2O, rt; then H3PO3, MeCN, rt, 64% b) 
tBuOOH, I2, THF, rt, 33%. 
 
Scheme 28: Synthesis of UDP-4-azido-Galp 99 starting from the acetyl protected uridine cycloSal 
phosphate trimester 110 and the acetyl protected 4-azido-4-deoxy-galactosyl 1-phosphate 114. 
Reagents and conditions: a) Molecular sieves (4 Å), DMF, rt, then MeOH/H2O/NEt3 (7:3:1), rt, 15% 
over two steps. 




2.3.4 Chemical Synthesis of UDP-Arabinofuranose and Functionalized 
UDP-Arabinofuranose 
Unfortunately, natural UDP--L-Araf is expensive and fairly unstable.208 There is 
only one chemical synthesis of UDP-Araf reported.209 It is based on UMP-morpholidate 
chemistry, using -L- Araf 1-phosphate which is coupled to morpholidate-activated UMP. 
However, it was decided to synthesize the substrates 101 and 124 applying the cycloSal 
strategy employing 110 to establish a synthetic method for the large-scale synthesis of 
natural and unnatural UDP-Araf donor substrates. The required -L-Araf 1-phosphate 118 
and 5-amino-5-deoxy--L-Araf 1-phosphate 122 were synthesized in a divergent manner 
starting from L-arabinose. The key intermediate 115 was synthesized following a reported 
procedure.210 L-Arabinose was forced into the furanose conformation by protecting the 
C5-hydroxyl group as a trityl-ether and the remaining hydroxyl groups as acetyl esters. 
Removal of the trityl group under acidic conditions gave then 115. 115 was either further 
acetylated with acetic anhydride in pyridine to give peracetylated Araf derivative 116 or 
equipped with an azide group at the C5-position. Installation of the azide functionality was 
achieved via tosylation of the C5-hydroxyl group (120) and subsequent SN2 reaction with 
sodium azide, analogously to a reported procedure211 for the synthesis of the respective 
D-isomer.  
To obtain the 1,2-cis-configured -L-Araf 1-phosphate 117, peracetylated Araf 
intermediate 116 was reacted with trimethylsilyl bromide and dibenzyl phosphate following 
a reported procedure209. The β-anomer of phosphate 117 was obtained exclusively, albeit 
in low yields. Removal of the benzyl protecting groups by catalytic hydrogenation over 
10% palladium on charcoal in the presence of trimethylamine afforded the acetyl 
protected phosphate 118209 which was further deprotected by stirring in a methanol-water 
mixture at high pH, yielding the fully deprotected β-Araf 1-phosphate 119.209 
Azido functionalized arabinofuranose 121 was converted into 5-azido-5-deoxy-β-
Araf 1-phosphate 122 following the same synthetic strategy. Reaction of the anomeric 
mixture of 121 with trimethylsilyl bromide resulted in the formation of the α-bromide, which 
was to unstable to be isolated, but could directly be reacted with dibenzyl phosphate, 
giving 122 as the 1,2-cis-isomer exclusively. Assignment of the anomeric proton of 122 
with a characteristic doublet of a doublet at 6.01 ppm and coupling constants J1,P  and J1,2 
of 5.5 Hz and 4.0 Hz confirmed the 1,2-cis-configuration.212 





Scheme 30: Synthesis of -L-Araf 1-phosphate 119 and 5-amino  -L-Araf 1-
phosphate 123. Reagents and conditions: a) Ac2O, pyridine, rt, 95%; b) TMSBr, 
DCM, 0 °C to rt then dibenzyl phosphate, NEt 3, 0 °C to rt, 21%; c) Pd/C (10 wt%), 
NEt3,  rt; d) NEt3 , MeOH/H2O (3:2), rt, 94% over two steps; e) TsCl,  pyridine, DCM, rt, 
70%; f) NaN3 , DMF, 70 °C, 79%; g) TMSBr, DCM, 0 °C to rt then dibenzyl phosphate, 
NEt3, 0 °C to rt, 9%; h) Pd/C (10 wt%), NEt3 , r t then NEt3 MeOH/H2O (3:2), rt, quant.  
Unfortunately, the synthesis of the desired intermediate 122 was low yielding (10% 
maximum yield obtained). Similar observations were reported in the literature for the 
synthesis of 5-N-acetyl arabinofuranosyl 1-phosphate, concluding that arabinofuranosyl 1-
phophate derivatives which do not have a strongly electron withdrawing group at the C5-
position are too unstable to be efficiently handled or purified.211 Thus, 122 was quickly 
converted into arabinofuranosyl 1-phosphate 123 by reduction of the azide and 
simultaneous removal of the benzyl protecting-groups under hydrogenolytic conditions, 
and subsequent cleavage of the acetyl protecting groups under basic conditions (scheme 
30). 
With β-L-Araf phosphates 118 and the amino functionalized β-L-Araf phosphate 
123 in hand, coupling reactions with activated UMP were tested. In an initial test reaction 
the tri-O-acetyl protected arabinofuranosyl phosphate 118 was coupled to 110 by stirring 
the reactants in DMF at rt under argon atmosphere with activated molecular sieves. 
Formation of the acetyl protected UDP--L-arabinofuranose was detected by MS, but 
unfortunately subsequent removal of the acetyl protecting groups by methanolysis 
resulted in decomposition of the pyrophosphate bond (scheme 31).  





Scheme 31: Synthesis of UDP- -L-Araf using the cycloSal active ester of UMP. 
Removal of the acetyl protecting groups under basic conditions has led to 
decomposition of the pyrophosphate bond. Reagents and conditions: a)  molecular 
sieves (4 Å), DMF, rt, then MeOH/H2O/NEt3 (7:3:1), rt . 
To avoid the necessity to deprotect the final UDP-Araf, next the traditional method 
using deprotected sugar-1-phoshates and UMP-morpholidate was tested by stirring 1-
phosphate 119 together with UMP-morpholidate in anhydrous pyridine and 1H-tetrazole 
as activator (scheme 32) for three days at rt.209 The desired UDP--L-Araf was isolated in 
pure form, but in very low yield (1%) after several HPLC and ion exchange 
chromatography purification steps. Apparently, fully deprotected arabinofuranosyl 1-
phosphates are relatively unstable211 which might have caused slow degradation of the 
starting material 119 during the coupling reaction with 125 (scheme 32). Furthermore, 
partial isomerization of UDP-Araf into the UDP-Arap form has been observed upon storing 
the crude reaction mixture at -20 °C before HPLC purification. 
 
Scheme 32: Synthesis of UDP- -L-Araf using the UMP-morpholidate method. 
Reagents and conditions: a) 1H-tetrazole, pyridine, rt, 1%.  
The amino functionalized UDP-β-L-Araf 101 was synthesized analogously to 124 
(scheme 33). Couplings of amino functionalized sugar phosphates to morpholidate 
activated nucleoside monophosphates have been reported in literature.213 Purification by 
semi-preparative HPLC using a Hypercarb column and subsequent ion exchange 
chromatography gave small amounts (100 µg) of the desired UDP 5-amino-5-deoxy--L-
arabinofuranose (101). Analysis by NMR spectroscopy (1H and 31P) confirmed the 
structure of the desired compound. The anomeric signal of arabinose appeared as a 
doublet of doublet at 5.65 ppm (J = 5.9, 3.2 Hz), indicating a 1,2-cis configuration, as for 
124. The 31P NMR-spectrum showed two doublets of the same intensity, indicating the 
presence of a diphosphate linkage. Though only small quantities of the product were 




isolated, the availability of compound 101 will allow the evaluation of putative plant 
arabinosyltransferases on the microarray.  
 
Scheme 33: Synthesis of amino-functionalized UDP- -L-Araf  using UMP-
morpholidate method. Reagents and conditions: a) 1H-tetrazole, pyridine, rt, 1%.  
 
2.3.5 Characterization of Plant Galactosyltransferases on Glycan 
Microarrays Using Functionalized UDP-Galactopyranose. 
Preliminary studies establishing the new high-throughput screening method for 
glycosyltransferases on glycan microarrays described above were performed using the 
functionalized UDP-Galp sugar donors (97 and 98) and the well-known 
galactosyltransferase GALACTAN SYNTHASE 1 (GALS1). In the literature, it was 
reported that heterologously expressed and affinity-purified GALS1 from 
glycosyltransferase family GT92 successively transfers galactose residues from UDP-Gal 
onto β(1,4)-galactopentaose and thereby forms new β(1,4)-galactosyl linkages.56 The 
soluble catalytic domain of GALS1 and GALS2 were obtained from our collaboration 
partner Dr. Breeanna Urbanowicz (CCRC, Athens, GA, USA) who expressed the 
enzymes by transient transfection of suspension culture HEK293 cells as previously 
reported for the expression of AtXXT2.214 
First, enzyme activity was confirmed by my colleague Dr. Ruprecht by incubation 
of GALS1 with the linear β(1,4)-linked tetragalactoside 25 and natural UDP-Gal followed 
by HPLC-MS analysis of the reaction products. HPLC analysis confirmed the previously 
described activity of the enzyme with natural UDP-Gal. Penta-, hexa-, hepta- and 
octasaccharides could be detected (fig. 21). Next, tolerance of GALS1 towards azido- and 
amino-functionalization of the sugar donor was investigated by incubating GALS1 with the 
linear β(1,4)-linked tetragalactoside 25 and azido- and amino-functionalized UDP-Gal 
derivatives 97 and 98 followed by HPLC-MS analysis of the reaction products. It was 
observed that GALS1 tolerates modifications at the Gal-C6-position of the donor 
substrates, as azido-functionalized penta- hexa- and heptasaccharides were formed 
(fig. 21). The 6-amino-Gal-UDP donor substrate 98 was well tolerated by GALS1 as well, 
but only the formation of the amino-functionalized pentasaccharide was detected (fig. 21), 




implying that the amino-functionalized pentasaccharide did not serve as an acceptor 
substrate for further elongation with 6-amino-Gal residues. 
 
Figure 21: HPLC analysis (ELSD traces) of GALS1-catalyzed reactions of 
tetragalactoside acceptor 25 with natural UDP-Gal (top chromatogram), 6-azido-
UDP-Gal (middle chromatogram) and 6-amino-UDP-Gal ( lower chromatogram). 
Peaks are annotated with galactan ol igosaccharides. The enzymes were incubated 
together with the acceptor and the donor substrate in HEPES buffer (50 mM, pH 6.8) 
for 16 h. The enzymatic reactions were stopped by heating to 80 °C before the crude 
reaction mixture was subjected to analytical HPLC-analysis. Star symbol marks UDP 
side-product. 
After having confirmed the tolerance of GALS1 towards different modifications of 
the UDP-donor substrates, first experiments to test the microarray assay were performed 
by my colleague Dr. Colin Ruprecht. 
The microarrays were equipped with a set of 44 glycans of which each was printed in two 
different concentrations. Additionally, 11-azido-3,6,9-trioxaundecan-1-amine was printed 
on the microarray surface as a positive control (fig. 22). The glycans were obtained by 
AGA as described in chapter 2 (compound 1 to 24 and 26, fig. 22), provided by my 
colleagues Dr. Pietro Dallabernardina215,216 (compound 38 to 41, fig. 22) and Deborah 
Senf103 (compound 37, fig. 22), by collaboration partners118,141,217 (compounds 25, 28 to 36 
and 42, fig. 22), or purchased as polysaccharides from Megazyme (compound 43 and 44 
fig. 22).  
 The microarray was incubated with GALS1 and 6-azido-UDP-Gal (97) (0.01 – 
0.5 mM) for 16 h in a Mn2+-containing HEPES buffer (50 mM, pH 6.8) solution. 




Subsequently, the reaction mixture was washed off the microarray surface and the azido 
groups incorporated into surface attached glycans were allowed to react with the 
fluorescent dye Sulfo-Cy5-alkyne in the presence of CuSO4, a THPTA ligand and sodium 
ascorbate. After incubation for 1 h, the slides were washed, and the products were 
detected by fluorescence read-out at 635 nm. A fluorescent signal was only detected at 
positions that were equipped with β(1,4)-galactans consisting of at least four galactose 
moieties (fig. 22, A, compound 2,3 and 6), confirming the previously reported acceptor-
substrate specificity of GALS156. Concurring results were obtained for the incubation of a 
microarray slide with GALS1 and 4-azido-UDP-Gal 99 (fig. 22, C). Detection of 
incorporated amino functionalities after incubation of the glycan microarray with GALS1 
and 6-amino-UDP Gal was also successful (fig. 22, B). Coupling of the fluorescent dye 
was achieved by reaction of the amino groups with a crosslinker containing an NHS ester 
and an azide before application of the alkyne-functionalized fluorescent dye for the “click-
chemistry” reaction. The pattern of fluorescent signals for the incorporated amino 
functions was equal to the pattern of the incorporated azido functions (fig. 22, B compare 
to A), demonstrating that both methods of visualization perform equally well.  
 Interestingly, a similar but not identical pattern of fluorescent signals was detected 
when the microarray was incubated with GALS2 and 6-azido UDP Gal. GALS2 is another 
galactosyltransferase from glycosyltransferase family GT92 in Arabidopsis which was also 
obtained from our collaboration partner Dr. Breeanna Urbanowicz. GALS2 catalyzed the 
attachement of 6-azido-functionalized galactose from donor 97 into different β(1,4)-linked 
galactan oligosaccharides (compounds 1 to 3 and 6 and 7 fig. 22, D). However, these 
were very preliminary results, and enzyme and donor concentrations during incubation on 
the microarray probably have to be carefully adjusted for each enzyme to enable a 
reliable comparison between different enzymes.  





Figure 22: Microarray assays to study the substrate specif icit ies of  
galactosyltransferases GALS1 and GALS2.  A) Fluorescent signal after incubation 
with GALS1 and 6-azido-UDP-Gal and subsequent reaction with Sulfo Cy5-alkyne. 
B) Fluorescent signal after incubation with GALS1 and 6-amino-UDP-Gal and 
subsequent reaction with a NHS-ester- linked azide and Sulfo-Cy5-alkyne. C)  
Fluorescent signal after incubation with GALS1 and 4-azido-UDP-Gal. D) 
Fluorescent signal on the microarray after incubation with GALS2 and 6-azido-UDP-
Gal. E) Printing pattern of glycans on the microarray. The absolute intensities of the 
signals in A)-D) cannot be directly compared, as the pictures were  taken with 
different gain. Bright signals in the bottom right result from the posit ive control 
spots. 




2.3.6 Conclusion and Outlook 
In summary, a set of five functionalized and one natural UDP-sugar has been 
synthesized as substrates for the glycan microarray-based characterization of 
glycosyltransferases. Functionalized galactosyl 1-phosphates equipped with an azido-
group (97 and 99) were coupled with activated UMP using the cycloSal activation method 
in good yields. The azido-functionalized UDP-galactoses 97 and 99 were further 
transformed into the respective amino-functionalized UDP-galactoses 98 and 100 by 
reduction of the azido groups. However, the cycloSal method failed for coupling 
arabinofuranosyl 1-phosphate 124 to UMP, due to degradation of the product upon 
subsequent removal of the acetal protecting groups. Instead, natural UDP-Araf 124 as 
well as amino-functionalized UDP-Araf 101 could be synthesized in low quantities by 
coupling the unprotected Araf 1-phosphates 119 and 123 to morpholidate activated UMP. 
The functionalized galactose-UDP substrates 97, 98, 99 and 100 were used for 
preliminary proof-of-principle studies to investigate the substrate specificities of 
glycosyltransferases on a microarray equipped with synthetic oligosaccharides.  
The enzymatic reaction products after incubation of the glycan microarrays with 
GALS1 or GALS2 and the functionalized donors (97 to 100) were visualized by reaction of 
the array-bound azido- or to the amino- functionalities with fluorescent probes. Analysis of 
the fluorescent signals on the microarray confirmed the expected substrate specificities of 
GALS1. Detection of the fluorescent signal after incubation with the genetically-related 
GALS2 revealed that GALS2 has a similar substrate specificity to GALS1.  
Hence, it was shown that the newly developed method employing functionalized 
UDP-sugars on glycan microarray surfaces allows a high-throughput analysis of the 
substrate specificities of plant glycosyltransferases. Further functionalized sugar-







3 Experimental Part 
3.1 General Information 
The automated syntheses were performed on a self-build synthesizer developed in 
the Max Planck Institute of Colloids and Interfaces. Galactan-degrading enzymes were 
obtained from Megazyme International Ireland. Linker-functionalized resins 23107 and 
56144 were synthesized according to literature procedures. Resin loading was determined 
by performing one glycosylation (Module A) with large excess of BB3 followed by DBU 
promoted Fmoc-cleavage and determination of dibenzofulvene production by measuring 
its UV absorbance.218 Advanced intermediates for the synthesis of the BBs for AG 
oligosaccharides p-tolyl 2-O-benzoyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside 
(12)131, p-tolyl 2-O-benzoyl-3-O-tert-butyldimethylsilane-4,6-O-benzylidene-1-thio-β-D-
galactopyranoside (11)130, 2,3,5-tri-O-benzoyl-1-methyl--L-arabinofuranoside (16)128, 
ethyl 2-O-benzoyl-3,4-O-dibenzyl-6-O-fluorenylcarbonylmethoxy-1-thio-D-
galactopyranoside (38)143, and the building blocks dibutoxyphosphoryloxy 2-O-benzoyl-
3,6-dibenzyl-4-O-fluorenylcarbonylmethoxy-D-galactopyranoside (BB1)130, 
dibutoxyphosphoryloxy 2-O-benzoyl-3-O-fluorenylcarbonylmethoxy-4,6-O-dibenzyl-D-
galactopyranoside (BB3)130, ethyl 2,3-di-O-benzoyl-5-O-fluorenylcarbonylmethoxy-1-thio-
-L-arabinofuranoside (BB6)128, ethyl 2,3,5-tri-O-benzoyl-1-thio--L-arabinofuranoside 
(BB4)128, methyl-2-O-benzoyl-4-O-benzyl-3-O-fluorenylmethoxycarbonyl-1-di-O-
butylphosphatidyl-D-glucopyranosyluronate (BB9)142 were synthesized as described 
before. Phosphate BBs (BB1-BB3 and BB7-BB9) were used in the automated synthesis 
as mixtures of α/β-anomers. Advanced intermediates for the synthesis of BBs for RG-II 
fragments p-tolyl 2,3-O-dibenzyl-1-thio-β-D-galactopyranoside (69)170,171, p-tolyl 3-O-
benzyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (71)130, p-toyl 3-C-hydroxymethyl-
2,3-O-isopropylidene-1-thio-β-D-erythrofuranoside (81)157 and N-benzyl-N-
benzyloxycarbonyl-2,2-difluoro-3-amino-1-propanol (88)173 were synthesized as reported. 
Lactone BBs p-tolyl 2,4-dibenzyl-1-thio-β-D-galactopyranosidurono-3,6-lactone (BB14)177, 
p-tolyl 2-O-benzyl-1thio-β-D-galactopyranosidurono-3,6-lactone (BB15)175 and 
intermediate p-tolyl-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-1-thio-β-D-
galactopyranoside175,219 were synthesized analogously to the reported S-phenyl 
derivatives. Advanced intermediates for the synthesis of sugar nucleotides 2,3,4-tri-O-
acetyl-6-azido-6-deoxy-D-galactopyranose (103)205, 1,2,3,4-tertra-O-acetyl-4-azido-4-
deoxy-D-galactopyranose (112)207, 2,3-di-O-acetyl-urindine (109)206, 5-nitro-cycloSal 





synthesized as reported in the literature. Uridine 5’-monophosphomorpholidate 4-
morpholine-N,N’-dicyclohexylcarboxamidine salt (125) was purchased from Sigma-Aldrich 
and used without further purifications. Solvents and reagents were used as supplied 
without any further purification. Anhydrous solvents were taken from a dry solvent system 
(JC-Meyer Solvent Systems). Column chromatography was carried out using Fluka 
Kieselgel 60 (230-400 mesh). NMR spectra were recorded on a Varian 400-MR (400 
MHz), a Varian 600- (600 MHz), a Bruker AVIII 400 (400MHz) or a Bruker AVIII 700 (700 
MHz) spectrometer using solutions of the respective compound in CDCl3, D2O and MeOD. 
NMR chemical shifts () are reported in ppm and coupling constants (J) in Hz. Spectra 
recorded in CDCl3 or MeOD used the solvent residual peak chemical shift as internal 
standard (CDCl3: 7.26 ppm 
1H, 77.1 ppm 13C; MeOD: 3.31 ppm 1H, 49.0 ppm 13C). 
Spectra recorded in D2O used either residual acetic (D2O: 2.08 ppm 
1H) acid or formic 
acid (D2O: 8.26 ppm 
1H) as internal standards in 1H NMR and an acetic acid (D2O: 21.03 
ppm 13C) or formic acid (D2O: 166.31 ppm 
13C) spike as internal standard in 13C NMR. The 
chemical shifts in 31P NMR of compound 97-100 were referenced to the reported shifts of 
97204. The chemical shifts in 31P NMR in compounds 124 and 101 were referenced to the 
reported shifts of 124209. NMR peaks of BBs and intermediates were assigned by COSY 
and HSQC NMR experiments. Yields of final deprotected oligosaccharides were 
determined after removal of residual acetic acid. Optical rotations were measured using a 
UniPol L1000 polarimeter (Schmidt&Haensch) with concentrations expressed as g/100 
mL. IR spectra were recorded on a Spectrum 100 FTIR spectrophotometer (Perkin-
Elmer). High resolution mass spectra were obtained using a 6210 ESI-TOF (Agilent) or a 
Xevo J2-XGQTOF (Waters) mass spectrometer. Analytical HPLC was performed on an 
Agilent 1200 series coupled to a quadrupole ESI LC/MS 6130 using a YMC-Pack DIOL-
300-NP column (150 x 4.6 mm), a Phenomenex Luna C5 column (250 x 4.6 mm), a 
Thermo Scientific Hypercarb column (150 x 4.6 mm), or a Phenomenex Synergy Hydro 
RP18 (250 x 4.6 mm). Preparative HPLC was performed on an Agilent 1200 series using 
a preparative YMC-Pack-DIOL-300-NP (150 x 20 mm), a semi-preparative Phenomenex 
Luna C5 column (250 x 10 mm), a semi-preparative Thermo Scientific Hypercarb column 
(150 x 4.6 mm) or a semi-preparative Phenomenex Hydro RP18 column (250 x 10 mm). 
Ion exchange chromatography was performed on a Knauer Azura system using a GE 
HiTrap Q XL 5 mL column with a linear gradient of 100% aq. 0.05 M NH4OAc (pH 6.8) 






3.1 Synthesizer Modules and Conditions  
After placement of the linker-functionalized resin 23 or 56 (12.9-22.1 µmol of 
hydroxyl groups) in the reaction vessel the resin was washed with DMF, THF, and DCM. 
Subsequently the glycosylation (Module A and D), deprotection (Module B and C) and 
capping (Module E) steps were performed. Mixing of the components was accomplished 
by bubbling Argon through the reaction mixture. 
Module A: Glycosylation with Glycosyl Phosphates. The resin (12.9-22.1 µmol 
of hydroxyl groups) was swollen in DCM (2 mL) and the temperature of the reaction 
vessel was adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed 
with TMSOTf in DCM and DCM. For the glycosylation reaction the DCM was drained and 
a solution of phosphate BB (3-5 equiv in 1 mL DCM) was delivered to the reaction vessel. 
After the set temperature was reached, the reaction was started by the addition of 
TMSOTf in DCM (3-5 equiv in 1 mL DCM). The glycosylation was performed for 5 min at -
35 C (BB1, BB3, BB7 and BB8) or -30 °C (BB2) and for 30 min at -20 °C (BB1, BB3, 
BB7 and BB8) or -10 °C (BB2) or for 15 min at -15 °C and for 45 min at 0 °C (BB9). 
Subsequently the solution was drained, and the resin was washed twice with DCM. The 
whole procedure was repeated once to enhance conversion of the acceptor sites.  
Module B: Fmoc Deprotection. The resin was washed with DMF, swollen in 2 
mL DMF and the temperature of the reaction vessel was adjusted to 25 °C. Prior to the 
deprotection step the DMF was drained and the resin was washed with DMF three times. 
For Fmoc deprotection 2 mL of a solution of 20% Et3N in DMF was delivered to the 
reaction vessel. After 5 min the solution was drained and the whole procedure was 
repeated another two times. After Fmoc deprotection was complete the resin was washed 
with DMF, THF and DCM.  
Module C: Lev Deprotection. The resin was washed with DCM three times and 
the temperature of the reaction vessel was adjusted to 25 °C. For Lev deprotection 1.3 
mL DCM remained in the reaction vessel and 0.8 mL of a solution of 0.15 M hydrazine 
acetate in pyridine/AcOH/H2O (4:1:0.25) was delivered to the reaction vessel. After 30 min 
the reaction solution was drained and the whole procedure was repeated another two 
times. After Lev deprotection was complete the resin was washed with DMF, THF and 
DCM. 
Module D: Glycosylation with Thioglycosides. The resin (16.9-22.1 µmol of 
hydroxyl groups) was swollen in DCM (2 mL) and the temperature of the reaction vessel 
was adjusted to -30 °C. Prior to the glycosylation reaction the resin was washed with 
TMSOTf in DCM and DCM. For the glycosylation reaction the DCM was drained and a 





vessel. After the set temperature was reached, the reaction was started by the addition of 
NIS (3.4-4.4 equiv.) and TfOH (0.4 equiv.) in DCM/dioxane (3:1). The glycosylation was 
performed for 5 min at -40 °C and for 40 min at -20 °C. Subsequently the solution was 
drained, and the resin was washed with DCM. The whole procedure was repeated once 
to enhance conversion of the acceptor sites. Afterwards the resin was washed three times 
with DCM at 25 °C. 
Module E: Benzoylation. The temperature was adjusted to 25 °C and the resin 
washed with pyridine (2 mL) three times. For benzoylation temperature was set to 40 °C 
and 2 mL pyridine and 1 mL of a solution containing 0.5 M benzoic anhydride and 0.25 M 
DMAP in DCE were delivered to the reaction vessel. After 30 min the reaction solution 
was drained and the whole procedure was repeated another two times. After capping was 
complete the resin was washed with DCM. 
Cleavage from the Solid Support. After assembly of the oligosaccharides, 
cleavage from the solid support was accomplished by modification of a previously 
published protocol,107 using the Vapourtec E-Series UV-150 photoreactor Flow Chemistry 
System. The medium pressure metal halide lamp is filtered using the commercially 
available red filter. The resin, suspended in DCM, was loaded into a plastic syringe. The 
suspension was then pumped using a syringe pump (PHD2000, Harvard Aparatus) at 1 
mL/min through a 10 mL reactor, constructed of 1/8 inch o.d. FEP tubing. The total 
volume within the photoreactor was 9 mL. The temperature of the photoreactor was 
maintained at 20 °C and the lamp power was 80%. The exiting flow was deposited in a 10 






3.3 Automated Glycan Assembly of Pectin Arabinogalactans 
3.3.1 Building Block Synthesis 




A solution of galactose derivative 12131 (4.20 g, 8.75 mmol) in DCM (50 mL) at 
0 °C was treated with DMAP (0.64 g, 5.25 mmol, 0.6 equiv), DIC (2.05 mL, 13.1 mmol, 
1.5 equiv) and levulinic acid (1.43 mL, 14.0 mmol, 1.6 equiv). The solution was stirred for 
3 h at rt. A white precipitate slowly formed and the solution turned slightly pink. After 
complete conversion of the starting material, the solvent was removed in vacuo and the 
residue was purified by silica gel column chromatography (EtOAc/hex = 2:3) to give 
galactose derivative 13 (4.30 g, 7.46 mmol, 85% yield). 
[α]D
25 = -14.7 (c 1.1, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.03 (d, J = 7.6 Hz, 2H, Ar), 
7.59 (t, J = 7.4 Hz, 1H,. Ar), 7.50 – 7.33 (m, 9H, Ar), 7.06 (d, J = 7.5 Hz, 2H, Ar), 5.53 (t, J 
= 9.8 Hz, 1H, H-2), 5.48 (s, 1H, PhCH), 5.17 (d, J = 9.9 Hz, 1H, H-3), 4.81 (d, J = 9.7 Hz, 
1H, H-1), 4.40 (m, J = 12.6 Hz, 2H, H-4, H-6), 4.04 (d, J = 12.3 Hz, 1H, H-6) 3.64 (s, 1H, 
H-5), 2.67 – 2.37 (m, 4H, Lev), 2.34 (s, 3H, SPhCH3), 1.86 (s, 3H, Lev(CH3)) ppm. 
13C 
NMR (101 MHz, CDCl3) δ = 206.2 (C=O), 172.1 (C=O), 165.0 (C=O), 138.5, 137.7, 134.6, 
133.3, 129.9, 129.8, 129.6, 129.2, 128.5, 128.2, 127.2, 126.7 (18 C, Ar), 101.2 (PhCH), 
85.4 (C-1), 73.67 (C-4), 73.4 (C-3), 69.9 (C-5), 69.2 (C-6), 67.4 (C-2), 37.9 (Lev), 29.5 
(Lev(CH3)), 28.3 (Lev), 21.4 (SPhCH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for 
C32H32NaO8S: 599.1715, found: 599.1687. IR (neat) νmax = 1711, 1252, 997, 717 cm
-1.  
p-Tolyl 2-O-benzoyl-3-O-levulinoyl-6-O-benzyl-1-thio-β-D-galactopyranoside (14) 
 
Galactose derivative 13 (4.30 g, 7.46 mmol) was dissolved in anhydrous DCM 
(50 mL) under nitrogen atmosphere and triethylsilane (7.16 mL, 44.7 mmol, 6 equiv) and 
TFAA (1.00 mL, 7.46 mmol, 1 equiv) were added. The solution was stirred at rt for 15 min 
before TFA (3.42 mL, 44.7 mmoL, 6 equiv) was added dropwise. The reaction was stirred 





and washed with brine. The organic phase was separated, dried over MgSO4, filtered and 
the solvent was removed under reduced pressure. Compound 14 (approx. 4.32 g, 




14 (3.00 g, 5.18 mmol) was dissolved in anhydrous DCM (50 mL) and anhydrous 
pyridine (2.09 mL, 25.9 mmol, 5 equiv) was added. The solution was stirred at rt for 15 
min before it was cooled down to 0 °C and 3.99 g (15.4 mmol, 3 equiv) FmocCl were 
added. The reaction was allowed to slowly warm up to rt and stirred for 6 h. The solvent 
was removed under vacuum and the residue co-evaporated with toluene twice before 
compound 15 was recrystallized from boiling ethanol in 66% yield (2.75 g, 3.43 mmol). 
[α]D
25 = +1.0 (c 0.4, CHCl3), 
1H NMR (400 MHz, CDCl3) δ = 8.02 (d, J = 7.3 Hz, 2H, Ar), 
7.76 (d, J = 6.4 Hz, 2H, Ar), 7.62 (d, J = 6.9 Hz, 3H, Ar), 7.48 – 7.21 (m, 12H, Ar), 7.03 (d, 
J = 7.8 Hz, 2H, Ar), 5.59 (t, J = 10.0 Hz, 1H, H-2), 5.37 (s, 1H, H-4), 5.22 (d, J = 9.9 Hz, 
1H, H-3), 4.81 (d, J = 10.0 Hz, 1H, H-1), 4.56 – 4.18 (m, 6H, CH2Ph, Fmoc), 3.94 (t, J = 
6.0 Hz, 1H, H-5), 3.66 (dt, J = 16.2, 9.4 Hz, 2H, H-6), 2.48 – 2.21 (m, 7H, Lev, SPhCH3), 
1.87 (s, 3H, LevCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 205.8 (C=O), 165.2 (C=O), 
154.9, 143.4, 143.3, 143.2, 141.4, 141.3, 138.4, 137.7, 133.5, 133.0, 130.0, 129.8, 129.5, 
129.0, 128.6, 128.5, 128.1, 128.0, 127.9, 127.5, 127.4, 127.3, 125.5, 125.3, 120.2, 120.1 
(30 C, Ar), 87.4 (C-1), 76.1 (C-5), 73.7 (CH2Ph), 72.7 (C-3), 72.0 (C-4), 70.4 (Fmoc), 67.9 
(C-2), 67.9 (C-6), 46.6 (Fmoc), 37.7 (Lev), 29.5 (Lev), 28.0 (Lev), 21.3 (SPhCH3) ppm. 
ESI-HRMS: m/z [M+Na]+ calcd. for C47H44NaO10S: 823.2552, found: 823.2570. IR (neat) 





To a suspension of activated molecular sieve (4 Å, 1.50 g) in anhydrous DCM 
(20 mL) was added dibutyl phosphate (1.40 mL, 6.86 mmol, 2 equiv) and the mixture was 
stirred for 30 min. Subsequently, the molecular sieve was allowed to settle for 30 min and 
the supernatant was added to a solution of 15 (2.75 g, 3.43 mmol) in anhydrous DCM 





and TfOH (0.06 mL, 0.69 mmol, 0.2 equiv) were added and the resulting purple reaction 
mixture was stirred for 1 h. The reaction was quenched by the addition of sat. aq. 
NaHCO3-solution and washed with sat. aq. Na2S2O3-solution until the color of the organic 
layer changed from purple to colorless. The layers were separated, the organic layer was 
dried over Na2SO4 and the solvent was removed in vacuo. The product was purified by 
silica gel column chromatograph (EtOAc/hex = 1:4 to 1:1) to give phosphate BB2 (2.08 g, 
2.38 mmol, 69% yield) as a mixture of α/β-anomers as a highly viscous and sticky oil. 
Analytical data for β-anomer: [α]D
25 = -4.9 (c 2.3, CHCl3)
 1H NMR (400 MHz, CDCl3) δ = 
8.08 – 8.03 (m, 2H, Ar), 7.78 (dd, J = 7.0, 4.4 Hz, 2H, Ar), 7.67 (dd, J = 11.2, 7.4 Hz, 2H, 
Ar), 7.61 – 7.56 (m, 1H, Ar), 7.50 – 7.34 (m, 6H, Ar), 7.33 – 7.21 (m, 5H, Ar), 5.72 (dd, J = 
10.5, 8.0 Hz, 1H, H-2), 5.48 (t, J = 7.7 Hz, 1H, H-1), 5.44 (d, J = 2.8 Hz, 1H, H-4), 5.24 
(dd, J = 10.5, 3.3 Hz, 1H, H-3), 4.55 – 4.43 (m, 3H, CH2Ph, Fmoc), 4.38 – 4.28 (m, 2H, 
CH2Ph, Fmoc), 4.10 – 3.98 (m, 3H , H-5, H-6), 3.81 – 3.61 (m, 4H, OBu), 2.58 – 2.23 (m, 
4H, Lev), 1.92 (s, 3H Lev(CH3)), 1.65 – 1.55 (m, 2H, OBu), 1.41 – 1.28 (m, 4H, OBu), 
1.02 (dq, J = 14.7, 7.4 Hz, 2H, OBu), 0.89 (t, J = 7.4 Hz, 3H, OBu(CH3)), 0.69 (t, J = 7.4 
Hz, 3H, OBu(CH3)). 
13C NMR (101 MHz, CDCl3) δ = 205.8 (C=O), 165.2 (C=O), 154.9 
(C=O), 143.3, 143.2, 141.4, 141.3, 137.5, 133.6, 130.0, 129.1, 128.6, 128.5, 128.1, 128.0, 
127.8, 127.5, 127.4, 125.4, 120.2, 120.2 (Ar 24 C) , 96.9 (d, J = 4.7 Hz, C-1), 73.7 
(CH2Ph), 72.8 (C-5), 71.4 (C-4), 71.3 (C-3), 70.6 (Fmoc), 69.25 (d, J = 9.1 Hz, C-2), 68.0 
(d, J = 6.3 Hz, OBu), 67.9 (d, J = 6.3 Hz, OBu), 67.1 (C-6), 46.7 (Fmoc), 37.7 (Lev), 31.9 
(d, J = 7.4 Hz, OBu), 31.7 (d, J = 7.3 Hz, OBu), 29.5 (Lev), 27.8 (Lev), 18.7 (OBu), 18.4 
(OBu), 13.7 (OBu), 13.5 (OBu) ppm. ESI-HRMS: m/z [M+H]+ calcd. for C47H45O10S: 





A solution of 34130 (6.07 g, 10.2 mmol) in DCM (100 mL) at 0 °C was treated with 
DMAP (0.75 g 6.13 mmol, 0.6 equiv), DIC (1.93 g, 15.3 mmol, 1.5 equiv) and levulinic 
acid (1.7 mL, 16.4 mmol, 1.6 equiv) was added. The solution was stirred for 3 h at rt. A 
white precipitate slowly formed and the solution became pink. After complete conversion, 
the solvent was removed in vacuo and the product was purified by silica gel column 
chromatography (hex/EtOAc = 3:2) to give 35 as a colorless foam in 91% yield (6.42 g, 
9.27 mmol) 
[α]D
25 = +23.1 (c 1.4, CHCl3). 
1H NMR (400 MHz,CDCl3) δ = 8.06 – 8.02 (m, 2H, Ar), 7.58 





Hz, 2H, Ar), 5.64 – 5.59 (m, 1H, H-2), 5.10 (d, J = 11.4 Hz, 1H, PhCH2), 4.71 (d, J = 9.6 
Hz, 1H, H-1), 4.56 (d, J = 11.4 Hz, 1H, PhCH2), 4.32 (dd, J = 11.2, 6.9 Hz, 1H, H-6), 4.21 
(dd, J = 11.2, 5.5 Hz, 1H, H-6), 3.97 (d, J = 8.8 Hz, 1H, H-3), 3.81 – 3.73 (m, 2H, H-4, H-5 
), 2.74 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.53 (t, J = 6.6 Hz, 2H, Lev(CH2)), 2.29 (s, 3H, 
SPhCH3), 2.19 (s, 3H, LevCH3), 0.77 (s, 9H, TBS), 0.10 (d, J = 3.5 Hz, 3H, TBS), -0.10 (s, 
3H, TBS) ppm. 13C NMR (101 MHz, CDCl3) δ = 206.6, 172.6, 165.3 (3 C, C=O), 138.5, 
137.7, 133.1, 132.6, 130.4, 129.9, 129.5, 128.4, 128.3, 127.9, 127.6 (18 C, Ar), 87.2 (C-
1), 76.9, 76.1, 75.7 (C-3), 75.0 (PhCH2), 71.0 (C-2), 63.6 (C-6), 38.0 (Lev), 29.9 (Lev), 
27.9 (Lev), 25.6 (TBS), 21.2 (SPhCH3), 17.9 (TBS), -3.92 (TBS), -4.98 (TBS) ppm. ESI-
HRMS: m/z [M+Na]+ calcd. for C38H48NaO8SSi: 715.2736, found: 715.2652 IR (neat) νmax 
= 1719, 1260, 1088, 1069 cm-1.  
p-Tolyl 2-O-benzoyl-4-O-benzyl-6-O-levulinoyl-1-thio-β-D-galactopyranoside (36) 
 
35 (6.37 g, 9.27 mmol) was dissolved in MeCN (80 mL), the solution was cooled to 
0 °C and boron trifluoride etherate (1.3 mL, 10.1 mmol, 1.1 equiv) was added. The 
solution was stirred at 0 °C for ten min and subsequently quenched by the addition of sat. 
aq. NaHCO3-solution. The product was extracted from the aq. solution with DCM and the 
organic layer was washed with water twice. The organic layer was dried over MgSO4. The 
product 36 was obtained in quantitative yields (5.32 g, 9.27 mmol) as a transparent oil 
after removal of the solvent in vacuo. 
[α]D
25 = +4.7 (c 1.1, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 8.1 Hz, 2H, Ar), 
7.57 (dd, J = 10.6, 4.2 Hz, 1H, Ar), 7.45 (t, J = 7.7 Hz, 2H, Ar), 7.37 – 7.28 (m, 7H, Ar), 
7.04 (d, J = 7.9 Hz, 2H, Ar), 5.23 (t, J = 9.7 Hz, 1H, H-2), 4.82 (d, J = 11.6 Hz, 1H, 
PhCH2), 4.76 – 4.66 (m, 2H, PhCH2, H-1), 4.35 (dd, J = 11.1, 6.9 Hz, 1H, H-6), 4.17 (dd, J 
= 11.2, 6.0 Hz, 1H, H-6), 3.88 (d, J = 2.3 Hz, 1H, H-3), 3.83 (dd, J = 9.5, 3.2 Hz, 1H, H-4), 
3.75 (t, J = 6.4 Hz, 1H, H-5), 2.74 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.54 (t, J = 6.4 Hz, 2H, 
Lev(CH2)), 2.30 (s, 3H, SPhCH3), 2.17 (s, 3H, LevCH3) ppm. 
13C NMR (101 MHz, CDCl3) 
δ = 206.9, 172.5, 166.8 (3 C, C=O), 138.1, 137.8, 133.4, 133.1, 130.0, 129.6, 129.6, 
128.8, 128.5, 128.5, 127.9, 127.9 (18 C, Ar), 86.3 (C-1), 76.5 (C-3), 76.1 (C-5), 75.5 
(PhCH2), 74.4(C-4), 72.1 (C-2), 63.0 (C-6), 37.9 (Lev), 29.9 (Lev), 27.8(Lev), 21.2 
(SPhCH3) ppm. [M+Na]
+ calcd. for C32H34NaO8S: 601.1872; found 601.1911. IR (neat) 










To a solution of 36 (5.32 g, 9.27 mmol) in DCM (100 mL) and pyridine (2.5 mL, 
30.9 mmol, 3.3 equiv) Fmoc-Cl (4.83 g, 18.6 mmol, 2 equiv) was added and the solution 
was stirred at rt for 6 h. Subsequently the mixture was evaporated in vacuo and the 
resulting oil re-dissolved in DCM (50 mL). The organic layer was washed with brine three 
times, dried over Na2SO4, filtered and the solvent was removed in vacuo. Recrystallization 
from boiling ethanol gave the pure product 37 in 75% yield (5.60 g, 6.99 mmol) as a 
colorless solid. 
[α]D
25 = +35.7 (c 1.1, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.08 – 8.03 (m, 2H, Ar), 7.69 
(dd, J = 7.5, 4.2 Hz, 2H, Ar), 7.56 (t, J = 7.4 Hz, 1H, Ar), 7.49 – 7.29 (m, 13H, Ar), 7.20 – 
7.03 (m, 4H, Ar), 5.72 (t, J = 10.0 Hz, 1H, H-2), 5.07 (dd, J = 10.0, 2.8 Hz, 1H, H-3), 4.83 
(d, J = 11.5 Hz, 1H, PhCH2), 4.80 (d, J = 10.0 Hz, 1H, H-1), 4.53 (d, J = 11.4 Hz, 1H, 
PhCH2), 4.37 – 4.29 (m, 2H, H-6, Fmoc), 4.27 – 4.14 (m, 2H, H-6, Fmoc), 4.07 (t, J = 7.5 
Hz, 1H, Fmoc), 4.04 (d, J = 2.4 Hz, 1H, H-4), 3.81 (t, J = 6.4 Hz, 1H, H-5), 2.74 (t, J = 6.1 
Hz, 2H, Lev(CH2)), 2.53 (t, J = 6.5 Hz, 2H, Lev(CH2)), 2.31 (s, 3H, SPhCH3), 2.18 (s, 3H, 
Lev(CH3)). 
13C NMR (101 MHz, CDCl3) δ = 206.5, 172.4, 165.1, 154.5 (4 C, C=O), 143.3, 
142.8, 141.3, 141.2, 138.2, 137.5, 133.4, 133.0, 130.0, 129.6, 129.6, 129.1, 129.1, 128.5, 
128.5, 128.4, 128.0, 127.9, 127.2, 127.2, 125.2, 125.0, 120.1 (26 C, Ar), 87.1 (C-1), 79.1 
(C-3), 75.9 (C-5), 75.0 (PhCH3), 73.5 (C-4), 70.3 (Fmoc), 68.6 (C-2), 62.7 (C-6), 46.5 
(Fmoc), 37.9 (Lev), 29.9 (Lev), 27.8 (Lev), 21.3 (SPhCH3) ppm. [M+Na]
+ calcd. for 





To a suspension of activated powdered molecular sieves (4 Å, 1 g) in anhydrous 
DCM (20 mL) was added dibutyl phosphate (1.0 mL, 5.01 mmol, 2 equiv) and the mixture 
was stirred for 1.5 h. Subsequently the molecular sieves were allowed to settle for 30 min, 
the supernatant was added to a solution of 37 (1.85 g, 2.50 mmol) in anhydrous DCM 
(50 mL) and cooled to 0 °C under argon atmosphere. NIS (0.73 g, 3.26 mmol, 1.3 equiv) 
and TfOH (0.07 mL, 0.79 mmol, 0.3 equiv) were added and the purple reaction mixture 





and washed with sat. aq. Na2S2O3-solution until the color of the organic layer changed 
from purple to colorless. The layers were separated, the organic layer was dried over 
Na2SO4 and the solvent removed in vacuo. The product was purified by silica gel column 
chromatograph (EtOAc/hex = 1:8 to 1:1) to give the phosphate BB7 (2.04 g, 2.30 mmol, 
92% yield) as a mixture of α/β-anomers (α/β~1:2 as a highly viscous and sticky oil.  
Analytical data for β-anomer: [α]D
25
 = +28.8 (c 0.5, CHCl3) 
1H NMR (400 MHz, CCDl3) δ = 
8.10 – 8.02 (m, 2H, Ar), 7.70 – 7.65 (m, 2H, Ar), 7.55 (t, J = 7.4 Hz, 1H, Ar), 7.48 (d, J = 
7.5 Hz, 1H, Ar), 7.45 – 7.40 (m, 1H, Ar), 7.39 – 7.28 (m, 6H, Ar), 7.16 – 7.06 (m, 2H, Ar), 
5.81 (dd, J = 10.5, 8.0 Hz, 1H, H-2), 5.42 (t, J = 7.7 Hz, 1H, H-1), 5.02 (dd, J = 10.5, 2.9 
Hz, 1H, H-3), 4.80 (d, J = 11.2 Hz, 1H, PhCH2), 4.52 (d, J = 11.2 Hz, 1H, PhCH2), 4.40 – 
4.18 (m, 4H, H-6, Fmoc), 4.15 – 3.97 (m, 5H, H-4, Fmoc, OBu), 3.91 (t, J = 6.4 Hz, 1H, 
H-5), 3.71 (ddq, J = 27.5, 9.8, 6.7 Hz, 2H, OBu), 2.75 (t, J = 6.5 Hz, 2H, Lev), 2.52 (t, J = 
6.5 Hz, 2H, Lev), 2.19 (s, 3H, CH3(Lev)), 1.65 – 1.57 (m, 2H, OBu), 1.42 – 1.21 (m, 4H, 
OBu ), 1.02 (dq, J = 14.7, 7.4 Hz, 2H, OBu), 0.90 (t, J = 7.4 Hz, 3H, CH3(OBu)), 0.68 (t, J 
= 7.4 Hz, 3H, CH3(OBu)). 
13C NMR (101 MHz, CDCl3) δ 206.4, 172.3, 165.1, 154.4 (4C, 
C=O), 143.2, 142.8, 141.3, 141.2, 137.2, 133.5, 130.0, 129.2, 128.6, 128.6, 128.2, 127.9, 
127.2, 127.1, 125.2, 125.0, 120.1 (18 C, Ar), 96.8 (d, J = 5.0 Hz), 77.4 (C-3), 75.4 
(PhCH2), 73.1 (C-4), 72.9 (C-5), 70.3 (Fmoc), 69.8 (C-2), 68.1 (d, J = 6.3 Hz, 1C OBu), 
68.0 (d, J = 6.3 Hz, OBu), 62.2 (C-6), 46.5 (Fmoc), 37.9 (Lev), 32.1 (d, J = 7.5 Hz, 1C, 
OBu), 31.8 (d, J = 7.4 Hz, 1C, OBu) 29.9 (Lev), 27.8 (Lev), 18.6, 18.3, 13.6, 13.4 (4C, 
OBu) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C48H55O14NaP: 909.3227, found: 909.3265. 





To a suspension of activated powdered molecular sieves (4 Å, 1g) in anhydrous 
DCM (50 mL) was added dibutyl phosphate (0.6 mL, 3.0 mmol, 2.2 equiv) and the mixture 
was stirred for 1.5 h. Subsequently the molecular sieves were allowed to settle for 30 min, 
the supernatant was added to a solution of ethyl 2-O-benzoyl-3,4-O-dibenzyl-6-O- 
fluorenylcarbonylmethoxy-1-thio-β-D-galactopyranoside (38)143 (0.98g, 1.38 mmol) in 
anhydrous DCM (100 mL) and cooled to 0 °C under argon atmosphere. NIS (0.41 g, 
1.80 mmol, 1.3 equiv) and TfOH (0.04 mL, 0.45 mmol, 0.3 equiv) were added and the 
purple reaction mixture was stirred at 0 °C for 1 h. The reaction was quenched by addition 





the organic layer changed from purple to colorless. The layers were separated, the 
organic layer was dried over Na2SO4 and the solvent removed in vacuo. The product was 
purified by silica gel column chromatography (EtOAc/hex = 1:8 to 1:1) to give the 
phosphate BB8 (0.98 g, 1.11 mmol, 80% yield) as a mixture of α/βanomers (α/β~2:1)as 
a highly viscous and sticky oil.  
Characterization for α-anomer: 1H NMR (400 MHz, CDCl3) δ = 8.05 (d, J = 7.5 Hz, 2H, 
Ar), 7.78 (d, J = 7.5 Hz, 2H, Ar), 7.63 – 7.55 (m, 3H, Ar), 7.43 (dt, J = 10.8, 7.6 Hz, 4H, 
Ar), 7.37 – 7.23 (m, 12H, Ar), 5.94 (dd, J = 6.7, 3.5 Hz, 1H, H-1), 5.66 (dt, J = 10.4, 3.2 
Hz, 1H, H-2), 5.02 (d, J = 11.4 Hz, 1H, PhCH2), 4.74 (s, 2H, PhCH2), 4.64 (d, J = 11.4 Hz, 
1H, PhCH2), 4.41 (m, 2H, Fmoc, H-5), 4.33 – 4.26 (m, 2H, Fmoc, H-6), 4.25 – 4.19 (m, 
2H, H-6, Fmoc), 4.16 (dd, J = 10.4, 2.4 Hz, 1H, H-3), 4.06 – 3.95 (m, 3H, H-4, OBu), 3.94 
– 3.75 (m, 2H, OBu), 1.58 – 1.48 (m, 2H, OBu), 1.38 – 1.23 (m, 4H, OBu), 1.14 (dq, J = 
15.1, 7.4 Hz, 2H, OBu), 0.84 (t, J = 7.4 Hz, 3H, OBu), 0.74 (t, J = 7.4 Hz, 3H, OBu) ppm. 
13C NMR (101 MHz, CDCl3) δ = 165.6, 154.7 (2 C, C=O), 143.1, 141.2, 137.6, 137.6, 
133.2, 129.8, 129.5, 128.4, 128.4, 128.3, 128.3, 127.9, 127.8, 127.6, 127.1, 125.0, 120.0 
(26 C, Ar), 94.8 (d, J = 6.4 Hz, C-1), 75.7 (C-5), 74.8 (PhCH3), 73.6 (C-4), 72.9 (PhCH2), 
70.3 (Fmoc), 70.3 (C-2), 69.9 (C-5), 67.75 (d, J = 5.6 Hz, OBu), 67.69 (d, J = 5.7 Hz, 
OBu), 66.4 (C-6), 46.6 (Fmoc), 32.07 (d, J = 7.3 Hz, OBu), 31.89 (d, J = 6.8 Hz, OBu), 
18.5 (OBu), 18.3 (OBu), 13.5 (OBu), 13.4 (OBu) ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C50H55NaO12P: 901.3328, found: 901.3199. IR (neat) νmax = 1743, 1724, 1251, 1027 cm
-1. 
3.3.1.2 Synthesis of Arabinose Building Blocks 
Methyl-1-α-L-arabinofuranoside (17) 
 
Benzoyl protected arabinofuranoside 16128 (5.00 g, 10.5 mmol) was dissolved in a 
mixture of MeOH and DCM (2:1) and sodium methoxide (2.60 g, 47.2 mmol, 4.5 equiv) 
was added. The solution was stirred overnight at rt before it was neutralized by the 
addition of H+-Amberlite resin. After filtration through a plug of cotton the solvents were 
removed in vacuo and the residue was purified through a short pad of silica gel 
(DCM/MeOH = 1:0 to 9:1) to give 17 (1.71 g, 10.4 mmol, 99%). 
1H NMR (400 MHz, CD3OD) δ = 4.80 (s, 1H), 3.99 – 3.92 (m, 2H), 3.89 – 3.85 (m, 1H), 
3.79 (dd, J = 11.9, 3.2 Hz, 1H), 3.68 (dd, J = 11.8, 5.3 Hz, 1H), 3.41 (s, 3H) ppm. The 







Methyl-1-α-L-arabinofuranoside (1.71 g, 10.4 mmol) was dissolved in anhydrous 
DMF (15 mL) at -5 °C and di-tert-butylsilanediyl bis(trifluoromethanesulfonate) (5.24 mL, 
15.6 mmol, 1.4 equiv) was added. After stirring the resulting solution for 5 min, 2,6-
dimethylpyridine (4.24 mL, 36.4 mmol, 3.5 equiv) was added dropwise and the reaction 
was stirred at -5 °C for ten more minutes before it was quenched by the addition of 
MeOH. The reaction mixture was sequentially washed with 1 M HCl, sat. aq. NaHCO3 
solution and brine. Purification by silica gel chromatography (EtOAc/hex = 1:9) gave 1.83 
g (6.00 mmol, 58%) of arabinofuranoside 18 as a colorless solid.  
[α]D
25 = -51.1 (c 1.4, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 4.81 (d, J = 3.3 Hz, 1H, H-1), 
4.38 – 4.29 (m, 1H, H-4), 4.12 (dt, J = 7.4, 3.8 Hz, 1H, H-2), 3.99 – 3.88 (m, 3H, H-3, H-
5), 3.42 (s, 3H, OMe), 1.06 (s, 9H, tBu), 0.99 (s, 9H, tBu) ppm. 13C NMR (101 MHz, 
CDCl3) δ = 109.0 (C-1), 81.8 (C-2), 81.7 (C-3), 73.8 (C-5), 67.6 (C-4), 56.2 (OCH3), 27.5 
(tBu), 27.2 (tBu), 22.8 (C(CH3)3), 20.2 (C(CH3)3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd. for 




Silane-acetal protected arabinofuranoside 18 (1.83 g, 6.00 mmol) was dissolved in 
anhydrous pyridine (40 mL) and the resulting solution was stirred at 0 °C for ten minutes 
before benzoyl chloride (2.79 mL, 24.0 mmol, 4 equiv) was added. After the addition was 
complete the cooling bath was removed and the reaction mixture was stirred overnight. 
The reaction mixture was diluted with DCM, poured into ice-cold water and stirred for 
20 min. The organic layer was separated and washed with sat. aq NaHCO3 solution and 
brine. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. 
Purification by silica gel chromatography (EtOAc/hex 1:9) gave arabinofuranoside 19 as 
colorless solid (2.31 g, 5.66 mmol, 94%).  
[α]D
25 = 14.7 (c 0.1, CHCl3)
1H NMR (400 MHz, CDCl3) δ = 8.10 – 8.05 (m, 2H, Ar), 7.62 – 
7.57 (m, 1H, Ar), 7.47 (dd, J = 10.6, 4.7 Hz, 2H, Ar), 5.32 (dd, J = 7.0, 2.3 Hz, 1H, H-2), 
4.89 (d, J = 2.3 Hz, 1H, H-1), 4.43 (dd, J = 8.8, 4.7 Hz, 1H, H-5), 4.29 (dd, J = 9.4, 7.0 Hz, 
1H, H-3), 4.12 – 3.96 (m, 2H, H-4 H-5), 3.43 (s, 3H, OMe), 1.06 (s, 9H, C(CH3)), 1.01 (s, 
9H C(CH3)) ppm. 
13C NMR (101 MHz, CDCl3) δ = 166.0 (C=O), 133.4, 129.9, 128.6 (6 C, 





27.2 (C(CH3), 22.8 (C(CH3), 20.28 (C(CH3). ESI-HRMS: m/z [M+Na]
+ calcd. for 




Arabinofuranoside 19 (2.31 g, 5.66 mmol) was stirred in a Sarstedt 50 mL plastic 
tube in a mixture of THF (30.0 mL) and py (5.00 mL) at 0 °C and a solution of HF·pyridine 
(0.80 mL, 6.23 mmol, 1.1 equiv) was added dropwise to the reaction mixture. The reaction 
was warmed up to rt and stirred for additional 3 h before it was poured into ethyl acetate 
and the resulting mixture was neutralized with sat. aq. NaHCO3 solution. The organic 
phase was separated, dried over MgSO4, and concentrated. Product 20 (1.08 g, 
4.03 mmol, 71%) was directly used for subsequent reactions without further purification. 
1H NMR (400 MHz, CDCl3) δ =  8.04 – 8.00 (m, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 
7.7 Hz, 2H), 5.16 (s, 1H), 5.07 (s, 1H), 4.19 (b, 2H), 3.94 (d, J = 11.4 Hz, 1H), 3.80 (d, J = 
11.7 Hz, 1H), 3.46 (s, 3H) ppm. NMR data is in agreement with literature data.221 
2,6-O-Dibenzoyl-1-methyl-α-L-arabinofuranoside (21) 
 
A solution of DEAD (0.99 mL, 6.04 mmol, 1.5 equiv) and benzoic acid (0.74 g, 
6.04 mmol, 1 equiv) in anhydrous THF was added dropwise to a solution of 20 (1.08 g, 
4.03 mmol) and triphenylphosphine (1.58 g, 6.04 mmol, 1 equiv) in anhydrous THF. The 
yellow color of the solution of DEAD and BzOH in THF disappears slowly upon addition. 
The reaction mixture was stirred at rt for 2 h. The solvent was removed in vacuo and the 
residue was purified by silica gel chromatography (EtOAc/hex = 1:3 to 1:1) to give 21 in 
77% (1.15 g, 3.10 mmol) yield. 
1H NMR (400 MHz, CDCl3) δ = 8.05 – 8.00 (m, 4H), 7.63 – 7.58 (m, 1H), 7.55 – 7.50 (m, 
1H), 7.47 – 7.42 (m, 2H), 7.35 (t, J = 7.8 Hz, 2H), 5.20 (s, 1H), 5.13 – 5.12 (m, 1H), 4.64 
(dd, J = 11.9, 3.9 Hz, 1H), 4.53 (dd, J = 11.9, 5.5 Hz, 1H), 4.43 (td, J = 5.6, 4.0 Hz, 1H), 









21 (1.15 g, 2.95 mmol) was dissolved in anhydrous DCM (20 mL) under nitrogen 
atmosphere and anhydrous pyridine (2.38 mL, 29.5 mmol, 10 equiv) was added. The 
solution was stirred at rt for 10 min before FmocCl (1.53 g, 5.91 mmol, 2 equiv) was 
added. The reaction mixture was stirred at rt for 6 h and the solvent was evaporated. The 
residue was purified by silica gel chromatography (EtOAc/hex = 1:7 to 1:3) to give the 
Fmoc-protected product 22 (1.43 g, 2.40 mmol, 81%) as colorless solid. 
[α]D
25 = +2.6 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.02 (dd, J = 21.9, 7.9 Hz, 4H, 
Ar), 7.77 (d, J = 7.5 Hz, 2H, Ar), 7.64 – 7.54 (m, 3H, Ar), 7.51 (t, J = 7.5 Hz, 1H, Ar), 7.40 
(q, J = 7.6 Hz, 4H, Ar), 7.31 (q, J = 7.4 Hz, 4H, Ar), 5.45 (s, 1H, H-2), 5.29 (d, J = 5.2 Hz, 
1H, H-3), 5.14 (s, 1H, H-1), 4.78 (dd, J = 11.6, 3.1 Hz, 1H, H-5), 4.61 (dd, J = 12.0, 4.6 
Hz, 1H. H-5), 4.56 – 4.51 (m, 1H, H-4), 4.50 – 4.37 (m, 2H, Fmoc), 4.26 (t, J = 7.4 Hz, 1H, 
Fmoc), 3.50 (s, 3H, OMe) ppm. 13C NMR (101 MHz, CDCl3) δ = 166.3 (C=O), 
154.6(C=O), 143.5, 143.3, 143.2, 141.4, 141.4, 133.6, 133.2, 130.0, 129.9, 128.6, 128.5, 
128.1, 128.0, 127.4, 127.3, 127.3, 125.3, 125.3, 120.2, 120.2, 120.2 (22C, Ar), 106.8 (C-
1), 82.1 (C-2), 80.8 (C-3), 80.3 (C-4), 70.6 (Fmoc), 63.6 (C-5), 55.1 (OMe), 46.8 (Fmoc) 
ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C35H30NaO9: 617.1787, found: 617.1793. IR 





Arabinose derivative 22 (1.43 g, 2.40 mmol) was dissolved in anhydrous DCM 
(20 mL) and ethanethiol (0.25 mL, 3.36 mmol, 1.4 equiv) was added. The solution was 
cooled to 0 °C and boron trifluoride etherate (0.91 mL, 7.20 mmol, 3 eq.) was added 
dropwise. The reaction mixture was stirred for 5 h at 0°C, subsequently diluted with DCM, 
and washed with sat. aq. NaHCO3 solution. The crude product was purified by silica 
column chromatography (hex/EtOAc 8:1) to give thioglycoside BB5 as colorless solid in 
76% yield (1.14 g, 1.83 mmol).  
[α]D
25 = -37.1 (c 0.5, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 8.03 (dd, J = 16.0, 7.5 Hz, 4H, 
Ar), 7.77 (d, J = 7.5 Hz, 2H, Ar), 7.65 – 7.55 (m, 3H, Ar), 7.52 (t, J = 7.5 Hz, 1H, Ar), 7.40 
(dd, J = 10.1, 5.4 Hz, 4H, Ar), 7.35 – 7.28 (m, 4H, Ar), 5.57 (s, 1H, H-1), 5.48 (s, 1H, H-2), 





4.27 (t, J = 7.6 Hz, 1H, Fmoc), 2.87 – 2.67 (m, 2H, SCH2CH3), 1.36 (t, J = 7.4 Hz, 3H, 
SCH2CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 166.2 (C=O), 165.5 (C=O), 154.5 (C=O), 
143.3, 143.1, 141.4,133.7, 133.2, 130.0, 129.8, 128.6, 128.5, 128.1, 127.4, 127.3, 125.3, 
125.3, 120.2, 120.2 (22C, Ar), 88.04 (C-1), 82.9 (C-2), 81.1 (C-3), 80.3 (C-4), 70.7 
(Fmoc), 63.3 (C-5), 46.8 (Fmoc), 25.4 SCH2CH3, 14.9 (SCH2CH3) ppm. m/z [M+Na]
+ 












Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  





Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded protected hexasaccharide 26. The crude product was purified by normal phase 
HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected hexasaccharide 26 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
30% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40%  to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected hexasaccharide 26 was dissolved in THF (3 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The product was not soluble in 
MeCN/water and therefore not purified by reversed phase HPLC but instead used in the 
final deprotection step without purification. 
Crude RP-HPLC of semi-protected hexasaccharide 26 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H 2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 5 mg). 
The suspension was flushed with argon for 10 min, then saturated with H2 for 10 min, and 
stirred under a H2-atmosphere overnight at rt. After filtration of the reaction mixture 





hexasaccharide 26 was purified by reversed phase HPLC using a semi-preparative 
Hypercarb column (0.4 mg, 0.36 µmol, 2% over 15 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.59 – 4.55 (m, 4H), 4.53 (d, J = 7.8 Hz, 1H), 4.35 (d, J = 8.0 
Hz, 1H), 4.10 (d, J = 3.2 Hz, 4H), 3.88 – 3.82 (m, 3H), 3.80 – 3.57 (m, 30H), 3.55 – 3.48 
(m, 1H), 2.94 (t, J = 7.5 Hz, 2H), 1.61 (tt, J = 14.1, 7.2 Hz, 4H), 1.42 – 1.36 (m, 2H) ppm. 
13C NMR (176 MHz, D2O) δ = 104.3, 104.2, 102.6, 77.6, 77.5, 77.1, 75.1, 74.5, 74.4, 
74.28, 74.22, 73.2, 72.7, 71.87, 71.80, 71.3, 71.2, 70.0, 68.6, 60.9, 60.7, 60.6, 60.5, 39.3, 
28.1, 26.3, 22.0 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C41H73NNaO31: 1098.4064; 
found 1098.4043. 
RP-HPLC of deprotected hexasaccharide 26 (ELSD trace): 
 
RP-HPLC was performed using a Hypercarb column and a linear gradient from 
97.5% to 30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 


















Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 






Crude NP-HPLC of protected terasaccharide 27 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The crude protected tetrasaccharide 27 was dissolved in THF (5 mL) and NaOMe (0.5 M 
in MeOH, 0.13 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The crude product was purified 
by reversed phase HPLC using a semi-preparative C5 column affording the semi-
protected tetrasaccharide 27. 
Crude RP-HPLC of semi-protected tetrasaccharide 27 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight at rt. After filtration of the reaction 
mixture through a syringe filter the solvents were evaporated and the fully deprotected 
tetrasaccharide 27 was purified by reversed phase HPLC using a semi-preparative 





1H NMR (600 MHz, D2O) δ = 4.48 – 4.44 (m, 2H), 4.41 (d, J = 7.8 Hz, 1H), 4.23 (d, J = 7.9 
Hz, 1H), 3.99 (t, J = 3.6 Hz, 2H), 3.96 (d, J = 3.2 Hz, 1H), 3.76 – 3.71 (m, 2H), 3.68 – 3.63 
(m, 4H), 3.61 – 3.46 (m, 16H), 3.39 (ddd, J = 9.9, 7.9, 3.7 Hz, 1H), 2.84 – 2.80 (m, 2H), 
1.54 – 1.45 (m, 4H), 1.30 – 1.24 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 99.5, 99.3, 
97.9, 77.4, 72.7, 72.4, 70.4, 70.0, 69.4, 68.6, 68.2, 68.0, 66.7, 66.6, 65.9, 65.2, 63.8, 63.7, 
56.2, 56.2, 55.7, 34.6, 23.4, 21.6, 17.3 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C29H53NNaO21: 774.3007; found: 774.2991. 
RP-HPLC of deprotected tetrasaccharide 27 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 









Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB2, TMSOTf, DCM, 2 x 35 min, -30 °C to -10 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (150 mM N2H4·AcOH, 3 x 30 min, 25 °C) 
Module D (2 x 3.8 equiv BB4, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 








Crude NP-HPLC of protected terasaccharide 28 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min). 
The protected tetrasaccharide 28 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected 
tetrasaccharide was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected tetrasaccharide 28 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide. The compound was purified once more after hydrogenation by filtration 
through a short C18 SepPak column (100% H2O) to yield the deprotected tetrasaccharide 





1H NMR (600 MHz, D2O) δ = 5.41 (s, 1H), 4.87 (s, 1H), 4.60 (d, J = 7.9 Hz, 1H), 4.49 (s, 
1H), 4.39 – 4.30 (m, 3H), 4.15 – 4.05 (m, 3H), 4.03 – 3.78 (m, 17H), 3.77 – 3.69 (m, 1H), 
3.15 (t, J = 7.4 Hz, 2H), 1.88 – 1.80 (m, 4H), 1.66 – 1.58 (m, 2H) ppm. 13C NMR (151 
MHz, D2O) δ = 107.1, 102.1, 100.7, 100.3, 82.0, 78.9, 78.0, 73.9, 72.8, 72.2, 72.0, 71.1, 
70.5, 68.9, 67.8, 66.4, 59.0, 58.8, 58.3, 46.8, 37.2, 25.9, 19.8 ppm. ESI-HRMS: m/z 
[M+Na]+ calcd. for C28H51NNaO20: 744.2902; found 744.2856. 
RP-HPLC of the deprotected tetrasaccharide 28 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB2, TMSOTf, DCM, 2 x 35 min, -30 °C to -10 °C)  
Module C (150 mM N2H4·AcOH, 3 x 30 min, 25 °C) 
Module D (2 x 3.8 equiv BB4, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 






Crude NP-HPLC of protected pentasaccharide 29 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected pentasaccharide 29 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected 
pentasaccharide was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected pentasaccharide 29 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide. The compound was purified once more after hydrogenation by filtration 
through a C18 SepPak column (100% water) to yield the deprotected pentasaccharide 29 





1H NMR (600 MHz, D2O) δ = 5.41 (s, 2H), 4.85 – 4.78 (m, 3H), 4.59 (dd, J = 7.9, 1.2 Hz, 
1H), 4.38 (dt, J = 3.0, 1.5 Hz, 1H), 4.37 – 4.32 (m, 3H), 4.32 – 4.28 (m, 1H), 4.26 (s, 1H), 
4.13 – 4.07 (m, 2H), 4.04 – 3.81 (m, 21H), 3.77 – 3.72 (m, 1H), 3.17 (t, J = 7.5 Hz, 2H), 
1.89 – 1.81 (m, 4H), 1.67 – 1.59 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 106.9, 102.1, 
102.0, 101.9, 100.4, 81.6, 79.0, 77.9, 75.5, 75.3, 75.1, 74.3, 72.7, 72.3, 72.2, 72.0, 71.0, 
70.9, 69.6, 69.0, 68.3, 67.7, 66.2, 58.9, 58.6, 58.5, 58.4, 58.3, 37.1, 25.9, 24.1, 19.8 ppm. 
ESI-HRMS: m/z [M+Na]+ calcd. for C34H61NNaO25: 906,3425; found 906.3387. 
RP-HPLC of deprotected tetrasaccharide 29 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv BB2, TMSOTf, DCM, 2 x 35 min, -30 °C to -10 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (150 mM N2H4·AcOH, 3 x 30 min, 25 °C) 
Module D (2 x 3.8 equiv BB4 NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 





Crude NP-HPLC of protected hexasaccharide 30 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected hexasaccharide 30 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.5 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected 
hexasaccharide was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected hexasaccharide 30 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
hexasaccharide. The compound was purified once more after hydrogenation by RP HPLC 
using a semi-preparative Hypercarb column to yield the deprotected hexasaccharide 30 
(0.8 mg, 0.79 µmol, 5%). 
1H NMR (700 MHz, D2O) δ = 5.48 (d, J = 1.4 Hz, 1H), 4.70 (d, J = 8.0 Hz, 1H), 4.68 (d, J = 





4.22 (dd, J = 3.6, 1.6 Hz, 1H), 4.21 – 4.16 (m, 4H), 4.08 (td, J = 6.1, 3.4 Hz, 1H), 3.97 – 
3.89 (m, 4H), 3.86 – 3.64 (m, 25H), 3.60 – 3.56 (m, 2H), 3.01 (t, J = 7.5 Hz, 2H), 1.73 – 
1.65 (m, 4H), 1.49 – 1.43 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 107.2, 102.1, 102.0, 
100.7, 100.4, 82.1, 78.9, 78.1, 75.7, 75.5, 74.9, 74.0, 72.9, 72.3, 72.2, 72.1, 72.0, 71.0, 
70.9, 70.5, 69.7, 69.3, 69.1, 69.0, 68.8, 67.7, 66.4, 59.1, 58.7, 58.5, 58.4, 58.4, 58.3, 37.1, 
25.9, 24.2, 19.8 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C40H72NNaO30: 1046.4139; 
found 1046.4105. 
RP-HPLC of deprotected hexasaccharide 30 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB2, TMSOTf, DCM, 2 x 35 min, -30 °C to -10 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv BB1, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (0.5 M Bz2O, 0.25 M DMAP in DCE, 3 x 30 min, 40 °C) 
Module C (150 mM N2H4·AcOH, 3 x 30 min, 25 °C) 
Module D (2 x 3.8 equiv BB5, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv BB4, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 






Crude NP-HPLC of protected pentasaccharide 31 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected pentasaccharide 31 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.6 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected 
pentasaccharide was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected pentasaccharide 31 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H 2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
pentasaccharide. The compound was purified once more after hydrogenation by filtration 
through a short C18 SepPak column (100% H2O) to yield the deprotected 
pentasaccharide 31 (1.1 mg, 1.31 µmol, 8%). 
1H NMR (600 MHz, D2O) δ = 5.42 (s, 1H), 5.36 (s, 1H), 4.89 – 4.86 (m, 1H), 4.60 (d, J = 
7.9 Hz, 1H), 4.55 (dd, J = 2.9, 1.4 Hz, 1H), 4.52 (s, 1H), 4.39 – 4.36 (m, 1H), 4.34 (d, J = 





3.1 Hz, 1H), 4.14 – 4.07 (m, 2H), 4.05 (dd, J = 9.3, 3.2 Hz, 1H), 4.03 – 3.81 (m, 19H), 
3.73 (ddd, J = 17.6, 9.8, 7.9 Hz, 1H), 3.17 (t, J = 7.5 Hz, 2H), 1.90 – 1.81 (m, 4H), 1.66 – 
1.59 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 107.4, 104.5, 102.2, 100.3, 100.1, 81.5, 
80.3, 79.3, 79.2, 77.9, 77.7, 75.8, 74.2, 72.9, 72.4, 72.0, 71.1, 70.4, 69.0, 68.8, 67.7, 66.4, 
58.8, 58.4, 58.3, 37.1, 25.9, 24.2, 19.8 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C33H59NNaO24: 876.3324; found 876.3301. 
RP-HPLC of deprotected pentasaccharide 31 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 








Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv BB5, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv BB4, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded protected trisaccharide 32.  
Crude NP-HPLC of protected trisaccharide 32 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 





The protected trisaccharide 32 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 
0.5 mL) was added. The reaction mixture was stirred overnight at rt and subsequently 
neutralized by the addition of prewashed Amberlite IR-120 resin. The resin was filtered off 
and the solvents were removed in vacuo. The semi-protected trisaccharide was purified 
by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected trisaccharide 32 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
trisaccharide. The compound was purified once more after hydrogenation by RP HPLC 
using a semi-preparative Hypercarb column yielding the deprotected trisaccharide 32 (1.5 
mg, 2.83 µmol, 17%). 
1H NMR (600 MHz, D2O) δ = 5.26 (s, 1H), 5.19 (s, 1H), 4.46 (d, J = 8.0 Hz, 1H), 4.37 (d, J 
= 1.3 Hz, 1H), 4.23 (td, J = 5.8, 3.1 Hz, 1H), 4.14 – 4.12 (m, 1H), 4.10 (d, J = 3.2 Hz, 1H), 
4.05 (dd, J = 5.9, 2.6 Hz, 2H), 3.98 – 3.93 (m, 2H), 3.86 (ddd, J = 25.8, 12.3, 3.1 Hz, 2H), 
3.80 – 3.68 (m, 7H), 3.62 (dd, J = 9.7, 8.1 Hz, 1H), 3.02 (t, J = 7.5 Hz, 2H), 1.75 – 1.65 
(m, 4H), 1.51 – 1.44 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 111.8, 109.7, 105.0, 
86.7, 85.5, 84.7, 83.6, 82.6, 82.3, 79.0, 77.56, 72.53, 72.4, 71.0, 63.7, 63.6, 63.4, 41.9, 









RP-HPLC of deprotected trisaccharide 32 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 





Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3.8 equiv BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  





Module D (2 x 3.8 equiv BB6, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv BB6, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv BB4, NIS, TfOH, DCM/dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded protected tetrasaccharide 33.  
Crude NP-HPLC of protected tetrasaccharide 33 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected tetrasaccharide 33 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.54 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected 
tetrasaccharide was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of semi-protected tetrasaccharide 33 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H 2O 





The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min, and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide 33 in 38% yield (4.2 mg, 6.35 µmol).  
1H NMR (600 MHz, D2O) δ = 5.40 (s, 1H), 5.24 (s, 2H), 4.61 (d, J = 7.9 Hz, 1H), 4.43 – 
4.38 (m, 1H), 4.38 – 4.35 (m, 2H), 4.28 (s, 2H), 4.26 – 4.23 (m, 2H), 4.18 – 4.15 (m, 2H), 
4.13 – 4.08 (m, 2H), 4.06 – 4.02 (m, 2H), 4.00 – 3.83 (m, 9H), 3.77 (t, J = 8.9 Hz, 1H), 
3.17 (t, J = 7.5 Hz, 2H), 1.91 – 1.78 (m, 4H), 1.67 – 1.58 (m, 2H) ppm. 13C NMR (151 
MHz, D2O) δ = 107.2, 105.4, 105.3, 100.4, 81.9, 80.2, 80.1, 79.1, 78.8, 78.7, 78.3, 74.6, 
74.6, 74.4, 72.9, 67.8, 67.8, 66.4, 64.8, 64.7, 59.1, 58.8, 37.3, 26.0, 24.3, 20.0 ppm. ESI-
HRMS: m/z [M+Na]+ calcd. for C26H47NNaO18: 684.2690; found 684.2670. 
RP-HPLC of deprotected tetrasaccharide 33 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected trisaccharide 41. The crude product was purified by normal phase 






Crude NP-HPLC of protected trisaccharide 41 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected trisaccharide 41 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 
0.5 mL) was added. The reaction mixture was stirred overnight and subsequently 
neutralized by addition of prewashed Amberlite IR-120 resin. The resin was filtered off 
and the solvents were removed in vacuo. The crude product was purified by reversed 
phase HPLC using a semi-preparative C5 column affording the semi-protected 
trisaccharide. 
Crude RP-HPLC of semi-protected trisaccharide 41 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). 
The suspension was flushed with argon for 10 min then saturated with H2 for 10 min and 
stirred under a H2-atmosphere overnight. After filtration of the reaction mixture through a 
syringe filter the solvents were evaporated to provide the fully deprotected trisaccharide 
41 (4.0 mg, 6.72 µmol, 39% over 9 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.64 (d, J = 7.9 Hz, 1H), 4.62 (d, J = 7.8 Hz, 1H), 4.58 (d, J = 
7.9 Hz, 1H), 4.23 – 4.21 (m, 2H), 4.15 – 4.05 (m, 8H), 3.98 – 3.91 (m, 2H), 3.88 – 3.81 
(m, 5H), 3.72 – 3.66 (m, 3H), 3.18 (t, J = 7.3 Hz, 2H), 1.89 – 1.82 (m, 4H), 1.65 – 1.60 (m, 





68.5, 68.5, 67.9, 67.0, 66.9, 66.4, 66.4, 58.8, 37.1, 25.9, 24.2, 19.8 ppm. HRMS: m/z 
[M+H]+ calcd. for C23H43NO16: 590.2660, found: 590.2710 
RP-HPLC of deprotected trigalactoside 41 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 





Linker functionalized resin 23 (43 mg, 13.7 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 5 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 5 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 





Module A (2 x 5 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 42. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 42 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min).  
The protected, branched tetrasaccharide 42 was dissolved in THF (5 mL) and NaOMe 
(0.5 mL 0.5 M in MeOH) was added. The solution was stirred overnight at rt. The reaction 
mixture was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off 
and the solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected trisaccharide 42 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). 
The suspension was flushed with argon for 10 min then saturated with H2 for 10 min and 
stirred under a H2-atmosphere overnight. After filtration of the reaction mixture through a 
syringe filter the solvents were evaporated to provide the fully deprotected tetrasaccharide 





1H NMR (600 MHz, D2O) δ = 4.79 (d, J = 7.8 Hz, 1H), 4.72 (d, J = 7.6 Hz, 1H), 4.57 (d, J = 
8.0 Hz, 1H), 4.54 (d, J = 7.9 Hz, 1H), 4.34 (dd, J = 7.2, 3.2 Hz, 2H), 4.18 – 4.12 (m, 1H), 
4.09 – 3.98 (m, 5H), 3.97 – 3.92 (m, 2H), 3.92 – 3.70 (m, 15H), 3.62 (dd, J = 9.8, 8.0 Hz, 
1H), 3.12 (t, J = 7.5 Hz, 2H), 1.80 (tt, J = 14.0, 7.2 Hz, 4H), 1.61 – 1.55 (m, 2H) ppm. 13C 
NMR (151 MHz, D2O) δ = 102.9, 102.5, 102.1, 101.0, 81.0, 80.6, 73.7, 73.7, 73.4, 72.0, 
71.3, 71.1, 69.6, 69.4, 68.8, 68.5, 68.5, 67.8, 67.2, 67.2, 67.1, 67.0, 59.6, 59.6, 59.5, 38.0, 
26.8, 25.0, 20.7 ppm. HRMS: m/z [M+Na]+ calcd. for C29H53NNaO21: 774.3007, found 774. 
3030 
RP-HPLC of deprotected tetrasaccharide 42 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 









Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.75 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected pentasaccharide 43. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HC of protected pentasaccharide 43 (ELSD trace):  
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min)  
The protected, branched pentasaccharide 43 was dissolved in THF (5 mL) and NaOMe 
(1 mL 0.5 M in MeOH) was added. The solution was stirred overnight at rt. The reaction 
mixture was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off 
and the solvent was removed in vacuo. The semi-protected product was purified by semi-






Crude RP-HPLC of semi-protected pentasaccharide 43 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). 
The suspension was flushed with argon for 10 min then saturated with H2 for 10 min and 
stirred under a H2-atmosphere overnight. After filtration of the reaction mixture through a 
syringe filter the solvents were evaporated to provide the fully deprotected 
pentasaccharide 43 (1.6 mg, 1.73 µmol, 10% over 13 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.82 (d, J = 7.8 Hz, 1H), 4.75 (d, J = 7.7 Hz, 1H), 4.61 – 4.56 
(m, 3H), 4.37 (dd, J = 8.1, 2.9 Hz, 2H), 4.19 – 4.14 (m, 2H), 4.11 – 3.98 (m, 9H), 3.97 – 
3.73 (m, 17H), 3.69 – 3.63 (m, 2H), 3.14 (t, J = 7.5 Hz, 2H), 1.82 (tt, J = 14.3, 7.4 Hz, 4H), 
1.63 – 1.56 (m, 2H) ppm. 13C NMR (176 MHz, D2O) δ = 102.0, 101.5, 101.2, 101.1, 100.0, 
80.1, 79.7, 72.8, 72.8, 72.5, 71.4, 70.9, 70.4, 70.3, 70.2, 68.7, 68.4, 68.4, 67.9, 67.6, 67.5, 
67.1, 67.0, 66.3, 66.1, 66.0, 58.7, 58.7, 58.6, 37.0, 25.8, 24.1, 19.8 ppm. HRMS: m/z 
[M+H]+ calcd. for C35H64NO26: 914.3716, found: 914.3783 
RP-HPLC of the deprotected pentasaccharide 43 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected hexasaccharide 44. The crude product was purified by normal 





Crude NP-HPLC of protected hexasaccharide 44 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min) 
The protected, branched hexasaccharide 44 was dissolved in THF (5 mL) and NaOMe 
(0.5 M in MeOH, 1 mL) was added. The solution was stirred overnight at rt. The reaction 
mixture was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off 
and the solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of the semi-protected hexasaccharide 44 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H 2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1. 0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 8 mg). 
The suspension was flushed with argon for 10 min then saturated with H2 for 10 min and 
stirred under a H2-atmosphere overnight. After filtration of the reaction mixture through a 
syringe filter the solvents were evaporated to provide the fully deprotected 
hexasaccharide 44 (0.9 mg, 0.84 µmol, 7% over 15 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 4.86 (d, J = 7.9 Hz, 1H), 4.79 (d, J = 7.7 Hz, 1H), 4.66 – 4.60 
(m, 4H), 4.43 – 4.39 (m, 2H), 4.24 – 4.18 (m, 3H), 4.15 – 4.06 (m, 11H), 4.04 (dd, J = 9.9, 
3.3 Hz, 1H), 4.01 – 3.81 (m, 17H), 3.78 (dd, J = 9.8, 7.7 Hz, 1H), 3.73 – 3.67 (m, 3H), 





D2O) δ = 102.1, 101.6, 101.2 (3 C), 100.1, 80.2, 79.7, 72.9, 72.8, 72.5, 71.5, 71.4, 71.0, 
70.5, 70.3, 70.3, 68.8, 68.5, 67.9, 67.7, 67.6, 67.2, 67.1, 67.0, 66.4, 66.2, 66.1, 58.8, 58.7, 
37.1, 25.9, 24.2, 19.8 ppm. HRMS: m/z [M+Na]+ calcd. for C41H73NNaO31: 1098.4064 
found: 1098.4163 
RP-HPLC of deprotected hexasaccharide 44 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected hexasaccharide 45. The crude product was purified by normal 






Crude NP-HPLC of protected hexasaccharide 45 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min) 
The protected branched hexasaccharide 45 was dissolved in THF (5 mL) and NaOMe 
(0.5 M in MeOH, 1 mL) was added. The solution was stirred overnight at rt. The reaction 
mixture was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off 
and the solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of the semi-protected hexasaccharide 45 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
hexasaccharide 45 (0.9 mg, 0.84 µmol, 5% over 15 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 4.87 – 4.84 (m, 2H), 4.79 (d, J = 7.6 Hz, 1H), 4.63 – 4.60 (m, 
3H), 4.42 – 4.35 (m, 3H), 4.23 – 4.18 (m, 2H), 4.13 – 4.03 (m, 8H), 4.02 – 3.76 (m, 23H), 
3.73 – 3.66 (m, 2H), 3.20 – 3.16 (m, 2H), 1.90 – 1.82 (m, 4H), 1.67 – 1.61 (m, 2H) ppm. 





72.9, 72.8, 72.5, 72.4, 71.4, 71.0, 70.5, 70.4, 70.3, 68.8, 68.5, 68.5, 67.9, 67.7, 67.6, 67.2, 
67.0, 66.4, 66.3, 66.2, 66.1, 66.1, 58.8, 58.7, 58.7, 37.1, 25.9, 24.1, 19.8 ppm. HRMS: 
m/z [M+Na]+ calcd. for C41H73NNaO31: 1098. 4064, found: 1098.4173 
RP-HPLC of the deprotected hexasaccharide 45 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 





Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (1 x 5 equiv. BB8, TMSOTf, DCM, 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 





Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (1 x 5 equiv. BB8, TMSOTf, DCM, 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 5 equiv. BB9, TMSOTf, DCM, 60 min, -15 °C to 0 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 46. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 46 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected tetrasaccharide 46 (6 mg, 3.06 µmol) was dissolved in THF (1 mL) and 
cooled to -5 °C. Hydrogen peroxide (1 µL of a 30% solution in water, 0.01 µmol, 3.5 
equiv) was added under stirring followed by the addition of LiOH (0.02 mL of a 1M 
solution in water, 0.02 mmol, 7 equiv). The solution was stirred for 2 hours at lowered 
temperature (-5 °C to 0 °C) and then overnight at rt. After stirring overnight the reaction 
mixture was again cooled to 0 °C, NaOH (0.05 mL of a 1 M solution in water, 0.05 mmol, 
15 equiv) and MeOH (0.15 mL) were added dropwise. The mixture was allowed to warm 
to rt and stirred over the weekend followed by neutralization by Amberlite H+ resin. The 
resin was filtered of and the solvents were removed in vacuo. The crude semi-protected 
intermediate was dissolved in H2O/MeCN (1:1, 4 mL) and purified over semi-preparative 






Crude RP-HPLC of semi-protected tetrasaccharide 46 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product (2 mg, 1.3 µmol) was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O 
(4:2:2:1, 5 mL) and the resulting solution was added to a round-bottom flask containing 
Pd/C (10% Pd, 10 mg). The suspension was flushed with argon for 10 min then saturated 
with H2 for 10 min and stirred under a H2-atmosphere overnight. After filtration of the 
reaction mixture through a syringe filter the solvents were evaporated and the fully de-
protected tetrasaccharide 46 (1.1 mg, 1.3 µmol, 100%) was obatained after purification by 
elution form a C18 SepPak column (50 mg). 
1H NMR (600 MHz, D2O) δ = 4.69 (d, J = 7.7 Hz, 1H), 4.66 (d, J = 7.7 Hz, 1H), 4.62 (d, J = 
7.7 Hz, 1H), 4.59 (d, J = 7.9 Hz, 1H), 4.24 – 4.18 (m, 4H), 4.15 – 4.05 (m, 11H), 3.90 – 
3.81 (m, 5H), 3.72 – 3.66 (m, 3H), 3.51 (t, J = 8.1 Hz, 1H), 3.18 (t, J = 7.3 Hz, 2H), 1.86 
(dp, J = 13.7, 7.2, 6.7 Hz, 4H), 1.63 (p, J = 7.9 Hz, 2H) ppm. 13C NMR (151 MHz, D2O) δ 
= 101.2, 101.0, 100.5, 100.5, 73.8, 73.3, 71.5, 70.7, 70.44, 70.36, 69.5, 68.48, 68.46, 
67.9, 66.4, 66.3, 37.1, 25.9, 24.2 19.8. HRMS: m/z [M+H]+ calcd. for C29H51NO22: 
766.2981, found: 766.2990 
RP-HPLC of deprotected tetrasaccharide 46 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 









Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 47. The crude product was purified by normal 






Crude NP-HPLC of protected tetrasaccharide 47 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 
40% hexane in ethyl acetate (35 min, f low rate 1 mL/min) and from 40% to 0% 
hexane in ethyl acetate (10 min, f low rate 1 mL/min)  
The protected tetrasaccharide 47 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The solution was stirred overnight at rt. The reaction mixture 
was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off and the 
solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of the semi-protected tetrasaccharide 47 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O 
(containing 0.1% of formic acid) in MeCN (50 min, f low rate 1.0 mL/min).  
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide 47 (2.0 mg, 2.81 µmol, 17% over 10 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ =  6.13 (s, 1H), 5.59 – 5.54 (m, 2H), 5.34 (d, J = 8.0 Hz, 1H), 
5.11 – 5.08 (m, 3H), 5.03 – 4.99 (m, 2H), 4.86 – 4.82 (m, 2H), 4.75 – 4.70 (m, 3H), 4.69 – 
4.55 (m, 15H), 3.90 (t, J = 7.5 Hz, 2H), 2.62 – 2.54 (m, 4H), 2.38 – 2.33 (m, 2H) ppm. 13C 





72.7, 72.5, 72.5, 68.0, 67.7, 67.6, 66.2, 66.1, 59.0, 58.6, 37.1, 25.9, 24.1, 19.8 ppm. 
HRMS: m/z [M+H]+ calcd. for C28H51NO20: 722.3082, found: 722.3036. 
RP-HPLC of the deprotected tetrasaccharide 47 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 
30% H2O (containing 0.1% of formic acid) in MeCN (45 min, f low rate 0.7 mL/min) 





Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 





Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (3 cycles)  
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 48. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 48 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min) 
The protected tetrasaccharide 48 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH 1 mL) was added. The solution was stirred overnight at rt. The reaction mixture 
was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off and the 
solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected terasaccharide 48 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 





The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide 48 (2.0 mg, 2.72 µmol, 17% over 11 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.15 (d, J = 1.4 Hz, 1H), 4.77 (d, J = 7.7 Hz, 1H), 4.70 (d, J = 
7.6 Hz, 1H), 4.54 (d, J = 8.0 Hz, 1H), 4.29 (dd, J = 12.5, 3.2 Hz, 2H), 4.16 (dd, J = 3.4, 1.7 
Hz, 1H), 4.13 (td, J = 6.0, 3.3 Hz, 1H), 4.07 – 4.00 (m, 3H), 3.99 – 3.95 (m, 2H), 3.94 – 
3.83 (m, 9H), 3.82 – 3.73 (m, 6H), 3.70 (dd, J = 9.9, 7.7 Hz, 1H), 3.13 – 3.07 (m, 2H), 1.82 
– 1.73 (m, 4H), 1.55 (dt, J = 15.4, 7.6 Hz, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 106.9, 
103.3, 102.9, 101.4, 82.9, 81.6, 81.0, 80.1, 75.5, 74.1, 73.8, 72.3, 71.5, 70.0, 69.1, 68.9, 
68.8, 67.6, 67.5, 67.5, 66.4, 60.2, 60.0, 60.0, 38.4, 27.2, 25.4, 21.1 ppm. HRMS: m/z 
[M+H]+ calcd. for C28H51NO20: 722.3082, found: 722.3042. 
RP-HPLC of the deprotected tetrasaccharide 48 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1 % of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 









Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 49. The crude product was purified by normal 






Crude NP-HPLC of protected tetrasaccharide 49 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min) 
The protected tetrasaccharide 49 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH 1 mL) was added. The solution was stirred overnight at rt. The reaction mixture 
was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off and the 
solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected tetrasaccharide 49 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide 49 (2.0 mg, 2.77 µmol, 16% over 11 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 5.39 (s, 1H), 4.70 (d, J = 7.8 Hz, 1H), 4.62 (d, J = 7.9 Hz, 
1H), 4.59 (d, J = 7.8 Hz, 1H), 4.38 – 4.37 (m, 1H), 4.32 (d, J = 2.3 Hz, 1H), 4.31 – 4.28 
(m, 1H), 4.24 – 4.19 (m, 2H), 4.15 – 4.05 (m, 8H), 4.00 (d, J = 12.5 Hz, 1H), 3.98 – 3.80 





2H) ppm. 13C NMR (176 MHz, D2O) δ = 107.0, 101.1, 100.8, 100.4, 81.6, 79.0, 77.9, 74.3, 
72.9, 71.5, 71.3, 70.4, 70.4, 68.5, 68.4, 67.9, 67.5, 67.0, 66.8, 66.4, 66.4, 66.2, 58.9, 58.7, 
37.1, 25.9, 24.2, 19.8 ppm. HRMS: m/z [M+Na]+ calcd. for C28H51NO20: 744.2902, found: 
744.2903. 
RP-HPLC of deprotected tetrasaccharide 49 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 




Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 





Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected tetrasaccharide 50. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected tetrasaccharide 50 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The Tetrasaccharide 50 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 1 mL) 
was added. The solution was stirred overnight at rt. The reaction mixture was neutralized 
using prewashed Amberlite IR-120 resin, the resin was filtered off and the solvent was 
removed in vacuo. The semi-protected product was purified by semi-preparative RP-
HPLC (C5 column). 
Crude RP-HPLC of semi-protected terasaccharide 50 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 





The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
tetrasaccharide 50 (1.2 mg, 1.66 µmol, 10% over 11 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (d, J = 1.3 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.60 (d, J = 
7.9 Hz, 1H), 4.40 – 4.37 (m, 2H), 4.30 (ddd, J = 12.3, 6.1, 3.0 Hz, 2H), 4.20 (dd, J = 10.3, 
3.0 Hz, 1H), 4.15 – 4.03 (m, 5H), 4.02 – 3.97 (m, 3H), 3.96 – 3.83 (m, 11H), 3.83 – 3.79 
(m, 1H), 3.69 (dd, J = 9.9, 7.9 Hz, 1H), 3.20 – 3.16 (m, 2H), 1.86 (tt, J = 14.2, 7.1 Hz, 4H), 
1.67 – 1.60 (m, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 107.0, 101.7, 101.2, 100.1, 81.6, 
80.1, 79.0, 77.6, 74.3, 72.9, 72.5, 71.2, 70.5, 68.5, 67.9, 67.7, 67.6, 66.9, 66.3, 66.2, 66.2, 
58.9, 58.7, 58.7, 37.1, 25.9, 24.1, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for C28H51NO20: 
722.3082, found: 722.3125. 
RP-HPLC of deprotected tetrasaccharide 50 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 







galactopyranosyl] β-D-galactopyranosyl-(1→3)-β-D-galactopyranoside (51) 
 
Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected pentasaccharide 51. The crude product was purified by normal 





Crude NP-HPLC of protected pentasaccharide 51 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected branched pentasaccharide 51 was dissolved in THF (5 mL) and NaOMe 
(0.5 M in MeOH, 0.5 mL) was added. The solution was stirred overnight at rt. The reaction 
mixture was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off 
and the solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected pentasaccharide 51 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
pentasaccharide 51 (2.7 mg, 3.05 µmol, 16% over 14 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (s, 1H), 4.85 (d, J = 7.7 Hz, 1H), 4.78 (d, J = 7.6 Hz, 
1H), 4.65 (d, J = 7.9 Hz, 1H), 4.62 (d, J = 8.0 Hz, 1H), 4.42 – 4.37 (m, 3H), 4.31 – 4.25 
(m, 2H), 4.21 (q, J = 8.7 Hz, 1H), 4.14 – 4.04 (m, 6H), 4.03 – 3.76 (m, 24H), 3.18 (t, J = 
7.4 Hz, 2H), 1.90 – 1.81 (m, 4H), 1.63 (dt, J = 15.0, 7.7 Hz, 2H) ppm. 13C NMR (151 MHz, 





72.5, 71.1, 70.3, 68.7, 67.9, 67.7, 67.6, 67.0, 66.3, 66.2, 66.2, 66.1, 58.9, 58.7, 58.7, 37.1, 
25.9, 24.1, 19.8 ppm. HRMS: m/z [M+H]+ calcd. for C34H61NO25: 884.3610, found: 
884.3550. 
RP-HPLC of deprotected pentasaccharide 51 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 





Module A (2 x 3.75 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected hexasaccharide 52. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected hexasaccharide 52 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and linear gradients from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected hexasaccharide 52 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH 0.5 mL) was added. The solution was stirred overnight at rt. The reaction mixture 
was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off and the 
solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected hexasaccharide 52 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 





through a syringe filter the solvents were evaporated to provide the fully deprotected 
hexasaccharide 52 (1.9 mg, 1.82 µmol, 11% over 17 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.33 (s, 1H), 4.79 (d, J = 7.8 Hz, 1H), 4.72 (d, J = 7.6 Hz, 
1H), 4.60 (d, J = 7.9 Hz, 1H), 4.56 – 4.54 (m, 2H), 4.35 – 4.30 (m, 3H), 4.24 – 4.21 (m, 
2H), 4.15 – 4.09 (m, 2H), 4.07 – 3.99 (m, 8H), 3.96 (dd, J = 9.9, 3.1 Hz, 1H), 3.94 – 3.90 
(m, 2H), 3.90 – 3.84 (m, 7H), 3.84 – 3.69 (m, 11H), 3.63 (dd, J = 9.7, 8.0 Hz, 1H), 3.11 (t, 
J = 7.4 Hz, 2H), 1.83 – 1.75 (m, 4H), 1.59 – 1.53 (m, 2H) ppm.13C NMR (151 MHz, D2O) δ 
= 108.0, 103.1, 102.7, 102.3, 102.1, 101.2, 82.7, 81.3, 80.8, 80.1, 79.0, 75.3, 74.0, 73.9, 
73.6, 72.3, 72.0, 71.6, 71.4, 69.8, 69.6, 69.0, 68.8, 68.7, 68.7, 68.3, 68.0, 67.4, 67.4, 67.3, 
67.3, 67.2, 60.0, 59.9, 59.8, 59.8, 38.2, 27.0, 25.2, 20.9 ppm. HRMS: m/z [M+Na]+ calcd. 
for C40H71NO30: 1068.3958, found: 1068.4056. 
RP-HPLC of deprotected hexaasaccharide 52 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 










Linker functionalized resin 23(53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles)  
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 





Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 3.8 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Module C (3 cycles) 
Module A (2 x 3.8 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected heptasaccharide 53. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column. 
Crude NP-HPLC of protected heptasaccharide 53 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The protected heptasaccharide 53 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.5 mL) was added. The solution was stirred overnight at rt. The reaction mixture 
was neutralized using prewashed Amberlite IR-120 resin, the resin was filtered off and the 
solvent was removed in vacuo. The semi-protected product was purified by semi-
preparative RP-HPLC (C5 column). 
Crude RP-HPLC of semi-protected heptasaccharide 53 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 





The product was dissolved in a mixture of EtOAc/MeOH/AcOH/H2O (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated to provide the fully deprotected 
heptasaccharide 53 (1.9 mg, 1.55  µmol, 9% over 21 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.40 (d, J = 0.8 Hz, 1H), 4.86 (d, J = 7.7 Hz, 1H), 4.78 (d, J = 
7.6 Hz, 1H), 4.69 (d, J = 7.9 Hz, 1H), 4.62 (dd, J = 7.9, 4.6 Hz, 3H), 4.41 (dd, J = 8.1, 3.2 
Hz, 2H), 4.38 (dd, J = 3.4, 1.5 Hz, 1H), 4.32 – 4.28 (m, 2H), 4.23 – 4.18 (m, 3H), 4.14 – 
4.05 (m, 11H), 4.03 (dd, J = 9.9, 3.2 Hz, 1H), 4.01 – 3.97 (m, 2H), 3.96 – 3.90 (m, 7H), 
3.90 – 3.80 (m, 11H), 3.78 (dd, J = 9.8, 7.7 Hz, 1H), 3.72 – 3.66 (m, 2H), 3.20 – 3.16 (m, 
2H), 1.90 – 1.82 (m, 4H), 1.63 (dt, J = 15.3, 7.7 Hz, 2H) ppm. 13C NMR (151 MHz, D2O) δ 
= 107.0, 102.1, 101.6, 101.2, 101.2, 100.9, 100.1, 81.6, 80.3, 79.7, 79.1, 77.9, 74.4, 72.9, 
72.9, 72.6, 71.4, 71.4, 71.0, 70.5, 70.4, 70.3, 68.8, 68.5, 68.5, 68.0, 67.7, 67.6, 67.3, 67.2, 
67.2, 66.9, 66.4, 66.4, 66.2, 66.2, 66.1, 59.0, 58.8, 58.8, 58.7, 37.1, 25.9, 24.2, 19.9 ppm. 
HRMS: m/z [M+Na]+ calcd. for C46H81NNaO35: 1230.4486, found: 1230.4396. 
RP-HPLC of deprotected heptasaccharide 53 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 









Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles) 
Module C (3 cycles) 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles) 
Module C (3 cycles) 
Module A (1 x 5 equiv. BB3 TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 5 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 






Crude NP-HPLC of ptotected tetrasaccharide 54 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and a linear gradient from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected tetrasaccharide 54 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.5 mL) was added. The reaction mixture was stirred overnight at rt and 
subsequently neutralized by the addition of prewashed Amberlite IR-120 resin. The resin 
was filtered off and the solvents were removed in vacuo. The semi-protected trisaccharide 
was purified by semi-preparative RP HPLC (C5 column). 
Crude RP-HPLC of the semi-protected tetrasaccharide 54 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/H2O/AcOH (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 5 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated. The fully deprotected 
tetrasaccharide 54 was re-dissolved in water and purified by filtration through a SepPak 
C18 column to give the tetrasaccharide 54 (1.2 mg, 1.66 µmol, 8% over 14 steps, based 
on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.41 (d, J = 1.2 Hz, 1H), 4.68 (d, J = 7.9 Hz, 1H), 4.65 (d, J = 





4.23 (ddd, J = 10.0, 4.7, 3.2 Hz, 2H), 4.17 – 4.04 (m, 8H), 4.02 – 3.80 (m, 11H), 3.69 
(ddd, J = 17.8, 9.8, 8.0 Hz, 1H), 3.19 – 3.15 (m, 2H), 1.91 – 1.82 (m, 4H), 1.64 (q, J = 8.0 
Hz, 2H) ppm. 13C NMR (151 MHz, D2O) δ = 107.0, 101.1, 100.9, 100.5, 81.6, 79.1, 78.0, 
74.3, 72.8, 71.6, 71.5, 70.4, 70.4, 68.5, 67.9, 67.7, 67.1, 66.5, 66.4, 66.2, 59.0, 58.7, 37.2, 
26.0, 24.3, 19.9 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for C28H51NNaO20: 744.2897, found: 
744.2928. 
RP-HPLC of the deprotected tetrasaccharide 54 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 










Linker functionalized resin 23 (53 mg, 16.9 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles) 
Module C (3 cycles) 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles) 
Module C (3 cycles) 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 





Module C (3 cycles) 
Module A (1 x 5 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (3 cycles) 
Module C (3 cycles) 
Module A (1 x 5 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 5 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected pentasaccharide 55. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column (18 mg, 6.06 µmol, 36%). 
Crude NP-HPLC of ptotected pentasaccharide 55 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and a linear gradient from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected pentasaccharide 55 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 0.3 mL) was added. Upon addition of the base a precipitate formed which could 
be dissolved again by addition of MeOH (1 mL). The reaction mixture was stirred 
overnight at rt and subsequently neutralized by the addition of prewashed Amberlite IR-
120 resin. The resin was filtered off and the solvents were removed in vacuo. The product 
was not soluble in MeCN/water and therefore not purified by reversed phase HPLC but 






Crude RP-HPLC of the semi-protected tetrasaccharide 55 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The crude semi-protected pentasaccharide 55 was dissolved in a mixture of 
EtOAc/MeOH/AcOH/H2O (4:2:2:1, 5 mL) and the resulting solution was added to a round-
bottom flask containing Pd/C (10% Pd, 10 mg). The suspension was flushed with argon 
for 10 min, then saturated with H2 for 10 min, and stirred under a H2-atmosphere overnight 
at rt. Due to incomplete benzyl cleavage after stirring overnight the hydrogenation 
procedure was repeated and the reaction was left stirring at rt overnight again. After 
filtration of the reaction mixture through a syringe filter the solvents were evaporated and 
the fully deprotected hexasaccharide 55 was purified by reversed phase HPLC using a 
semi-preparative Hypercarb column (0.2 mg, 0.14 µmol, 1% over 18 steps, based on 
resin loading). 
1H NMR (700 MHz, D2O) δ = 5.41 (d, J = 1.6 Hz, 1H), 4.68 (d, J = 8.0 Hz, 1H), 4.67 – 4.63 
(m, 3H), 4.59 (d, J = 7.9 Hz, 1H), 4.38 (dd, J = 3.5, 1.8 Hz, 1H), 4.30 (td, J = 6.2, 3.3 Hz, 
1H), 4.28 (d, J = 3.3 Hz, 1H), 4.22 (ddd, J = 8.3, 6.2, 2.7 Hz, 4H), 4.15 – 4.05 (m, 14H), 
4.00 (dd, J = 12.2, 3.3 Hz, 1H), 3.97 – 3.92 (m, 2H), 3.91 – 3.81 (m, 9H), 3.73 – 3.66 (m, 
4H), 3.20 – 3.17 (m, 2H), 1.86 (dp, J = 14.4, 7.3 Hz, 4H), 1.63 (p, J = 7.8 Hz, 2H) ppm. 
ESI-HRMS: m/z [M+H]+ calcd. For C40H72NO30: 1046,4139, found: 1046.4185. The 











Linker functionalized resin 56 (60 mg, 15.1 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected trisaccharide 57. The crude product was purified by normal phase 






Crude NP-HPLC of protected trisaccharide 57 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and a linear gradient from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected trisaccharide 57 was dissolved in THF (5 mL) and NaOMe (0.5 M in MeOH, 
1 mL) was added. The reaction mixture was stirred overnight and subsequently 
neutralized by addition of prewashed Amberlite IR-120 resin. The resin was filtered off 
and the solvents were removed in vacuo. The crude product was purified by reversed 
phase HPLC using a semi-preparative C5 column affording the semi-protected 
trisaccharide. 
Crude RP-HPLC of the semi-protected trisaccharide 57 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/H2O/AcOH (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 5 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated. The fully deprotected trisaccharide 
57 was re-dissolved in 0.5 mL water and stirred for one hour with a spatula tip of H+-
Amberlite resin to hydrolyze a side product that has formed by condensation of the 
oligosaccharide with the cleaved linker. Without removal of the water the fully de-





preparative Hypercarb column to give an α/βmixture of the trisaccharide 57 (0.6 mg, 
1.19 µmol, 8% over 9 steps, based on resin loading). 
1H NMR (600 MHz, D2O) δ = 5.30 (d, J = 3.4 Hz, 1H), 4.70 (t, J = 7.4 Hz, 1H), 4.65 (t, J = 
8.1 Hz, 2H), 4.28 (d, J = 2.0 Hz, 1H), 4.22 (b, 2H), 4.14 (t, J = 6.1 Hz, 1H), 4.01 (qd, J = 
10.3, 3.2 Hz, 1H), 3.94 (d, J = 3.2 Hz, 1H), 3.88 – 3.82 (m, 2H), 3.81 – 3.61 (m, 13H) 
ppm. 13C NMR (151 MHz, D2O) δ = 106.6, 98.7, 85.0, 84.6, 81.9, 77.3, 77.2, 75.1, 73.6, 
73.5, 72.8, 71.1, 70.9, 63.7, 63.5, 63.5, 63.4, 63.4 ppm. ESI-HRMS: m/z [M+Na]+ calcd. 
for C18H32NaO16: 527.1588, found: 527.1534 
RP-HPLC of the deprotected trisaccharide 57 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 









Linker functionalized resin 56 (60 mg, 15.1 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows: 
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 4 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module E (0.5 M Bz2O, 0.25 M DMAP, Py, DCE, 3 x 30 min, 40 °C) 
Module C (0.15 M N2H4 in Py/AcOH/H2O (4:1:0.25), 3 x 30 min, 25 °C) 
Module A (2 x 4 equiv. BB3, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module D (2 x 4 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected pentasaccharide 58. The crude product was purified by normal 






Crude NP-HPLC of protected pentasaccharide 59 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and a linear gradient from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected pentasaccharide 59 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The reaction mixture was stirred overnight and subsequently 
neutralized by addition of prewashed Amberlite IR-120 resin. The resin was filtered off 
and the solvents were removed in vacuo. The crude product was purified by reversed 
phase HPLC using a semi-preparative C5 column affording the semi-protected 
hexasaccharide. 
Crude RP-HPLC of the semi-protected pentasaccharide (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/H2O/AcOH (4:2:2:1, 3 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. After filtration of the reaction mixture 
through a syringe filter the solvents were evaporated until approx. 1 mL of the solvent 
mixture remained and the solvents were removed at a lyophilizer. The fully deprotected 





HPLC using a semi-preparative Hypercarb column to give an α/β-mixture of the 
pentasaccharide 59 (1.2 mg, 1.48 µmol, 10% over 14 steps, based on resin loading). 
1H NMR (600 MHz, D2O): δ = 5.15 (s, 1H), 5.10 (s, 1H), 4.55 (t, J = 8.0 Hz, 1H), 4.48 (t, J 
= 8.6 Hz, 1H), 4.34 (d, J = 6.2 Hz, 1H), 4.16 (s, 1H), 4.08 (d, J = 15.4 Hz, 3H), 3.97 (d, J = 
15.5 Hz, 2H), 3.93 – 3.74 (m, 7H), 3.73 – 3.45 (m, 17H) ppm. 13C NMR (151 MHz, D2O): δ 
= 111.8, 111.8, 106.9, 106.4, 106.4, 105.8, 98.7, 98.7, 94.7, 86.4, 84.9, 84.9, 84.5, 83.8, 
83.8, 82.8, 82.8, 81.9, 79.0, 79.0, 77.6, 77.5, 77.3, 75.8, 75.8, 75.1, 73.6, 73.5, 72.7, 72.6, 
72.5, 71.8, 71.7, 71.7, 71.7, 71.1, 71.0, 71.0, 71.0, 70.9, 69.9, 63.8, 63.7, 63.5 ppm. 
[M+Na]+ calcd. for C29H50NaO25: 821.2538, found: 821.2538 
RP-HPLC of the deprotected pentasaccharide 59 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 










Linker functionalized resin 56 (85 mg, 22.1 µmol) was placed in the reaction vessel 
of the synthesizer and synthesizer modules were applied as follows:  
Module A (2 x 3 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt) 
Module A (2 x 3 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Module A (2 x 3 equiv. BB7, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module C (0.15 M N2H4 in Py/AcOH/H2O (4:1:0.25), 3 x 30 min, 25 °C) 
Module D (2 x 3 equiv. BB4, NIS, TfOH, DCM/Dioxane, 2 x 45 min, -40 °C to -20 °C) 





Module A (2 x 3 equiv. BB8, TMSOTf, DCM, 2 x 35 min, -35 °C to -20 °C)  
Module B (20% NEt3 in DMF, 3 x 5 min, rt)  
Cleavage from the resin using UV irradiation at 305 nm in a continuous flow photoreactor 
afforded the protected hexasaccharide 60. The crude product was purified by normal 
phase HPLC using a preparative YMC Diol column (23 mg, 8.01 µmol, 36%). 
Crude NP-HPLC of protected hexasaccharide 60 (ELSD trace): 
 
HPLC was performed using a YMC Diol column and a linear gradient from 90% to 40% hexane in 
ethyl acetate (35 min, flow rate 1 mL/min) and from 40% to 0% hexane in ethyl acetate (10 min, 
flow rate 1 mL/min). 
The protected hexasaccharide 60 was dissolved in THF (5 mL) and NaOMe (0.5 M in 
MeOH, 1 mL) was added. The reaction mixture was stirred overnight and subsequently 
neutralized by addition of prewashed Amberlite IR-120 resin. The resin was filtered off 
and the solvents were removed in vacuo to afford the semi-protected hexasaccharid. 
Crude RP-HPLC of the semi-protected hexasaccharide 60 (ELSD trace): 
 
HPLC was performed using a C5 column and a linear gradient from 80% to 0% H2O (containing 
0.1% of formic acid) in MeCN (50 min, flow rate 1.0 mL/min). 
The product was dissolved in a mixture of EtOAc/MeOH/H2O/AcOH (4:2:2:1, 5 mL) and 
the resulting solution was added to a round-bottom flask containing Pd/C (10% Pd, 
10 mg). The suspension was flushed with argon for 10 min, then saturated with H2 for 10 
min and stirred under a H2-atmosphere overnight. The hydrogenation procedure was 





mixture through a syringe filter the solvents were evaporated. The fully deprotected 
hexasaccharide 60 was re-dissolved in 0.5 mL water and stirred for one hour with a 
spatula tip of H+-Amberlite resin to hydrolyze a side product that has been formed by 
condensation of the oligosaccharide with the cleaved linker. The fully deprotected 
hexasaccharide 60 was purified by reversed phase HPLC using a semi-preparative 
Hypercarb column to give an α/β-mixture of the hexasaccharide 60 (0.8 mg, 0.85 µmol, 
4% over 15 steps, based on resin loading). 
1H NMR (700 MHz, D2O) δ = 5.29 (d, J = 3.8 Hz, 1H), 5.11 (s, 1H), 4.65 – 4.61 (m, 2H), 
4.55 (d, J = 7.9 Hz, 1H), 4.52 – 4.47 (m, 2H), 4.31 (dd, J = 7.8, 4.0 Hz, 1H), 4.23 (d, J = 
3.0 Hz, 1H), 4.14 – 4.13 (m, 1H), 4.10 – 4.05 (m, 5H), 4.00 – 3.67 (m, 24H), 3.65 – 3.62 
(m, 1H), 3.58 – 3.55 (m, 2H), 3.52 (dd, J = 9.8, 8.1 Hz, 1H) ppm. 13C NMR (176 MHz, 
D2O) δ = 107.8, 104.3, 103.4, 103.2, 103.1, 96.4, 92.3, 83.8, 82.2, 81.0, 76.4, 75.0, 73.7, 
73.5, 72.6, 72.5, 71.7, 71.0, 70.7, 70.6, 69.7, 69.5, 69.4, 69.3, 69.2, 68.9, 68.7, 68.6, 68.5, 
68.2, 67.3, 61.1, 60.9 ppm. [M+Na]+ calcd. for C35H60NaO30: 983.3067, found: 983.3007 
RP-HPLC of the deprotected hexasaccharide 60 (ELSD trace): 
 
HPLC was performed using a Hypercarb column and a linear gradient from 97.5% to 30% H2O 
(containing 0.1% of formic acid) in MeCN (45 min, flow rate 0.7 mL/min) and from 30% to 0% H2O 







3.4 Synthesis of RG-II Fragments 
3.4.1 Synthesis of Building Blocks for the Automated Glycan Assembly 
of Substituted Homogalacturonan Fragments 
p-Tolyl 2,3-O-dibenzyl-6-O-levulinoyl-1-thio-β-D-galactopyranoside (70a) 
 
To a solution of dihydroxy galactose 69170 (3.00 g, 6.43 mmol) in anhydrous DCM 
(150 mL) at -6 °C (salt-water-ice bath) were subsequently added DMAP (78.1 mg, 0.643 
mmol, 0.1 equiv) and DIC (1.00 mL, 6.43 mmol, 1 equiv). Levulinic acid (0.622 mL, 
6.11 mmol) dissolved in anhydrous DCM (10 mL) was added dropwise. The solution was 
stirred at 0 °C for 1 h, slowly allowed to warm to rt and kept stirring at rt overnight. The 
reaction was quenched by the addition of water (10 mL) and the reaction mixture was 
washed with brine. The organic phase was separated, dried over MgSO4, the solvent was 
removed in vacuo and the residue was subjected to silica column chromatography 
(hex/EtOAc = 3:2), yielding the levulinoyl protected intermediate 70a (2.93 g, 5.19 mmol, 
81%) as a colorless foam. [α]D
25 = +15.9 (c 1.1, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 
7.49 – 7.44 (m, 2H, Ar), 7.44 – 7.39 (m, 2H, Ar), 7.38 – 7.28 (m, 8H, Ar), 7.11 – 7.07 (m, 
2H, Ar), 4.83 (d, J = 10.3 Hz, 1H, OCH2Ph), 4.74 (d, J = 10.3 Hz, 1H, OCH2Ph), 4.71 (d, J 
= 1.8 Hz, 2H, OCH2Ph), 4.55 (d, J = 9.7 Hz, 1H, H-1), 4.40 – 4.29 (m, 2H, H-6), 4.03 – 
3.99 (m, 1H, H-4), 3.69 (dd, J = 9.7, 9.0 Hz, 1H, H-2), 3.63 – 3.55 (m, 2H, H-3, H-5), 2.78 
– 2.73 (m, 2H, OLev), 2.60 – 2.55 (m, 2H, OLev), 2.40 (dd, J = 2.8, 1.1 Hz, 1H, 4-OH), 
2.32 (s, 3H, SPhCH3), 2.18 (s, 3H, OLev) ppm. 
13C NMR (101 MHz, CDCl3) δ = 206.7 
(C=O), 172.8 (C=O), 138.3, 137.8, 137.6, 132.7, 129.9, 129.8, 128.7, 128.5, 128.4, 128.2, 
128.1, 128.0 (18 C, Ar), 88.0 (C-1), 82.4 (C-3), 76.9 (C-2), 75.9 (OCH2Ph), 75.6 (C-5), 
72.4 (OCH2Ph), 66.5 (C-4), 63.4 (C-6), 38.1 (OLev), 30.0 (OLev), 28.0 (OLev), 21.3 
(SPhCH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd for C32H36NaO7S: 587.2074, found: 






Intermediate 70a (0.699 g, 1.24 mmol) was dissolved in anhydrous DCM (50 mL) 
under argon atmosphere. Anhydrous pyridine (0.400 mL, 4.96 mmol) was added at rt, the 





The reaction was left stirring at rt under argon atmosphere overnight. As after stirring 
overnight still starting material was detected by TLC, another 1.00 g (3.88 mmol, 
3.1 equiv) FmocCl was added and the reaction was left stirring at rt for additional three 
hours. Recrystallization from boiling EtOH gave the desired product (0.554 g, 0.704 mmol, 
57%) as a colorless solid. [α]D
25 = -1.4 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 7.79 
(d, J = 7.6 Hz, 2H, Ar), 7.63 (dd, J = 19.2, 7.4 Hz, 2H, Ar), 7.51 (d, J = 7.9 Hz, 2H, Ar), 
7.47 – 7.38 (m, 4H, Ar), 7.33 (m, 7H, Ar), 7.22 – 7.15 (m, 3H, Ar), 7.11 (d, J = 7.8 Hz, 2H, 
Ar), 5.41 (d, J = 3.1 Hz, 1H, H-4), 4.84 – 4.75 (m, 3H, OCH2Ph), 4.64 (d, J = 9.6 Hz, 1H, 
H-1), 4.57 (d, J = 11.3 Hz, 1H, OCH2Ph), 4.47 – 4.30 (m, 3H, H-6’, Fmoc), 4.27 – 4.19 (m, 
2H,H-6´´, Fmoc), 3.82 (t, J = 6.9 Hz, 1H, H-5), 3.78 (t, J = 9.5 Hz, 1H, H-2), 3.69 (dd, J = 
9.2, 3.1 Hz, 1H, H-3), 2.75 (t, J = 6.5 Hz, 2H, OLev), 2.60 – 2.56 (m, 2H, OLev), 2.31 (s, 
3H, SPhCH3), 2.17 (s, 3H, OLev) ppm. 
13C NMR (101 MHz, CDCl3) δ = 206.6 (C=O), 
172.4 C=O), 155.1, 143.7, 143.3, 141.4, 141.4, 138.3, 137.9, 137.6, 132.7, 129.8, 129.7, 
128.5, 128.4, 128.1, 128.0, 128.0, 127.9, 127.9, 127.3, 127.3, 125.5, 125.3, 120.1, 120.1 
(30 C, Ar), 88.2 (C-1), 81.0 (C-3), 76.7 (C-2), 76.0 (OCH2Ph), 74.1 (C-5), 72.2 (OCH2Ph), 
70.9 (C-4), 70.3 (OFmoc), 62.3 (C-6), 46.7 (OFmoc), 38.1 (OLev), 29.9 (OLev), 28.0 
(OLev), 21.3 (SPhCH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd for C47H46NaO9S: 809.2755, 
found 809.2771. IR (neat) max: 1745, 1707, 1260, 1235 cm
-1. 
 
p-Tolyl 2,3-O-dibenzyl-6-O-acetyl-1-thio-β-D-galactopyranoside (70b) 
 
To a solution of 69170 (1.68 g, 3.61 mmol) in DCM (50 mL) at 0 °C were 
subsequently added DMAP (44.0 mg, 0.361 mmol, 0.1 equiv), DCC (0.745 g, 3.61 mmol, 
1 equiv) and acetic acid (0.227 mL, 3.97 mmol, 1.1 equiv) dissolved in DCM (5.00 mL). 
The solution was stirred at rt for 2 h. A white precipitate slowly formed. After complete 
conversion, the solvent was removed under reduced pressure and purification by column 
chromatography (hex/EtOAc = 3:1 to 3:2) yielded 70b (1.51 g, 2.97 mmol, 82% yield) as a 
colorless solid. 
[α]D
25 = +8.8 (c 1.4, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.50 – 7.46 (m, 2H, Ar), 7.44 – 
7.41 (m, 2H, Ar), 7.39 – 7.29 (m, 8H, Ar), 7.12 – 7.07 (m, 2H, Ar), 4.85 (d, J = 10.3 Hz, 
1H, OCH2Ph), 4.74 (d, J = 10.3 Hz, 1H, OCH2Ph), 4.71 (s, 2H, OCH2Ph), 4.55 (d, J = 9.7 
Hz, 1H, H-1), 4.39 – 4.28 (m, 2H, H-6), 3.99 – 3.97 (m, 1H, H-4), 3.70 (t, J = 9.3 Hz, 1H, 
H-2), 3.64 – 3.55 (m, 2H, H-3, H-5), 2.40 (dd, J = 2.7, 1.2 Hz, 1H, 4-OH) 2.33 (s, 3H, 
SPhCH3), 2.07 (s, 3H, OAc) ppm. 
13C NMR (101 MHz, CDCl3) δ = 170.9 (C=O), 138.2, 
137.8, 137.6, 132.7, 129.9, 129.7, 128.7, 128.5, 128.4, 128.3, 128.2, 128.0, 128.0 (18 C, 





(C-4), 63.4 (C-6), 21.2 (SPhCH3), 21.0 (OAc) ppm. ESI-HRMS: m/z [M+Na]
+ calcd for 
C29H32NaO6S: 531.1812, found: 531.1812. IR (neat) max: 1718, 1270, 1081, 1046 cm
-1. 
 
p-Tolyl phenyl 2,3-O-dibenzyl-4-O- fluorenylcarbonylmethoxy -6-O-acetyl-1-thio-β-D-
galactopyranoside (BB10b) 
 
70b (1.43 g, 2.81 mmol) was dissolved in anhydrous DCM (50 mL) under argon 
atmosphere and pyridine (0.453 mL, 5.62 mmol, 2 equiv) was added at rt. FmocCl 
(1.46 g, 5.62 mmol, 2 equiv) was added and the reaction was left stirring under argon 
atmosphere overnight. The solvent was removed in vacuo and the residue was subjected 
to silica gel column chromatography (hex/EtOAc = 4:1) to obtain product BB10b (1.54 g, 
2.10 mmol, 75%) as a colorless solid. 
[α]D
25 = -2.7 (c 0.2, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 7.82 – 7.75 (m, 2H, Ar), 7.67 – 
7.58 (m, 2H, Ar), 7.53 – 7.49 (m, 2H, Ar), 7.46 – 7.39 (m, 4H, Ar), 7.38 – 7.26 (m, 7H, Ar), 
7.21 – 7.16 (m, 3H, Ar), 7.13 – 7.09 (m, 2H, Ar), 5.37 (dd, J = 3.3, 1.0 Hz, 1H, H-4), 4.84 – 
4.74 (m, 3H, OCH2Ph), 4.62 (d, J = 9.7 Hz, 1H, H-1), 4.56 (d, J = 11.2 Hz, 1H, OCH2Ph), 
4.48 – 4.20 (m, 5H, H-6, Fmoc), 3.84 – 3.72 (m, 2H, H-2, H-5), 3.68 (dd, J = 9.1, 3.2 Hz, 
1H, H-3), 2.31 (s, 3H, SPhCH3), 2.08 (s, 3H, OAc) ppm.
 13C NMR (101 MHz, CDCl3) δ = 
170.7 (C=O), 155.1 (C=O), 143.6, 143.2, 141.4, 141.3, 138.2, 138.0, 137.5, 132.7, 129.8, 
129.7, 128.5, 128.4, 128.4, 128.0, 128.0, 127.9, 127.9, 127.3, 127.2, 125.5, 125.3, 120.2, 
120.1, 120.1 (30 , Ar), 88.2 (C-1), 81.0 (C-3), 76.7 (C-2), 76.0 (OCH2Ph), 74.3 (C-5), 72.2 
(OCH2Ph), 71.0 (C-4), 70.3 (Fmoc), 62.5 (C-6), 46.7 (Fmoc), 21.3 (SPhCH3), 20.9 (OAc) 
ppm. ESI-HRMS: m/z [M+Na]+ calcd for C44H42NaO8S: 753.2503, found: 753.2493. IR 
(neat) max: 1743, 1258, 1225, 1034 cm
-1. 
p-Tolyl 2,3,4-tri-O-benzyl-1-thio-β-D-galactopyranoside (68) 
 
To solution of 4-methyl phenyl 2,3-O-dibenzyl-4,6-O-benzylidene-1-thio-β-D-
galactopyranoside (67)222 (6.99 g, 12.6 mmol) in anhydrous DCM (50 mL) under argon 
atmosphere at 0 °C were sequentially added borane (25.2 mL of a 1 M solution in THF, 
25.2 mmol, 2 equiv) and TMSOTf (1.14 mL, 6.30 mmol, 0.5 equiv). The reaction was 
stirred at 0°C for 90 min before it was allowed to warm to rt. The reaction was left stirring 
at rt for one hour. After completion, the reaction was quenched by the addition of NEt3 





yielding intermediate 68 (7.00 g, 12.6 mmol) in quantitative yield. 1H NMR (400 MHz, 
CDCl3) δ = 7.48 – 7.44 (m, 2H), 7.42 – 7.29 (m, 15H), 7.04 (d, J = 7.9 Hz, 2H), 4.98 (d, J 
= 11.6 Hz, 1H), 4.83 (d, J = 10.2 Hz, 1H), 4.79 – 4.74 (m, 3H), 4.67 – 4.56 (m, 3H), 3.92 
(t, J = 9.4 Hz, 1H), 3.87 – 3.80 (m, 1H), 3.61 (dd, J = 9.2, 2.8 Hz, 1H), 3.52 (dd, J = 11.3, 
5.1 Hz, 1H), 3.45 – 3.40 (m, 1H), 2.31 (s, 3H) ppm. The analytical data is in agreement 
with literature data.223 
p-Tolyl 2,3,4-tri-O-benzyl-6-O-acetyl-1-thio-β-D-galactopyranoside (BB12) 
 
To a solution of 68 (7.00 g, 12.6 mmol) in DCM (200 mL) at 0 °C were added 
DMAP (0.154 g, 1.26 mmol, 0.1 equiv), DIC (1.96 mL, 12.6 mmol, 1 equiv), and acetic 
acid (0.792 mL, 13.8 mmol, 1.1 equiv) dissolved DCM (5.00 mL). A white precipitate 
slowly formed when the solution was stirred for 3 h at rt. The solvent was removed in 
vacuo and purification over silica column chromatography (hex/EtOAc = 3:2) yielded 
BB12 (4.36 g, 7.28 mmol, 58% yield) as a colorless solid.  
1H NMR (400 MHz, CDCl3) δ = 7.52 (d, J = 7.6 Hz, 2H), 7.46 – 7.31 (m, 15H), 7.07 (d, J = 
7.6 Hz, 2H), 5.03 (d, J = 11.4 Hz, 1H), 4.87 (d, J = 10.0 Hz, 1H), 4.81 – 4.75 (m, 3H), 4.68 
(d, J = 11.8 Hz, 1H), 4.61 (d, J = 9.4 Hz, 1H), 4.30 (dd, J = 11.2, 6.7 Hz, 1H), 4.15 (dd J = 
11.3, 5.5 Hz, 1H), 3.96 (t, J = 9.3 Hz, 1H), 3.90 – 3.86 (m, 1H), 3.63 (dt, J = 12.6, 4.6 Hz, 
2H), 2.34 (s, 3H), 2.03 (s, 3H) ppm.The analytical data is in agreement with literature 
data.224  
p-Tolyl 2-O-naphtyl-3-O-benzyl-4,6-O-benzylidene-1-thio-β-D-galactopyranoside (72) 
 
The benzylidene intermediate 71225 (3.98 g, 8.57 mmol) was dissolved in a mixture 
of anhydrous DCM and anhydrous DMF (1:1, 100 mL) under argon atmosphere. To the 
solution were added sodium hydride (1.03 g, 26.0 mmol, 60% dispension in mineral oil, 
3 equiv) and BnBr (2.32 mL, 3.34 g, 19.5 mmol, 2.3 equiv) at 0° C. The ice-bath was 
removed and the mixture was stirred at rt for 3 h. After quenching of the excess sodium 
hydride by careful addition of methanol, the reaction was worked up with sat. aq. NH4Cl-
solution and brine. The organic phase was dried over MgSO4, filtered and the solvent was 





(hex/EtOAc = 10:1), yielding 72 (4.62 g, 7.64 mmol, 89% yield over two steps) as a 
colorless solid.  
[α]D
25 = -32.6 (c 2.2, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.79 (m, 4H, Ar), 7.65 
– 7.57 (m, 3H, Ar), 7.56 – 7.45 (m, 4H, Ar), 7.42 – 7.38 (m, 3H, Ar), 7.36 – 7.32 (m, 2H, 
Ar), 7.30 – 7.25 (m, 3H, Ar), 7.03 – 6.98 (m, 2H,Ar), 5.49 (s, 1H, PhCH), 4.88 (s, 2H, 
ONapCH2), 4.73 (s, 2H, OCH2Ph), 4.61 (d, J = 9.5 Hz, 1H, H-1), 4.39 (dd, J = 12.3, 1.6 
Hz, 1H, H-6’), 4.17 (d, J = 3.0 Hz, 1H, H-4), 4.00 (dd, J = 12.3, 1.7 Hz, 1H, H-6’’), 3.90 (t, 
J = 9.4 Hz, 1H, H-2), 3.66 (dd, J = 9.2, 3.4 Hz, 1H, H-3), 3.43 (b, 1H, H-5), 2.31 (s, 3H 
SPhCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 138.2, 138.0, 137.8, 136.2, 133.6, 133.4, 
133.1, 129.8, 129.2, 128.7, 128.5, 128.2, 128.17, 128.1, 127.98, 127.96, 127.81, 126.84, 
126.4, 126.3, 126.0, 125.9 (22 C, Ar), 101.5 (PhCH), 86.7 (C-1), 81.5 (C-3), 75.6 
(ONapCH2), 75.5 (C-2), 73.7 (C-4), 71.9 (OCH2Ph), 69.9 (C-5), 69.6 (C-6), 21.3 (SPhCH3) 
ppm. ESI-HRMS: m/z [M+Na]+ calcd for C38H36NaO5S: 627.2176, found: 627.2187. IR 
(neat) max: 1100, 1090, 1057 cm
-1. 
p-Tolyl 2-O-naphtyl-3-O-benzyl-1-thio-β-D-galactopyranoside (73) 
 
To a solution of 72 (4.60 g, 7.61 mmol) in DCM (200 mL) a solution of TFA (5.00 
ml, 64.9 mmol, 8.5 equiv) in water (20.0 mL) was added. The reaction was stirred at rt for 
1 h before it was quenched by the addition of sat. aq. NaHCO3-solution after one hour, 
although TLC did not indicate full conversion of the educt but also the formation of the 
naphthyl de-protected side-product. The separated organic phase was dried over MgSO4, 
filtrated and concentrated under reduced pressure. The residue was subjected to silica 
gel column chromatography (hex/EtOAc = 1:1) yielding 73 (1.99 g, 3.85 mmol, 51% yield). 
[α]D
25 = +12.1 (c 0.3, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.87 – 7.79 (m, 4H, Ar), 7.57 
(dd, J = 8.4, 1.7 Hz, 1H, Ar), 7.51 – 7.45 (m, 4H, Ar), 7.37 – 7.28 (m, 5H, Ar), 7.14 – 7.08 
(m, 2H, Ar), 5.01 (d, J = 10.5 Hz, 1H, ONapCH2), 4.91 (d, J = 10.6 Hz, 1H, ONapCH2), 
4.72 (d, J = 1.9 Hz, 2H, OCH2Ph), 4.63 (d, J = 9.8 Hz, 1H, H-1, H-1), 4.09 – 4.06 (m, 1H, 
H-4), 4.02 – 3.94 (m, 1H, H-6’), 3.84 – 3.75 (m, 2H, H-2, H-6’’), 3.61 (dd, J = 8.9, 3.3 Hz, 
1H, H-3), 3.52 – 3.46 (m, 1H, H-5), 2.63 (dd, J = 2.1, 1.1 Hz, 1H, 4-OH)2.33 (s, 3H, 
SPhCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 138.0, 137.6, 135.8, 133.4, 133.2, 132.7, 
129.9, 129.8, 128.7, 128.2, 128.1, 128.0, 127.8, 127.0, 126.4, 126.2, 126.0 (22 C, Ar), 
88.0 (C-1), 82.6 (C-3), 78.1 (C-5), 76.9 (C-2), 75.9 (ONapCH2), 72.4 (OCH2Ph), 67.5 (C-
4), 62.9 (C-6), 21.3 (SPhCH3) ppm. ESI-HRMS: m/z [M+Na]
+ calcd for C31H32NaO5S: 






p-Tolyl 2-O-naphtyl-3-O-benzyl-6-O-acetyl-1-thio-β-D-galactopyranoside (74) 
 
To a solution of 73 (1.96 g, 3.79 mmol) in anhydrous DCM (100 mL) at 0 °C were 
added DMAP (46.0 mg, 0.379 mmol, 0.1 equiv), DIC (0.621 mL, 3.98 mmol, 1.05 equiv), 
and acetic acid (0.239 mL, 4.17 mmol, 1.1 equiv) dissolved in anhydrous DCM (5.00 mL). 
The solution was stirred at rt overnight. A white precipitate slowly formed. After complete 
conversion, the solvent was removed in vacuo and the residue was subjected to 
purification by silica gel column chromatography (hex/EtOAc = 3:2), yielding 74 (1.41 g, 
2.52 mmol, 66% yield) as a colorless solid.  
[α]D
25 = +19.9 (c 2.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.87 – 7.79 (m, 4H, Ar), 7.57 
(dd, J = 8.4, 1.7 Hz, 1H, Ar), 7.51 – 7.46 (m, 4H, Ar), 7.36 – 7.28 (m, 5H, Ar), 7.14 – 7.07 
(m, 2H, Ar), 5.01 (d, J = 10.6 Hz, 1H, ONapCH2), 4.90 (d, J = 10.5 Hz, 1H, ONapCH2), 
4.72 (s, 2H, OCH2Ph), 4.59 (d, J = 9.8 Hz, 1H, H-1), 4.40 – 4.31 (m, 2H, H-6’,H-6’’), 4.00 
(d, J = 2.6 Hz, 1H, H-4), 3.76 (t, J = 9.3 Hz, 1H, H-2), 3.65 – 3.58 (m, 2H, H-3, H-5), 2.33 
(s, 3H, SPhCH3), 2.08 (s, 3H, OAc) ppm. 
13C NMR (101 MHz, CDCl3) δ = 171.0 (C=O), 
137.9, 137.6, 135.7, 133.4, 133.3, 133.2, 132.7, 129.9, 129.8, 128.7, 128.2, 128.1, 128.0, 
127.8, 127.0, 126.4, 126.2, 126.0 (22 C, Ar), 88.1 (C-1), 82.4 (C-3), 77.1 (C-2), 75.9 
(ONapCH2), 75.7 (C-5), 72.5 (OCH2Ph), 66.8 (C-4), 63.5 (C-6), 21.3 (SPhCH3), 21.0 
(OAc) ppm. ESI-HRMS: m/z [M+Na]+ calcd for C33H34NaO6S: 581.1968, found: 581.1981. 





74 (1.20 g, 2.15 mmol) was dissolved in anhydrous DCM (100 mL) under argon 
atmosphere and pyridine (0.347 mL, 4.30 mmol, 2 equiv) was added. The solution was 
stirred at rt for 5 min and FmocCl (1.11 g, 4.30 mmo, 2 equiv) was added. The reaction 
was stirred for 6 h at rt, the solvent was removed in vacuo and the product BB11 was 
recrystallized as a colorless solid from boiling ethanol (1.13 g, 1.45 mmol, 67% yield). 
[α]D
25 = +6.9 (c 1.1, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.74 (m, 6H, Ar), 7.72 – 
7.39 (m, 10H, Ar), 7.38 – 7.27 (m, 4H, Ar), 7.17 (dd, J = 5.2, 1.9 Hz, 2H, Ar), 7.14 – 7.09 
(m, 2H, Ar), 5.39 (dd, J = 3.2, 1.0 Hz, 1H, H-4), 5.00 – 4.90 (m, 2H, OCH2Ph), 4.81 (d, J = 





ONapCH2), 4.47 – 4.32 (m, 2H, H-6’, H-6’’), 4.32 – 4.22 (m, 3H, C-5, OFmoc), 3.88 – 3.81 
(m, 2H, H-2, OFmoc), 3.71 (dd, J = 9.1, 3.2 Hz, 1H, H-3), 2.31 (s, 3H, SPhCH3), 2.08 (s, 
3H, OAc) ppm. 13C NMR (101 MHz, CDCl3) δ = 170.7 (C=O), 155.2 (C=O), 144.2, 143.7, 
143.3, 141.5, 141.4, 138.0, 137.6, 135.7, 133.4, 133.2, 132.8, 129.8, 129.8, 128.4, 128.2, 
128.2, 128.1, 128.0, 128.0, 127.9, 127.8, 127.3, 127.3, 127.3, 127.0, 126.4, 126.1, 126.0, 
125.5, 125.3, 125.1, 120.2, 120.2, 120.2 (34 C, Ar), 88.3 (C-1), 81.1 (C-3), 77.4 (C-2), 
76.1 (OCH2Ph), 74.4 (Fmoc), 72.3 (ONapCH2), 71.1 (C-4), 70.4 (Fmoc), 62.5 (C-6), 46.7 
(C-5), 21.3 (SPhCH3), 21.0 (OAc) ppm. ESI-HRMS: m/z [M+Na]
+ calcd for C48H44NaO8S: 
803.2649, found: 803.2678. IR (neat) max: 1744, 1259, 1226 cm
-1.  
p-Tolyl 3-C-acetoxymethyl-2,3-O-isopropylidene-1-thio-β-D-erythrofuranoside (82) 
 
To a solution of the β-anomer of 81157 (0.208 g, 0.702 mmol) in anhydrous DCM 
(20 mL) at 0 °C was subsequently added DMAP (85.7 mg, 0.0702 mmol, 0.1 equiv), DIC 
(0.120 mL, 0.772 mmol, 1.1 equiv) and acetic acid (48.2 µL, 0.842 mmol, 1.2 equiv). The 
solution was stirred at rt overnight. A white precipitate slowly formed. After complete 
consumption of the educt, the solvents were removed in vacuo and the residue was 
subjected to silica gel column chromatography (hex/EtOAc = 3:2) to obtain 82 (0.230 g, 
0.680 mmol, 97% yield) as a colorless solid. 
[α]D
25 = -230.9 (c 0.5, CHCl3).
1H NMR (400 MHz, Chloroform-d) δ 7.43 – 7.31 (m, 2H, Ar), 
7.20 – 7.09 (m, 2H, Ar), 5.60 (s, 1H, H-1), 4.54 (s, 1H, H-2), 4.41 (d, J = 11.7 Hz, 1H, H-
3’a), 4.29 (d, J = 11.7 Hz, 1H, H-3’a), 4.17 (d, J = 10.5 Hz, 1H, H-4a), 4.04 (d, J = 10.5 
Hz, 1H, H-4b), 2.33 (s, 3H, SPhCH3), 2.15 (s, 3H, COCH3), 1.48 (s, 3H, C(CH3)2), 1.41 (s, 
3H, C(CH3)2). 
13C NMR (101 MHz, CDCl3) δ 170.8 (C=O), 138.2, 133.0, 130.0, 129.4 (Ar, 
6C), 114.4 (C(CH3), 93.5 (C-1), 90.6 (C-3), 87.8 (C-2), 73.8 (C-4), 65.4 (C-3’), 27.8 
(C(CH3)2, 27.6 (C(CH3)2, 21.3 (SPhCH3), 21.0 (COCH3). ESI-HRMS [M+Na]
+ calcd. for 
C17H22NaO5S: 361.1080, found: 361.1068. IR (neat) max =1748, 1222, 1075, 1037 cm
-1. 
p-Tolyl 3-C-acetoxymethyl-2,3-O-benzylidene-1-thio--D-erythrofuranoside (83) 
 
The acetyl protected intermediate 82 (0.230 g, 0.680 mmol) was dissolved in 90% 
aq. TFA (2.00 mL) and stirred at rt for 90 min before the solvent was removed in vacuo. 





was dissolved in anhydrous toluene (5 mL) and (dimethoxymethyl)benzene (0.508 mL, 
3.39 mmol, 5 equiv) and a catalytic amount of CSA were added. The reaction was stirred 
at rt overnight. The reaction was quenched by the addition of excess NEt3, the solvents 
were removed in vacuo and the residue was subjected to silica gel column 
chromatography (hex/EtOAc = 9:1) yielding 83 (90.0 mg, 0.233 mmol, 35% yield over two 
steps). 
[α]D
25 = -189.9 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.54 – 7.49 (m, 2H, Ar), 7.43 
– 7.34 (m, 5H, Ar), 7.17 – 7.10 (m, 2H, Ar), 5.93 (s, 1H, PhCH), 5.77 (s, 1H, H-1), 4.61 (s, 
1H, H-2), 4.51 (d, J = 11.9 Hz, 1H, H-3’a), 4.42 (d, J = 11.9 Hz, 1H, H-3’b), 4.29 – 4.19 
(m, 2H, H-4), 2.34 (s, 3H, SPhCH3), 2.18 (s, 3H, COCH3) ppm. 
13C NMR (101 MHz, 
CDCl3) δ = 170.7 (C=O), 138.3, 135.8, 133.0, 130.3, 130.1, 129.1, 128.6, 127.3 (Ar, 12C), 
106.6 (PhCH), 92.8 (C-1), 90.6 (C-3), 87.8 (C-2), 72.9 (C-4), 64.1 (C-3’), 21.3 (SPhCH3), 
21.0 (COCH3) ppm. ESI-HRMS [M+Na]
+ calcd. for C21H22NaO5S: 409.1080, found: 
409.1080. IR (neat) max = 1746, 1222, 1061, 1041 cm
-1. 
p-Tolyl 3-C-hydroxy-2,3-O-benzylidene-1-thio-β-D-erythrofuranoside (84) 
 
Intermediate 83 (90.0 mg, 0.233 mmol) was dissolved in MeOH (5 mL) at rt and 
sodium methoxide (62.6 mg, 1.16 mmol, 5 equiv) was added. The reaction was stirred at 
rt overnight and quenched by the addition of H+-Amberlite resin until neutral pH. The resin 
was filtered off and the solvent was removed under reduced pressure to give product 84 
in 96% yield (0.08 g, 0.22 mmol).  
[α]D
25 = -239.2 (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.55 – 7.48 (m, 2H, Ar), 7.43 
– 7.33 (m, 5H, Ar), 7.17 – 7.11 (m, 2H, Ar), 5.96 (s, 1H, PhCH), 5.79 (s, 1H, H-1), 4.62 (s, 
1H, H-2) 4.26 – 4.14 (m, 2H, H-4), 4.04 (d, J = 12.0 Hz, 1H, H-3’a), 3.97 (d, J = 11.9 Hz, 
1H, H-3’b), 2.34 (s, 3H, SPhCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 133.0, 130.2, 
130.1, 129.1, 128.6, 127.2 (12 C, Ar), 106.7 (PhCH), 93.0 (C-1), 92.6 (C-3), 87.4 (C-2), 
73.1 (C-4), 63.8 (C’-3), 21.3 (SPhCH3) ppm. ESI-HRMS [M+Na]
+ calcd. for C19H20NaO4S: 










Intermediate 84 (77.0 mg, 0.224 mmol) was dissolved in a mixture of anhydrous 
DCM and anhydrous DMF (1:1, 10 mL) under argon atmosphere. The solution was cooled 
to 0 °C and sodium hydride (16.1 mg, 0.671 mmol, 3 equiv) and naphthyl bromide 
(99.0 mg, 0.447 mmol, 2 equiv) were added. The reaction was stirred under argon 
atmosphere at rt overnight. The reaction was quenched by the addition of sat. aq. NH4Cl-
solution until no further gas evolved from the mixture. The organic phase was separated, 
washed with brine, dried over MgSO4 and filtered. The solvent was removed in vacuo and 
the residue was subjected to silica gel column chromatography. The product BB13eluted 
with hex/EtOAc (9:1) (93.0 mg, 0.192 mmol, 86% yield).  
[α]D
25 = -149.6 (c 0.8, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.92 – 7.79 (m, 4H, Ar), 7.56 
– 7.45 (m, 5H, Ar), 7.42 – 7.31 (m, 5H, Ar), 7.16 – 7.05 (m, 2H, Ar), 5.98 (s, 1H, PhCH), 
5.76 (s, 1H, H-1), 4.85 (s, 2H, OCH2Nap), 4.69 (s, 1H, H-2), 4.26 – 4.15 (m, 2H, H-4), 
3.88 (s, 2H, H-3’), 2.33 (s, 3H, SPhCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 138.0, 
136.3, 135.3, 133.4, 133.2, 133.2, 132.8, 130.1, 130.0, 129.6, 128.5, 128.5, 128.0, 127.9, 
127.3, 126.6, 126.4, 126.2, 125.6 (Ar, 22 C), 106.7 (PhCH), 93.0 (C-1), 92.1 (C-3), 87.7 
(C-2), 74.0 (OCH2Nap), 73.0 (C-4), 70.7 (C-3), 21.3 (SPhCH3) ppm. ESI-HRMS [M+Na]
+ 
calcd. for C30H28NaO4S: 507.1601, found: 507.1604. IR (neat) max =1056, 809, 731, 697 
cm-1. 
 
3.4.2 Solution-Phase Synthesis of the RG-II Galacturonan Backbone 




BB10b (0.200 g, 0.274 mmol, 2.7 equiv) and difluoro-linker 88173 (34.0 mg, 
0.101 mmol) were dissolved in a mixture of anhydrous DCM (2 mL) and anhydrous 





3.0 equiv) and TfOH (one drop) were added. The reaction was slowly allowed to warm to 
rt and stirred until TLC confirmed full consumption of the acceptor. The reaction was 
quenched by the addition of sat. aq. NaHCO3-solution and sat. aq. Na2S2O3-solution. The 
organic phase was separated, dried over MgSO4, filtered and concentrated in vacuo. The 
residue was taken up in DCM (9 mL) and NEt3 (3.00 mL) was added. The reaction was 
stirred overnight at ambient temperature. The reaction mixture was washed with sat. aq. 
NH4Cl-solution, the organic phase was separated, dried over MgSO4, filtrated and 
concentrated under reduced pressure. The crude product was subjected to silica gel 
column chromatography (hex/EtOAc = 3:1 to 3:2) yielding product 89 (50.0 mg, 0.0695 
mmol, 70% yield).  
1H NMR (400 MHz, CDCl3) δ = 7.44 – 7.08 (m, 20H, Ar), 5.19 (s, 2H), 5.02 – 4.53 (m, 7H), 
4.37 – 4.19 (m, 2H), 4.02 – 3.56 (m, 8H), 2.05 (s, 3H, OAc) ppm. 13C NMR (101 MHz, 
CDCl3) δ = 170.9, 137.0, 128.7, 128.6, 128.5, 128.3, 128.2, 128.04, 128.01, 127.9, 127.6, 
127.5, 98.1, 75.5, 73.1, 68.2, 67.9, 67.7, 63.6, 60.5, 51.3, 20.9 ppm. ESI-MS: m/z [M+Na]+ 





Donor BB11 (47.7 mg, 0.0610 mmol, 2 equiv) and acceptor 89 (22.0 g, 
0.0306 mmol) were dissolved in a mixture of anhydrous DCM (2 mL) and anhydrous 
dioxane (0.2 mL), and molecular sieves (4 Å, powdered, 0.100 g) was added. The mixture 
was stirred for 10 min before it was cooled to 0 °C and treated with NIS (15.1 mg, 
0.0672 mmol, 2.2 equiv) and TfOH (one drop). The reaction mixture was stirred at 0°C, 
slowly allowed to warm to rt and stirred for further two hours. The reaction was stopped by 
the addition of sat. aq. NaHCO3-solution and sat. aq. Na2SO3-solution. The organic phase 
was separated, dried over MgSO4, filtered and concentrated in vacuo. The crude Fmoc 
protected intermediate was dissolved in DCM (1 mL) and NEt3 (0.100 mL) was added. 
The reaction was stirred at rt overnight before it was worked up with sat. aq. NH4Cl-
solution. The organic phase was separated, dried over MgSO4, filtered and concentrated 
in vacuo. Purification over a silica gel column (hex/EtOAc = 3:1 to 3:2) yielded 90 (10.0 





1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.71 (m, 4H), 7.52 – 7.42 (m, 3H), 7.39 – 7.22 (m, 
25H), 5.15 (s, 2H), 5.02 – 4.59 (m, 10H), 4.42 – 4.26 (m, 2H), 4.22 – 4.10 (m, 1H), 4.07 – 
4.01 (m, 1H), 3.98 – 3.84 (m, 4H), 3.83 – 3.57 (m, 4H), 1.92 (s, 6H) ppm. 13C NMR (101 
MHz, CDCl3) δ = 170.61 170.60, 138.1, 137.1, 135.6, 133.4, 133.1, 128.7, 128.68, 
128.63, 128.4, 128.3, 128.2, 128.1, 128.08, 128.03, 127.97, 127.92, 127.8, 127.6, 127.4, 
126.5, 126.2, 126.1, 100.0, 98.0, 77.9, 75.5, 75.2, 73.0, 72.4, 69.4, 67.9, 67.8, 67.0, 62.8, 
62.6, 21.0, 20.9 ppm. ESI-MS: m/z [M+Na]+ calcd. for C62H67F2NNaO15: 1176.4, found: 
1176.2. 
 
3.4.3 Solution-Phase Synthesis of the RG-II Galacturonan Backbone 
using Galacturonic Acid Lactone Building Blocks 
3.4.3.1 Synthesis of Galacturonic Acid Lactone Building Blocks 
p-Tolyl 2-O-naphtyl-3,4-O-isopropylidene-1-thio-β-D-galactopyranoside (92) 
 
To a solution of p-tolyl-3,4-O-isopropylidene-6-O-(1-methoxy-1-methylethyl)-1-thio-
β-D-galactopyranoside 219 (6.29 g, 15.8 mmol) in anhydrous THF (50 mL) was added NaH 
(1.26 g, 31.6 mmol, 2 equiv of a 60% dispersion in mineral oil) at 0°C. The mixture was 
stirred at 0 °C for 15 min before naphthyl bromide (3.84 g, 17.4 mmol, 1.1 equiv) was 
added. After removal of the ice-bath the reaction was allowed to warm to rt and stirred 
overnight. When full consumption of the starting material was detected by TLC, the 
reaction was quenched by the addition of MeOH and water and the aqueous phase was 
extracted with DCM (three times 100 mL). The organic phase was separated, dried over 
MgSO4, filtrated and concentrated in vacuo. The residue was dissolved in MeOH (20 mL) 
which resulted in a cloudy solution. CSA (36.7 mg, 0.158mmol, 0.01 equiv) was added 
and the solution was stirred at rt for 15 min until the solution became clear. The solvent 
was evaporated in vacuo and the residue was subjected to silica gel column 
chromatography (hex/EtOAc = 4:1 to 1:1). The product was isolated in 42% yield over 
three steps (3.10 g, 6.64 mmol) as a colorless solid. 
1H NMR (400 MHz CDCl3) δ = 7.88 – 7.76 (m, 4H, Ar), 7.58 (dd, J = 8.3, 1.7 Hz, 1H, Ar), 
7.53 – 7.39 (m, 4H,Ar), 7.08 (d, J = 7.9 Hz, 2H, Ar), 4.99 (d, J = 11.5 Hz, 1H, OCH2Nap), 
4.85 (d, J = 11.5 Hz, 1H, OCH2Nap), 4.61 (d, J = 9.6 Hz, 1H, H-1), 4.31 (t, J = 6.0 Hz, 1H, 





(m, 2H, H-5, H-6’’), 3.56 (dd, J = 9.6, 6.4 Hz, 1H, H-2), 2.31 (s, 3H, SPhCH3), 1.37 (s, 3H, 
CH3), 1.35 (s, 3H, CH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 138.0, 135.3, 133.3, 133.2, 
132.8, 129.8, 129.5, 128.2, 128.0, 127.8, 127.3, 126.5, 126.1, 126.0 (16 C, Ar), 110.5 
((O)2C(CH3)), 86.4 (C-1), 80.0 (C-3), 78.3 (C-2), 76.8 (C-5) 74.1 (C-4), 73.6 (OCH2Nap), 
62.8 (C-6), 27.9 (CH3), 26.5 (CH3), 21.3 (SPhCH3) ppm. ESI-MS: m/z [M+Na]
+ calcd. for 
C27H30NaO5S: 489.2, found: 489.2. 
p-Tolyl 2-O-naphthtyl-1-thio-β-D-galactopyranosidurono-3,6-lactone (BB16) 
 
Intermediate 92 (3.00 g, 6.43 mmol) was dissolved in DCM (50 mL), and H2O 
(20 mL), TEMPO (0.201 g, 1.29 mmol, 0.2 equiv) and BAIB (5.19 g, 16.1 mmol, 2.5 equiv) 
were added. After stirring the solution for 2 h at rt, sat. aq. Na2S2O3-solution was added, 
and the mixture was extracted with EtOAc. The combined organic extracts were washed 
with brine, dried over MgSO4, filtered and the solvent was removed in vacuo. The crude 
acid (theo. amount: 9.13 mmol) was stirred at 65 °C in AcOH/H2O (4:1, 50 mL) until TLC 
showed consumption of the starting material. The mixture was concentrated in vacuo and 
co-evaporated with toluene (three times 50 mL). The crude product was dissolved in 
anhydrous DCM (60 mL) followed by the addition of DIPEA (1.34 mL, 7.72mmol, 
1.2 equiv) of ethyl chloroformate (0.673 mL, 7.07 mmol, 1.1 equiv). After stirring at rt for 
3 h, the mixture was evaporated in vacuo and the residue was subjected to silica gel 
column chromatography (hex/EtOAc = 4:1 to 3:2) to afford lactone BB16 (0.459 g, 1.09 
mmol, 17% yield). 
[α]D
25 = -122.5 (c 0.5, CHCl3).
1H NMR (400 MHz, CDCl3) δ = 7.88 – 7.83 (m, 3H, Ar), 7.79 
– 7.75 (m, 1H, Ar), 7.53 (dt, J = 6.2, 3.4 Hz, 2H, Ar), 7.44 (dd, J = 8.5, 1.7 Hz, 1H, Ar), 
7.26 – 7.22 (m, 2H, Ar), 7.08 – 7.03 (m, 2H, Ar), 5.32 (s, 1H, H-1), 4.85 – 4.73 (m, 3H, H-
3, OCH2Nap), 4.70 – 4.66 (m, 1H; H-4), 4.33 (d, J = 4.7 Hz, 1H, H-2), 4.00 (t, J = 1.4 Hz, 
1H, H-5), 2.31 (s, 3H, SPhCH3) ppm. 
13C NMR (101 MHz, CDCl3) δ = 173.1 (C=O), 138.7, 
133.9, 133.6, 133.4, 133.3, 129.9, 129.7, 128.9, 128.1, 127.9, 127.5, 126.7, 126.6, 125.8 
(16 C, Ar), 86.0 (C-1), 81.3 (C-3), 78.6 (C-2), 73.6 ,( OCH2Nap) 72.5 (C-5), 70.1 (C-4), 
21.3 (SPhCH3) ppm. [M+Na]
+ calcd. for C24H22NaO5S: 445.1080, found: 445.1078. 






3.4.3.2 Synthesis of RG-II Galacturonan Backbione Disaccharides 




A solution of donor BB14 (0.100 g, 0.216 mmol), diphenyl sulfoxide (48.1 mg, 
0.238 mmol, 1.1 equiv) and tri-tert-butylpyridine (80.2 mg, 0.324 mmol, 1.5 equiv) in DCM 
(5 mL) was stirred over activated powdered molecular sieves (4 Å). The mixture was 
cooled to -60 °C before triflic acid anhydride (40.0 µL, 0.238 mmol, 1.1 equiv) was added. 
The mixture was allowed to warm to -45 °C before it was re-cooled to -60 °C and a 
mixture of acceptor BB15 (0.121 g, 0.324 mmol, 1.5 equiv) over activated powdered 
molecular sieves (4 Å) in a small amount of DCM was added. The reaction was stirred 
under argon atmosphere and the reaction mixture was allowed to warm to -10 °C. The 
reaction was quenched by the addition of NEt3 (0.15 mL, 1.10 mmol, 5 equiv), diluted with 
DCM and washed with sat. aq. NaHCO3-solution. The aqueous phase was extracted with 
DCM. The combined organic layers were dried over MgSO4, filtered and concentrated 
under reduced pressure. The residue was subjected to silica gel column chromatography 
(hex/EtOAc = 3:1) to afford product 93a (0.0540 mg, 0.076 mmol, 35% yield) as a 
diasteromeric mixture.  
1H NMR (400 MHz, CDCl3) δ = 7.28 – 7.14 (m, 30H), 7.08 (ddd, J = 12.1, 7.4, 1.6 Hz, 4H), 
6.98 (dd, J = 7.9, 5.5 Hz, 4H), 5.19 (s, 1H, H-1), 5.02 (d, J = 2.8 Hz, 1H, H-1), 4.86 – 
4.81 (m, 3H), 4.73 (dd, J = 5.1, 1.7 Hz, 1H), 4.70 (d, J = 11.6 Hz, 1H), 4.65 – 4.58 (m, 
2H), 4.57 – 4.51 (m, 5H), 4.50 – 4.40 (m, 6H), 4.32 (ddd, J = 9.5, 6.8, 5.5 Hz, 4H), 4.12 (d, 
J = 4.8 Hz, 1H), 4.07 (d, J = 1.6 Hz, 1H), 4.04 – 3.98 (m, 3H), 3.88 (d, J = 1.5 Hz, 1H), 
3.81 (dt, J = 5.2, 2.7 Hz, 2H), 2.20 (s, 3H), 2.19 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) 
δ = 172.4 (C=O), 171.2 (C=O), 171.0 (C=O), 170.8 (C=O), 138.7, 138.2, 137.0, 136.9, 
136.7, 136.6, 136.5, 136.4, 133.4, 131.6, 130.1, 130.0, 129.8, 129.6, 128.89, 128.85, 
128.8, 128.7, 128.64, 128.63, 128.5, 128.45, 128.41, 128.3, 128.2, 128.1, 128.0, 127.9, 
98.5 (C-1’), 98.0 (C-1’), 86.3 (C-1), 86.1 (C-1), 81.0, 80.2, 80.19, 80.15, 78.1, 77.3, 
77.1, 76.8, 75.3, 74.8, 74.7, 74.6, 74.3, 74.2,5 74.23, 73.8, 73.1, 72.19, 72.17, 71.8, 70.5, 






Benzyl 2,4-dibenzyl-O--D-galactopyranosiduronate-(1→4)-benzyl 4-methyl phenyl 
2-O-benzyl-1-thio-/-D-galactopyranosiduronate (95a) 
 
To a solution of 93a (42.0 mg, 0.0715 mmol) in DCM (5 mL) at rt was added 75.1 
µL (0.0751 mmol, 1.05 equiv) of 1 M TMSONa in DCM. After 15 min full conversion of the 
educt was detected by TLC and the reaction was neutralized with a drop of acetic acid. 
The solvent was removed by co-evaporation with toluene (two times 10 mL). The 
remaining yellow solid was re-dissolved in anhydrous DMF (5 mL) under argon 
atmosphere and Cs2CO3 (51.3 mg, 0.157 mmol 2.2 equiv) and BnBr (25.5 µL, 0.215 
mmol, 3 equiv) were added at rt. The reaction was monitored by TLC (hex/EtOAc = 1:1) 
until full conversion of the educt was detected after 90 min stirring at rt. The reaction 
mixture was diluted with EtOAc and the organic phase was washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. Purification by silica gel column 
chromatography (hex/EtOAc = 2:1) gave 95a (0.0200 g, 0.0216 mmol, 30% yield) as a 
diasteromeric mixture. 
1H NMR (400 MHz, CDCl3) δ = 7.56 – 7.51 (m, 2H), 7.47 – 7.23 (m, 50H), 7.21 – 7.17 (m, 
2H), 7.06 (d, J = 8.0 Hz, 2H), 6.83 (d, J = 7.9 Hz, 2H), 5.81 (t, J = 2.4 Hz, 1H), 5.38 (d, J = 
3.4 Hz, 1H, H-1), 5.28 – 5.17 (m, 3H), 5.16 – 5.14 (m, 2H), 5.12 (s, 1H, H-1), 5.09 – 
5.04 (m, 2H), 5.02 – 4.90 (m, 4H), 4.85 – 4.76 (m, 2H), 4.75 – 4.68 (m, 3H), 4.66 (d, J = 
1.9 Hz, 2H), 4.63 – 4.43 (m, 8H), 4.37 (dd, J = 2.6, 1.2 Hz, 1H), 4.28 – 4.24 (m, 2H), 4.06 
– 4.01 (m, 2H), 4.01 – 3.97 (m, 2H), 3.91 – 3.78 (m, 4H), 2.36 (s, 3H), 2.30 (s, 3H) ppm. 
13C NMR (101 MHz, CDCl3) δ = 168.8, 168.0, 167.8, 167.6, 138.4, 138.3, 138.2, 138.0, 
137.9, 137.7, 137.5, 137.1, 135.4, 135.3, 135.2, 135.0, 134.9, 131.8, 130.1, 129.8, 129.5, 
128.81, 128.80, 128.69, 128.66, 128.62, 128.59, 128.56, 128.54, 128.51, 128.46, 128.40, 
128.39, 128.32, 128.28, 128.23, 128.1, 128.0, 127.85, 127.81, 127.7, 127.6, 127.3, 98.5, 
98.4, 87.2, 85.4, 80.4, 77.6, 77.2, 77.0, 76.9, 76.0, 75.7, 75.5, 75.1, 75.0, 74.9, 74.8, 72.9, 
72.6, 72.1, 71.2, 71.0, 70.6, 69.9, 69.5, 69.2, 67.4, 67.2, 67.1, 67.0, 21.3, 21.2, 21.1 ppm. 









A solution of donor BB14 (50.0 mg, 0.108 mmol), diphenyl sulfoxide (24.0 mg, 
0.119 mmol, 1.1 equiv) and tri-tert-butylpyridine (40.1 mg, 0.162 mmol, 1.5 equiv) in DCM 
(5 mL) was stirred over activated powdered molecular sieves (4 Å). The mixture was 
cooled to -60 °C before triflic acid anhydride (0.0200 mL, 0.119 mmol, 1.1 equiv) was 
added. The mixture was allowed to warm to -45 °C before it was re-cooled to -60 °C and a 
mixture of acceptor BB16 (68.4 mg, 0.162 mmol, 1.5 equiv) over activated molecular 
sieves (4 Å) in a small amount of DCM was added. The reaction was stirred under argon 
atmosphere and the reaction mixture was allowed to warm to -10 °C.  The reaction was 
quenched with NEt3 (0.0753 mL, 0.540 mmol, 5 equiv.), diluted with DCM and washed 
with sat. aq. NaHCO3-solution. The aqueous phase was extracted with DCM. The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The 
residue was subjected to silica gel column chromatography (hex/EtOAc = 9:1 to 7:1) to 
afford product 93b in 35% yield (29.0 mg, 0.0381 mmol).  
1H NMR (400 MHz, CDCl3) δ = 7.93 – 7.83 (m, 4H Ar), 7.78 (d, J = 1.6 Hz, 1H), 7.57 – 
7.50 (m, 2H), 7.47 – 7.43 (m, 1H), 7.39 – 7.28 (m, 8H), 7.25 – 7.20 (m, 3H), 7.07 – 7.03 
(m, 2H), 5.28 (s, 1H, H-1), 5.02 (dd, J = 4.9, 1.4 Hz, 1H), 4.98 (d, J = 2.5 Hz, 1H, H-1’), 
4.78 (s, 2H), 4.76 – 4.72 (m, 2H), 4.68 (td, J = 4.5, 1.5 Hz, 1H), 4.59 (d, J = 2.9 Hz, 2H), 
4.51 – 4.45 (m, 2H), 4.33 (d, J = 4.8 Hz, 1H), 4.18 (d, J = 1.5 Hz, 1H), 4.03 (d, J = 1.4 Hz, 
1H), 3.95 (dd, J = 5.0, 2.5 Hz, 1H), 2.32 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ = 
172.4, 171.3, 138.7, 137.0, 136.9, 136.7, 133.8, 133.4, 133.3, 133.25, 133.22, 131.7, 
130.1, 129.9, 129.6, 128.9, 128.8, 128.7, 128.5, 128.4, 128.2, 128.0, 127.9, 127.6, 126.6, 
126.5, 98.1, 80.2, 78.3, 75.3, 74.7, 74.3, 73.5, 72.2, 71.8, 71.7, 70.5, 21.3 ppm. ESI-






Benzyl 2,4-dibenzyl-O--D-galactopyranosiduronat-(1→4)-benzyl 4-methyl phenyl 2-
O-naphthyl-1-thio-/-D-galactopyranosiduronate (95b) 
 
To a solution of 93b (10.0 mg, 0.0132 mmol) in DCM (1 mL) at rt was added 13.8 
µL (0.0138 mmol, 1.05 equiv) of 1 M TMSONa in DCM. After 15 min full conversion of the 
educt was detected by TLC and the reaction was neutralized with a drop of acetic acid. 
The solvent was removed by co-evaporation with toluene (two times 10 mL). The 
remaining yellow solid was re-dissolved in anhydrous DMF (5 mL) under argon 
atmosphere and Cs2CO3 (9.46 mg, 0.0290 mmol 2.2 equiv) and BnBr (4.70 µL, 
0.0396 mmol, 3 equiv) were added at rt. The reaction was monitored by TLC until full 
conversion of the educt was detected after 90 min stirring at rt. The reaction mixture was 
diluted with EtOAc and the organic phase washed with brine, dried over MgSO4, filtered 
and concentrated in vacuo. Purification by silica gel column chromatography (hex/EtOAc 
= 2:1) gave product 95b in 20% yield (3.00 mg, 0.00259 mmol).  
1H NMR (400 MHz, CDCl3) δ = 7.86 – 7.68 (m, 8H), 7.59 – 7.10 (m, 50H), 6.98 (d, J = 8.0 
Hz, 2H), 6.83 (d, J = 7.8 Hz, 2H), 5.78 (d, J = 4.6 Hz, 1H, H-1), 5.28 (d, J = 2.6 Hz, 1H), 
5.26 – 4.98 (m, 7H), 4.93 (dd, J = 12.2, 4.0 Hz, 2H), 4.84 (d, J = 11.8 Hz, 2H), 4.80 – 4.58 
(m, 9H), 4.51 (d, J = 9.1 Hz, 1H, H-1), 4.47 – 4.32 (m, 5H), 4.23 (s, 1H), 4.12 (d, J = 7.2 
Hz, 1H), 4.01 – 3.92 (m, 2H), 3.89 (t, J = 2.0 Hz, 1H), 3.82 – 3.58 (m, 10H), 2.30 (s, 4H), 
2.29 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ = 170.4, 170.3, 170.1, 169.5, 168.7, 
167.9, 167.8, 167.5, 138.3, 138.2, 137.8, 137.6, 137.4, 135.3, 135.2, 135.1, 134.9, 134.8, 
134.4, 133.1, 133.09, 133.06, 133.00, 131.7, 130.0, 129.7, 129.6, 129.5, 128.8, 128.7, 
128.65, 128.63, 128.62, 128.60, 128.56, 128.53, 128.48, 128.45, 128.43, 128.3, 128.24, 
128.22, 128.18, 128.15, 128.0, 127.99, 127.95, 127.80, 127.78, 127.73, 127.72, 127.66, 
127.55, 127.50, 126.4, 126.24, 126.21, 126.1, 126.0, 98.2 (C-1’), 98.1 (C-1’), 87.2 (C-1), 
87.0, 85.3 (C-1), 79.6, 75.9, 75.5, 75.2, 74.9, 74.8, 74.7, 74.3, 72.8, 72.5, 72.4, 72.0, 
71.1, 70.8, 70.6, 69.8, 69.4, 69.1, 67.3, 67.2, 67.1, 66.9, 29.7, 21.3, 21.1 ppm. ESI-MS: 





3.5 Synthesis of Functionalized Sugar Nucleotides 
3.5.1 Synthesis of Functionalized UDP-Galp 
2,3,4-Tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranosyl phosphite mono 
trimethylamine salt (104) 
 
To a solution of an anomeric mixture of 103205 (0.600 g, 1.81 mmol) in anhydrous 
dioxane (2 mL) containing NEt3 (0.0510 mL, 3.62 mmol, 2 equiv), 2-chloro-4H-
benzodioxaphosphorin-4-one (0.439 g 2.17 mmol,1.2 equiv) was added and the mixture 
was stirred at rt for 30 min, before water (0.100 mL) was added. The solution was stirred 
for additional 5 min before it was concentrated in vacuo. The residue was dissolved in 
THF (2 mL). A colorless precipitate formed within 2 min. The precipitate was filtered off 
and the filtrate was concentrated in vacuo. The crude residue was subjected to silica gel 
column chromatography (DCM/MeOH 20:1 to 9:1) to afford 0.418 g (0.842 mmol) of the 
anomeric mixture of the galactopyranosyl phosphite 104. Compound 104 was dissolved in 
anhydrous MeCN and phosphorous acid (0.414 g, 5.05 mmol, 6 equiv) was added. The 
mixture was stirred at rt under argon atmosphere overnight before the reaction mixture 
was neutralized by the addition of NEt3 (0.819 mL, 5.89 mmol, 7 equiv) and concentrated 
in vacuo. Filtration of the crude residue through a short plug of silica (DCM/MeOH 8.5:1.5) 
yielded exclusively the α-anomer of the triethylamine salt 104 (0.418 g, 0.842 mmol, 47%) 
as a sticky oil. 
1H NMR (400 MHz, MeOD) δ = 5.79 (dd, J = 8.7, 3.5 Hz, 1H), 5.46 (dd, J = 3.4, 1.3 Hz, 
1H), 5.38 (dd, J = 10.8, 3.4 Hz, 1H), 5.17 – 5.12 (m, 1H), 4.41 (ddd, J = 7.2, 5.4, 1.4 Hz, 
1H), 3.48 (dd, J = 12.7, 7.5 Hz, 1H), 3.28 (dd, J = 12.7, 7.4 Hz, 1H), 3.21 (q, J = 7.3 Hz, 
6H), 2.16 (s, 3H), 2.07 (s, 3H), 1.96 (s, 3H), 1.31 (t, J = 7.3 Hz, 9H) ppm. 13C NMR (101 
MHz, MeOD) δ = 171.9, 171.8, 171.5, 93.2 (d, JC-P = 4.6 Hz), 70.2, 70.0, 68.95, 68.90 (d, 
JC-P = 5.9 Hz), 51.5, 47.8, 20.7, 20.6, 20.5, 9.2 ppm. The analytical data is in agreement 






2,3,4-Tri-O-acetyl-6-azido-6-deoxy-α-D-galactopyranosyl phosphate (105) 
 
104 (0.100 g, 0.202 mmol) was dissolved in THF (5 mL) and passed through a 5 mL 
syringe filled with H+-ion exchange resin (prewashed Amberlite). The column was flushed 
with additional THF (10 mL) and the eluent was concentrated to approx. 5 mL. tBuOOH 
(48.6 µL of 5 M in decan, 0.243 mmol, 1.2 equiv) and a spatula tip of iodine were added. 
The solution turned brownish and was stirred at rt under argon atmosphere overnight. The 
reaction was neutralized by the addition of NEt3 (34.0 µL, 0.243 mmol) and concentrated 
in vacuo. The product was purified by reverse-phase HPLC using a semi-preparative 
Synergy-C18 column (H2O + 0.1% formic acid in MeCN, the product eluted with 30% 
MeCN) yielding the galactose-1-phosphate 105 (20.0 mg, 0.05 mmol, 25%). 
1H NMR (400 MHz, MeOD) δ = 5.81 (dd, J = 7.4, 3.4 Hz, 1H,), 5.49 (dd, J = 3.4, 1.3 Hz, 
1H), 5.37 (dd, J = 10.9, 3.4 Hz, 1H), 5.13 – 5.07 (m, 1H), 4.42 – 4.35 (m, 1H 4.39 (t, J = 
6.3 Hz, 2H), 3.49 (dd, J = 12.7, 6.9 Hz, 1H), 3.34 – 3.31 (m, 1H), 2.16 (s, 3H), 2.07 (s, 
3H), 1.98 (s, 3H) ppm. 13C NMR (101 MHz, MeOD) δ = 172.0, 171.9, 171.5, 94.29 (d, JC-P 
= 4.9 Hz), 70.2, 69.7, 68.9 (d, JC-P = 7.3 Hz), 68.6, 51.3, 20.6, 20.6, 20.5 ppm. The 
analytical data is in agreement with literature data.204 
5-Nitro-cycloSal-2’,3’-O-diacetyluridine monophosphate (110) 
 
To a solution of acetyl protected uracil 109206 (0.100 g, 0.305 mmol) in MeCN (2 
mL) was added NEt3 (0.118 mL, 0.854 mmol, 2.8 equiv) at 0 °C. Subsequently, 5-nitro-
cyclo-Sal-chlorophosphite (107)203 (0.610 mmol. 2 equiv) dissolved in anhydrous MeCN (5 
mL) was added. The solution turned bright yellow immediately upon addition of the 
phosphite. The solution was allowed to warm to rt and stirred until full consumption of the 
uracil starting material was detected by TLC. To the stirred solution at rt was added 0.464 
g (3.05 mmol, 10 equiv) oxone dissolved in water (5 mL). After stirring for 30 min at rt, 
DCM was added and the organic phase washed with water three times. The organic 
phase was separated, dried over MgSO4, filtrated and concentrated in vacuo. The crude 
product was subjected to silica gel column chromatography (hex/EtOAc/AcOH = 1:4:0.1), 
yielding a sticky oil that was dissolved in anhydrous MeCN and freeze-dried to give a 





1H NMR (400 MHz, CDCl3) δ = 9.16 (d, J = 7.4 Hz, 1H, Ar), 8.27 – 8.19 (m, 1H, Ar), 8.09 
(td, J = 2.7, 1.3 Hz, 1H, Ar), 7.36 (dd, J = 8.2, 7.4 Hz, 1H, Ar), 7.23 (dd, J = 9.0, 4.8 Hz, 
1H, Ar), 5.90 (dd, J = 7.8, 5.3 Hz, 1H), 5.58 – 5.45 (m, 2H), 5.43 – 5.27 (m, 2H), 4.64 – 
4.54 (m, 1H), 4.52 – 4.41 (m, 1H), 4.35 – 4.28 (m, 1H), 2.12 (s, Hz, 1.5H), 2.10 (s, 1.5 H), 
2.09 (s, 1.5 H) 2.09 (s, 1.5 H) ppm. 13C NMR (101 MHz, CDCl3) δ = 169.9, 169.8, 162.94, 
162.90, 154.5, 154.43, 154.42, 154.3, 150.1, 150.0, 144.22, 144.19, 140.4, 140.3, 125.93, 
125.91, 125.89, 122.0, 121.7, 121.65, 121.64, 121.5, 120.0, 119.9, 119.8, 119.7, 103.5, 
103.4, 88.9, 88.6, 80.5, 80.4, 77.5, 77.2, 76.8, 72.8, 72.7, 69.7, 68.4, 68.3, 68.1, 68.0, 
67.7, 67.6, 20.7, 20.6, 20.56, 20.53 ppm. ESI-HRMS: m/z [M+Na]+ calcd. for 
C20H20N3NaO13P: 564.0626, found: 564.0624 
Uridine 5’-(6-azido-6-deoxy--D-galactopyranosyl) diphosphate (97) 
 
The galactosyl-1-phosphate 105 (0.0200 g, 0.0486 mmol, 1.0 equiv) was dissolved 
under argon atmosphere in anhydrous DMF (3 mL) and 3 spatula tips of activated 
powdered molecular sieves (4 Å) were added. After 1 h storage over the activated 
molecular sieves, phosphate ester 110 (34.0 mg, 0.0628 mmol, 1.3 equiv) was added and 
the reaction mixture was stirred at rt overnight. The reaction mixture was subsequently 
filtered through a short bed of celite and the solvent was removed in vacuo. The residue 
was dissolved in water and washed with EtOAc. The aqueous phase was concentrated in 
vacuo yielding the crude intermediate (41.0 mg). The crude intermediate was dissolved in 
MeOH/H2O/NEt3 (7:3:1; 5.5 mL) and stirred at rt overnight. The solvent was removed in 
vacuo. The crude product was taken up in water (4.50 mL) and subjected to ion exchange 
chromatography, in five portions of 900 µL each. Fractions that still contained impurities 
after ion exchange chromatography were subsequently subjected to a Carbograph C18 
column from which the product eluted with 10% MeCN in water to obtain the azido-
functionalized UDP-galactose 97 in 25% yield (6.75 g, 0.0114 mmol). 
1H NMR (600 MHz, D2O) δ = 7.98 (d, J = 8.1 Hz, 1H), 6.05 – 5.96 (m, 2H), 5.64 (dd, J = 
7.1, 3.6 Hz, 1H), 4.40 – 4.38 (m, 2H), 4.33 – 4.19 (m, 4H), 4.02 (d, J = 3.3 Hz, 1H), 3.94 
(dd, J = 10.3, 3.3 Hz, 1H), 3.81 (dt, J = 10.1 Hz, 1H), 3.59 (dd, J = 12.7, 7.2 Hz, 1H), 3.48 
(dd, J = 12.8, 6.0 Hz, 1H) ppm. 13C NMR (151 MHz, D2O) δ = 168.9, 154.5, 144.3, 105.3, 
98.45 (d, J = 6.5 Hz), 91.1, 85.95 (d, J = 9.2 Hz), 76.5, 72.8, 72.3, 71.89 (d, J = 2.6 Hz), 





-12.9 (d, J = 20.8 Hz) ppm. ESI-HRMS: m/z [M-H]- calcd for C15H23N5O16P2: 590.0542, 
found: 590.0550. The analytical data is in agreement with literature data.204 
Uridine 5’-(6-amino-6-deoxy--D-galactopyranosyl) diphosphate (98) 
 
The azido functionalized UDP-galactose 97 (0.500 mg, 0.846 µmol) was dissolved 
in H2O (1 mL) and Pd/C (10 wt% on activated carbon, 2.00 mg) was added. The solution 
was stirred under H2 atmosphere for 30 min at rt before the catalyst was filtered off 
through a RC-syringe filter. The solvent was removed in vacuo yielding 0.400 mg 
(0.708 µmol, 84%) of 98. 
1H NMR (600 MHz, D2O) δ = 7.95 (d, J = 8.2 Hz, 1H), 6.02 – 5.97 (m, 2H), 5.67 (dd, J = 
6.5, 3.9 Hz, 1H), 4.42 – 4.36 (m, 3H), 4.33 – 4.26 (m, 2H), 4.25 – 4.18 (m, 1H), 4.05 (d, J 
= 3.2 Hz, 1H), 3.96 (dd, J = 10.3, 3.3 Hz, 1H), 3.87 – 3.83 (m, 1H), 3.32 – 3.24 (m, 2H) 
ppm. ESI-HRMS: m/z [M-H]- calcd for C15H24N3O16P2: 564.0637, found: 564.0652. The 
analytical data is in agreement with literature data.204 
2,3,6-Tri-O-acetyl-4-azido-4-deoxy-α-D-galactopyranosyl phosphite (113) 
 
To a solution of 1,2,3,6-tetra-O-acetyl-4-azido-4-deoxy--D-galactopyranose207 
(112) (150 mg, 0.402 mmol) in DMF (4 mL), hydrazine acetate (41.0 mg 0.446 mmol, 
1.1 equiv) was added and the solution was stirred for 90 min at 50 °C. The reaction was 
subsequently diluted with EtOAc, washed with water and brine, dried over MgSO4, 
filtrated and concentrated in vacuo to give 2,3,6-tri-O-acetyl-4azido-4-deoxy-α/β-D-
galactopyranose (133 mg, 0.402 mmol) as a colorless oil. Without further purification, 
parts of the anomeric mixture (120 mg, 0.362 mmol, 1 equiv) were dissolved in anhydrous 
dioxane (5 mL) containing NEt3 (120 µL, 0.861 mmol, 2.4 equiv) under argon atmosphere, 
and 2-chloro-4H-benzodioxaphosphorin-4-one (89.0 mg, 0.435 mmol, 1.2 equiv) was 
added to the mixture. The reaction mixture was stirred at rt for 30 min before water 
(0.200 mL) was added, and the reaction was stirred for further 5 min. After concentration 
of the reaction mixture in vacuo, the residue was dissolved in THF (2 mL). Upon solvation 
in THF a colorless precipitate formed within 2 min. The precipitate was filtered off and the 
filtrate was concentrated in vacuo. Purification of the residue by silica gel column 





131 mg (0.265 mmol, 66%) of 113 as an anomeric mixture of the monotriethylamine salt. 
The anomeric mixture was dissolved in anhydrous MeCN (4 mL) and phosphorous acid 
(162 mg, 1.98 mmol, 6 equiv) was added. The mixture was stirred under argon 
atmosphere at rt overnight. The reaction mixture was neutralized by the addition of NEt3 
(275 µL, 1.98 mmol) and the solvent was removed in vacuo. The product was filtered 
through a short plug of silica (DCM/MEOH = 9:1), yielding 4-azido--galactosyl phosphite 
113 (91.0 mg, 0.184 mmol, 64%) as slightly brown sticky oil. 
[α]D
25 = +42.9 (c 0.5, CHCl3) 
1H NMR (400 MHz, MeOD) δ = 5.68 (dd, J = 8.6, 3.5 Hz, 1H, 
H-1), 5.53 (dd, J = 10.6, 3.7 Hz, 1H, H-3), 5.16 (ddd, J = 10.8, 3.7, 1.6 Hz, 1H, H-2), 4.42 
(td, J = 6.3, 1.7 Hz, 1H, H-5), 4.30 (dd, J = 3.8, 1.7 Hz, 1H, H-4), 4.19 (dd, J = 6.2, 4.6 Hz, 
2H, H-6), 2.10 (s, 3H, OAc), 2.07 (s, 3H, OAc), 2.06 (s, 3H, OAc) ppm. 13C NMR (101 
MHz, MeOD) δ = 172.2 (C=O), 171.8 (C=O), 171.2 (C=O), 93.2 (d, JC-P = 4.7 Hz, C-1), 
70.7 (C-3), 69.2 (d, JC-P = 5.8 Hz, C-2), 68.8 (C-5), 64.1 (C-6), 62.4 (C-4) 20.6 (OAc), 20.6 
(OAc), 20.4 (OAc) ppm. ESI-HRMS: m/z [M+Na]+ calcd for C12H18N3NaO10P: 418.0622, 
found: 418.0620. IR (neat) max: 2115, 1744, 1214, 918 cm
-1. 
2,3,6-Tri-O-acetyl-4-azido-4-deoxy-α-D-galactopyranosyl phosphate (114) 
 
The mono-triethylammonium salt of phosphite 113 (46.0 mg, 0.0929 mmol) was 
dissolved in THF (5 mL) and passed through a 5 mL syringe filled with H+-ion exchange 
resin (prewashed Amberlite). The column was flushed with additional THF (10 mL) and 
the eluent was concentrated in vacuo to approx 5 mL. tBuOOH (22.3 µL, 5 M in decane, 
0.111 mmol, 1.1 equiv) and a spatula tip of iodine were added. The resulting brown 
solution was stirred under Ar atmosphere at rt overnight. The reaction was neutralized by 
the addition of NEt3 (16.0 µL 0.111 mmol) and concentrated in vacuo yielding 114. The 
crude product was dissolved in water and purified by HPLC using a semipreparative 
Synergy C18 column. The product was eluted from the column with 31% MeCN in H2O 
containing 0.1% formic acid in 33% yield (12.0 mg, 0.0292 mmol). 
[α]D
25 = +64.9 (c 0.5, CHCl3). 
1H NMR (400 MHz, MeOD) δ = 5.73 (dd, J = 7.2, 3.5 Hz, 1H, 
H-1), 5.52 (dd, J = 10.7, 3.7 Hz, 1H, H-3), 5.13 (dt, J = 10.8, 2.6 Hz, 1H, H-2), 4.40 (t, J = 
6.0 Hz, 1H, H-5), 4.33 (dd, J = 3.8, 1.5 Hz, 1H, H-4), 4.21 (d, J = 6.2 Hz, 2H, H-6), 2.12 (s, 
3H, OAc), 2.07 (d, J = 2.1 Hz, 6H, OAc). 13C NMR (101 MHz, MeOD) δ = 172.3 (C=O), 
171.9 (C=O), 171.2 (C=O), 94.26 (d, J = 4.9 Hz, C-1), 70.3 (C-3), 69.12 (d, J = 7.5 Hz, C-





m/z [M+Na]+ calcd for C12H18N3NaO11P: 434.0571, found: 434.0579. IR (neat) max: 2115, 
1743, 1218, 943 cm-1. 
Uridine 5’-(4-azido-4-deoxy-α-D-galactopyranosyl) diphosphate (99) 
 
114 (10.0 mg, 0.0243 mmol) was dissolved in anhydrous DMF (2 mL) and three 
spatula tips of activated powdered molecular sieves (4 Å) were added. After storage over 
activated molecular sieves for 1 h, phosphate ester 110 (17.1 mg, 0.0316 mmol, 
1.3 equiv) was added and the reaction mixture was stirred at rt overnight. The reaction 
mixture was subsequently filtered through a short bed of celite and the solvent was 
removed in vacuo. The residue were dissolved in water and washed with EtOAc. The 
aqueous phase was concentrated in vacuo, yielding the crude intermediate. The crude 
intermediate was dissolved in MeOH/H2O/NEt3 (7:3:1, 5.50 mL) and stirred at rt overnight. 
The solvents were removed in vacuo and the residue was taken up in 1.80 mL water. The 
resulting solution was subjected to ion exchange chromatography in two portions of 
0.9 mL each. Fractions that still contained impurities after ion exchange chromatography 
were subsequently subjected to a Carbograph C18 column, from which the product eluted 
with 10% MeCN in water. In total 2.10 mg (0.00355 mmol, 15%) of 99 were obtained. 
1H NMR (700 MHz, D2O) δ 7.96 (d, J = 8.1 Hz, 1H, uracil), 6.02 – 5.96 (m, 2H, uracil, H-1 
Rib), 5.60 (dd, J = 6.8, 4.0 Hz, 1H, H-1 Gal), 4.41 – 4.36 (m, 2H, H-2 Rib, H-3 Rib), 4.30 – 
4.23 (m, 3H, H-4 Rib, H-5 Gal, H-5a Rib), 4.23 – 4.17 (m, 2H, H-3 Gal, H-5b Rib), 4.13 (d, 
J = 2.3 Hz, 1H, H-4 Gal), 3.81 (d, J = 10.4 Hz, 1H, H-2 Gal), 3.77 (dd, J = 11.8, 6.9 Hz, 
1H, H-6a Gal), 3.72 (dd, J = 11.6, 5.5 Hz, 1H, H-6b Gal). 13C NMR (176 MHz, D2O) δ = 
168.9 (C=O), 154.5 (C=O), 144.3 (uracil), 105.3 (uracil), 98.2 (d, J = 6.3 Hz, C-1 Gal) , 
91.0 (C-1 Rib), 85.87 (d, J = 9.1 Hz, C-4 Rib), 76.4 (C-3 Rib), 72.9 (C-5 Gal), 72.4 (C-3 
Gal), 72.3 (C-2 Rib), 71.14 (d, J = 8.7 Hz, C-2 Gal), 67.58 (d, J = 5.5 Hz, C-5 Rib), 65.9 
(C-4 Gal), 63.5 (C-6 Gal) ppm. 31P NMR (243 MHz, D2O) δ = -11.3 (d, J = 20.7 Hz), -13.0 







Uridine 5’-(4-amino-4-deoxy-α-D-galactopyranosyl) diphosphate (100) 
 
The azido functionalized UDP-galactose 99 (0.380 mg, 0.643 µmol) was dissolved 
in 1.5 mL H2O and Pd/C (10 wt% on activated carbon, 2.00 mg) was added. The solution 
was stirred under H2 atmosphere for 30 min at rt before the catalyst was filtered off 
through a syringe filter. The solvent was removed using a lyophilizer, yielding 0.363 mg 
(0.643 µmol, quant.) of 100. 
1H NMR (600 MHz, D2O) δ = 7.95 (d, J = 8.0 Hz, 1H, uracil), 5.99 – 5.93 (m, 2H, uracil, H-
1 Rib), 5.68 – 5.64 (m, 1H, H-1 Gal), 4.35 (d, J = 8.5 Hz, 2H), 4.28 – 4.06 (m, 5H), 3.80 
(d, J = 5.2 Hz, 2H), 3.74 – 3.62 (m, 2H, H-6 Gal) ppm. ESI-HRMS: m/z [M-H]- calcd for 
C15H24N3O16P2: 564.0637, found: 564.0640.  
 
3.5.2 Synthesis of Natural and Functionalized UDP-Araf 
1,2,3,5-Tetra-O-acetyl-L-arabinofuranose (116) 
 
To a solution of 1,2,3–tri-O-acetyl-L-arabinofuranose (115)210 (0.100 g, 
0.362 mmol) in anhydrous pyridine (10 mL) under argon atmosphere, acetic anhydride 
(68.4 µL, 0.724 mmol, 2 equiv) was added. The reaction was stirred at rt until TLC 
indicated consumption of the starting material. The reaction was quenched by the addition 
of few a drops water and the solvent was removed in vacuo. The residue was subjected 
to silica gel column chromatography (hex/EtOAc = 2:1) to give 116 as an anomeric 
mixture (α/β 1:1) in the form of a colorless oil (0.109 g, 0.343 mmol, 95%). 
1H NMR (400 MHz, CDCl3) δ = 6.38 (d, J = 3.9 Hz, 1H), 6.19 (s, 1H), 5.37 – 5.34 (m, 3H), 
5.21 (d, J = 1.7 Hz, 1H), 5.07 – 5.03 (m, 1H), 4.43 – 4.33 (m, 2H), 4.29 – 4.18 (m, 3H), 
2.14 – 2.08 (7 s, 21H), 2.03 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ = 170.8, 170.7, 
170.4, 170.1, 169.9, 169.6, 169.4, 99.4, 93.8, 82.5, 80.6, 79.8, 75.3, 74.7, 64.7, 63.2, 







Dibenzyl 2,3,5-tri-O-acetyl--L-arabinofuranosyl phosphate (117)209 
 
To a solution of 116 (0.733 g, 2.31 mmol) in anhydrous DCM (10 mL) under argon 
atmosphere at 0 °C was added bromotrimethylsilane (6.07 mL, 4.60 mmol, 20 equiv) 
dropwise. After addition the solution was allowed to warm to rt and the reaction was 
stirred at rt overnight before the solvent and excess bromotrimethylsilane were removed 
in vacuo. The crude residue was taken up in anhydrous toluene (5 mL) under argon 
atmosphere and a solution of dibutyl phosphate (0.834 g 3.00 mmol, 1.3 equiv) and 
anhydrous triethylamine (0.964 mL, 6.93 mmol, 3 equiv) in anhydrous toluene (10 mL) 
was added dropwise at 0 °C. The solution was allowed to warm to rt and the reaction was 
stirred overnight at rt. The solvent was removed in vacuo and the crude residue was 
subjected to silica gel column chromatography (hex/EtOAc = 3:2 to 1:1) to afford 
compound 117 (0.260 g, 0.484 mmol, 21%) as the -anomer exclusively. 
1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.30 (m, 10H Ar), 6.02 (dd, J = 5.5, 4.3 Hz, 1H), 
5.44 – 5.37 (m, 1H), 5.24 (ddd, J = 7.4, 4.3, 2.0 Hz, 1H, H-2), 5.07 – 5.03 (m, 4H), 4.48 – 
4.40 (m, 1H), 4.21 (ddd, J = 6.8, 5.7, 3.7 Hz, 1H), 4.17 – 4.10 (m, 1H), 2.10 (s, 3H), 1.98 
(s, 3H), 1.95 (s, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ 170.7, 170.3, 170.2, 128.7, 
128.0, 97.88 (d, J = 5.1 Hz), 80.0, 75.98 (d, J = 7.0 Hz), 74.0, 69.6, 69.5, 69.5, 64.6, 20.9, 
20.8, 20.5 ppm. The analytical data is in agreement with literature data.209 
-L-arabinofuranosyl 1-phosphate (119)209 
 
To a solution of 117 (0.110 g, 0.205 mmol) in NEt3 (10 mL) was added Pd/C 
(10 wt% on activated carbon, 20.0 mg) and the mixture was stirred under hydrogen 
atmosphere for 2 h at rt. The catalyst was filtered off through a syringe filter and the 
solvent was removed in vacuo. The crude residue was dissolved in a mixture of 
MeOH/H2O (3:2, 3.50 mL) and NEt3 (0.500 mL) was added. The reaction was stirred at rt 
overnight. The solvents were removed in vacuo, yielding 119 as the 
monotriethylammonium salt in the form of a sticky oil (64.0 mg, 0.193 mmol, 94%). 
1H NMR (400 MHz, D2O) δ = 5.41 (dd, J = 5.3, 3.7 Hz, 1H), 4.07 – 4.02 (m, 2H), 3.85 – 
3.73 (m, 1H), 3.70 (dd, J = 12.6, 3.0 Hz, 1H), 3.60 – 3.55 (m, 1H), 3.10 (q, J = 7.3 Hz, 





83.1, 77.44 (d, J = 7.7 Hz), 74.0, 63.0, 47.4, 9.1 ppm. The analytical data is in agreement 
with literature data.209 
Uridine 5’-(-L-arabinofuranosyl) diphosphate (124) 
 
The triethylammonium salt of -L-arabinofuranosyl phosphate (119)209 (64.0 mg, 
0.193 mmol) was dried by co-evaporation with anhydrous pyridine (3 x 2 mL) before 
commercially available uridine 5′-monophosphomorpholidate 4-morpholine-N,N′-
dicyclohexylcarboxamidine salt (125) (0.305 g, 0.444 mmol, 2.3 equiv) was added and the 
mixture was again dried by co-evaporation with anhydrous pyridine (2 x 2 mL). The 
residue was left under high vacuum for 90 min before it was dissolved in anhydrous 
pyridine (2 mL) under argon atmosphere at rt. To the mixture was added a solution of 1H-
tetrazole in MeCN (1.33 mL of a 0.45 M solution, 0.598 mmol. 3.1 equiv) and the reaction 
was allowed to stir at rt for three days before the solvent was removed in vacuo. The 
crude product was taken up in water and subjected to HPLC purification using a semi-
preparative reversed-phase Hypercarb column. The product was eluted with 25% MeCN 
in aqueous ammonium acetate (0.05 M, pH 6.9), after running a gradient of aqueous 
ammonium acetate/MeCN. As the product still contained UMP as an impurity after semi-
preparative HPLC, the product was subjected to ion exchange chromatography, yielding 
0.730 mg (0.00136 mmol, 1%) of pure UDP--L-arabinofuranose. 
1H NMR (600 MHz, D2O) δ = 7.97 (d, J = 8.2 Hz, 1H, Uracil), 6.00 (d, J = 4.1 Hz, 1H, H-1 
Rib), 5.99 (d, J = 8.1 Hz, 1H, Uracil), 5.65 (dd, J = 5.6, 3.6 Hz, 1H, H-1 Ara), 4.40 – 4.38 
(m, 2H, H-2 Rib, H-3 Rib), 4.28 – 4.19 (m, 3H, H-4 Rib, H-5a Rib, H-5b Rib), 4.19 – 4.13 
(m, 2H, H-2 Ara, H-3 Ara), 3.96 – 3.89 (m, 1H, H-4 Ara), 3.81 (dd, J = 12.6, 3.1 Hz, 1H, H-
5a Ara), 3.71 (dd, J = 12.7, 6.1 Hz, 1H, H-5b Ara) ppm. 31P NMR (243 MHz, D2O) δ = -
11.5 (d, J = 21.1 Hz), -12.9 (d, J = 21.1 Hz). ESI-HRMS: m/z [M-H]- calcd for 









To a solution of 1,2,3–tri-O-acetyl-L-arabinofuranose (115)210 (0.584 g, 2.11 mmol) 
in anhydrous DCM under argon atmosphere were added anhydrous pyridine (1.50 mL, 
18.6 mmol 9 equiv) and tosyl chloride (0.605 g, 3.17 mmol, 1.5 equiv) and the reaction 
was stirred at rt overnight. The reaction was quenched by the addition of sat. aq. 
NaHCO3-solution and the resulting mixture was extracted with DCM. The combined 
organic layers were dried over MgSO4, filtrated and concentrated in vacuo. The crude 
product was subjected to silica gel column chromatography (hex/EA 3:1 to 1:1) to give an 
anomeric mixture (α/β = 1:1) of 120 as a colorless oil (0.636 g, 1.48 mmol, 70% yield). 
1H NMR (400 MHz, CDCl3) δ = 7.83 – 7.76 (m, 2H, Ar), 7.39 – 7.30 (m, 2H, Ar), 6.33 (d, J 
= 3.9 Hz, 1H, H-1(β)), 6.11 (s, 1H, H-1(α)), 5.34 – 5.28 (m, 2H, H-2(β), H-3(β)), 5.15 (d, J 
= 1.5 Hz, 1H, H-2(α)), 4.99 (dt, J = 4.3, 1.0 Hz, 1H, H-3(α)), 4.34 – 4.08 (m, 6H, H-4(α), H-
4(β), H-5(α), H-5(β), H-5a(α), H-5a(β)), 2.45 (d, J = 1.2 Hz, 6H, CH3(α), CH3(β)), 2.10 (s, 
3H), 2.10 (s, 3H, OAc), 2.09 (s, 3H, OAc), 2.08 (s, 3H, OAc), 2.07 (s, 3H, OAc), 2.05 (s, 
3H, OAc). The analytical data is in agreement with literature data for an anomeric mixture 
of the D-isomer.211 
1,2,3-Tri-O-acetyl-5-azido-5-deoxy-L-arabinofuranose (121) 
 
To a solution of 120 (0.444 g, 1.03 mmol) in anhydrous DMF under argon 
atmosphere was added sodium azide (0.267 g, 4.12 mmol, 4 equiv). The reaction was 
stirred at 70 °C overnight. The reaction was quenched by the addition of an excess of 
water and the reaction mixture was extracted with diethyl ether. The combined organic 
layers were dried over MgSO4, filtrated and concentrated in vacuo. The crude product 
was subjected to silica gel column chromatography (hex/EtOAc = 2:1) to give an anomeric 
mixture of 121 as a colorless oil (0.245 g, 0.813 mmol, 79% yield). 
1H NMR (400 MHz, CDCl3) δ = 6.40 (d, J = 4.1 Hz, 1H, H-1 ()), 6.22 (s, 1H, H-1 ()), 
5.41 – 5.33 (m, 2H, H-2 (),H-3 ()), 5.22 (dd, J = 1.4, 0.5 Hz, 1H, H-2 ()), 5.05 (ddd, J = 
4.6, 1.4, 0.8 Hz, 1H, H-3 ()), 4.29 (td, J = 4.6, 3.1 Hz, 1H, H-4 ()),4.15 – 4.11 (m, 1H, H-
4 ()), 3.69 (dd, J = 13.3, 3.2 Hz, 1H, H-5a ()), 3.61 (dd, J = 13.3, 3.6 Hz, 1H, H-5a ()), 
3.45 (ddd, J = 13.4, 5.5, 1.9 Hz, 2H, H-5b ()), 2.14, 2.13, 2.12 (s each, 3H each OAc 
()), 2.12, 2.10, 2.09 (s each, 3H each, OAc ()) ppm. The analytical data is in agreement 





Dibenzyl 2,3-di-O-acetyl-5-azido-5-deoxy--L-arabinofuranosyl phosphate (122) 
 
To a solution of 121 (0.670 g, 2.22 mmol) in anhydrous DCM (10 mL) under argon 
atmosphere at 0 °C was added bromotrimethylsilane (5.90 mL, 44.5 mmol, 20 equiv) 
dropwise. After addition the solution was allowed to warm to rt and the reaction was 
stirred at rt overnight before the solvent and excess bromotrimethylsilane were removed 
in vacuo. The crude residue was taken up in anhydrous toluene (10 mL) under argon 
atmosphere and a solution of dibutyl phosphate (0.678 g 2.44 mmol, 1.1 equiv) and 
anhydrous triethylamine (0.927 mL, 6.66 mmol, 3 equiv) in anhydrous toluene (2 mL) was 
added dropwise at 0 °C. The solution was allowed to warm up to rt and the reaction was 
stirred overnight at rt. The solvent was removed in vacuo and the crude residue was 
subjected to silica gel column chromatography (hex/EtOAc = 3:2 to 1:1) to exclusively 
afford the -isomer of compound 122 (0.107 g, 0.206 mmol, 9%).  
1H NMR (400 MHz, CDCl3) δ = 7.40 – 7.30 (m, 10H, Ar), 6.01 (dd, J = 5.5, 4.0 Hz, 1H, H-
1), 5.30 – 5.20 (m, 2H, H-2, H-3), 5.07 (d, J = 4.5 Hz, 2H, CH2Ph), 5.05 (d, J = 4.3 Hz, 2H, 
CH2Ph), 4.11 – 4.07 (m, 1H, H-4), 3.53 – 3.49 (m, 2H, H-5), 2.10 (s, 3H, OAc), 1.94 (s, 
3H, OAc). 13C NMR (101 MHz, CDCl3) δ = 170.5 (C=O), 170.1 (C=O), 135.57 (d, JC-P = 
7.2 Hz), 128.8, 128.8, 128.8, 128.7, 128.1 (12 C, Ar), 97.9 (d, JC-P = 5.2 Hz, C-1), 81.4 (C-
4), 75.8 (d, JC-P’ = 6.6 Hz, C-2), 74.9 (C-3), 69.67 (t, JC-P = 5.4 Hz, CH2Ph) 53.8 (C-5), 20.9 
(OAc), 20.5 (OAc) ppm. ESI-MS: m/z [M-Na]+ calcd for C23H26N3O9P: 542.1, found: 542.8  
Due to the low stability of 122 IR data and optical rotation could not be measured. 
5-Amino-5-deoxy--L-arabinofuranosyl 1-phosphate (123) 
 
To a solution of 122 (0.100 g, 0.193 mmol) in a mixture of MeOH/NEt3 (1:1, 4 mL) 
was added Pd/C (10 wt% on activated carbon, 50.0 mg) and the mixture was stirred 
under hydrogen atmosphere for 30 min at rt. The catalyst was filtered off through a 
syringe filter and the solvent was removed in vacuo. The crude residue was dissolved in a 
mixture of MeOH/H2O (3:2, 3.50 mL) and NEt3 (1.00 mL) was added. The reaction was 
stirred at rt overnight. The solvents were removed in vacuo, yielding the 
monotriethylammonium salt of 123 as a brownish sticky oil (0.0637 g, 0.193 mmol, quant). 
1H NMR (400 MHz, D2O) δ = 5.44 (dd, J = 5.2, 4.0 Hz, 1H), 4.11 – 3.98 (m, 3H, H-2, H-3, 





NEt3), 1.18 (t, J = 7.3 Hz, 9H, NEt3) ppm. 
13C NMR (101 MHz, D2O/MeOD) δ = 98.5 (d, J 
= 5.7 Hz, C-1), 79.7 (C-4), 78.6 (d, J = 7.8 Hz, C-.2), 76.8 (C-3), 48.1 (NEt3), 43.2 (C-5), 
9.7 (NEt3) ppm. ESI-HRMS: m/z [M-H]
- calcd for C5H12NO7P: 228.0279, found: 228.0289. 
Due to the low stability of 123 IR data and optical rotation could not be measured. 
Uridine 5’-(5-amino-5-deoxy--L-arabinofuranosyl) diphosphate (101) 
 
The triethylammonium salt of 5-amino-5-deoxy--L-arabinofuranosyl phosphate 
(123) (19.0 mg, 0.0576 mmol) was dried by co-evaporation with anhydrous pyridine (3 x 
2 mL) before commercially available uridine 5′-monophosphomorpholidate 4-morpholine-
N,N′-dicyclohexylcarboxamidine salt (125) (90.7 mg, 0.132 mmol, 2.3 equiv) was added 
and the mixture was dried by co-evaporation with anhydrous pyridine (2 x 2 mL). The 
residue was left under high vacuum for 90 min before it was dissolved in anhydrous 
pyridine (2 mL) under argon atmosphere at rt. To the mixture was added a solution of 1H-
tetrazole in MeCN (0.397 mL of a 0.45 M solution, 0.179 mmol. 3.1 equiv) and the 
reaction was allowed to stir at rt for three days before the solvent was removed in vacuo. 
The crude product was taken up in water and subjected to HPLC-purification using a 
semi-preparative reversed-phase Hypercarb column. The product was eluted with 25% 
MeCN in aqueous ammonium acetate (0.05 M, pH 6.8) running a gradient of aqueous 
ammonium acetate/MeCN. As the product was still contaminated with UMP after semi-
preparative HPLC, the product was subjected to IE chromatography (GE HiTrap Q XL 5 
mL column, from 100% 0.05 M NH4OAc buffer (pH 6.8) to 100% 0.5 M NH4OAc buffer 
(pH 6.8)) yielding 0.120 mg (0.00024 mmol, 0.4%) of 101. 
1H NMR (600 MHz, D2O) δ = 7.94 (d, J = 8.1 Hz, 1H, Uracil), 5.96 – 5.93 (m, 2H, H-1 Rib, 
Uracil), 5.65 (dd, J = 5.9, 3.2 Hz, 1H, H-1 Ara), 4.32 – 4.27 (m, 2H, H-2 Rib, H-3 Rib), 
4.23 – 4.17 (m, 2H,), 4.14 (d, J = 4.9 Hz, 2H), 4.10 – 4.08 (m, 1H), 4.04 (dd, J = 5.2, 2.7 
Hz, 1H), 3.37 – 3.24 (m, 2H, H-5a Ara, H-5b Ara) ppm. 31P NMR (243 MHz, D2O) δ = -
10.02 (d, J = 21.5 Hz), -11.40 (d, J = 21.2 Hz) ppm. ESI-HRMS: m/z [M-H]- calcd for 
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